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radiologists independently and blindly reviewed three image sets: 1) MDCT, 2) 
dynamic MRI (unenhanced and EOB-enhanced dynamic MR images), and 3) 
combined MRI (dynamic MRI + hepatobiliary phase images) using a five-point 
rating scale on a lesion-by-lesion basis. Receiver operating characteristics 
(ROC) analysis was performed, and sensitivity and specificity were calculated.
Results: The area under the ROC curve (Az) of dynamic MRI was equivalent to that 
of MDCT for both readers. For both readers, Az and sensitivity of combined MRI for 
smaller lesions (<1.5cm) were significantly higher than that of dynamic MRI and 
MDCT (P < 0.0166). The majority of false-negative nodules on dynamic MRI or MDCT 
(75% and 62%, respectively) were due to a lack of identified washout findings.
Conclusion: Hepatobiliary phase images can increase the value of EOB-
enhanced MRI in the diagnosis of early-stage HCC. The sensitivity and accuracy 
were significantly superior to MDCT for the diagnosis of lesions less than 1.5cm.
SS 1.04
Small  (l 20 mm) enhancing lesions seen only during the 
hepatic arterial phase: evaluation with gadoxetic acid 
(Gd-EOB_DTPA) enhanced MR imaging during the 
hepatobiliary phase
M.L. Mennini, R. Di Miscio, V.C. lombardo, S. Santinelli,  
C. Catalano, R. Passariello; Rome/IT
Purpose: To retrospectively assess whether gadoxetic acid (Gd-EOB-enhanced MR 
imaging during the hepatobiliary phase can improve the characterization of small 
() 20 mm) hepatic arterial phase-enhancing (HAPE) lesions that are occult during 
portal and equilibrium phases and at unenhanced T1- and T2-weighted MR images.
Material and Methods: This study was approved by the institutional review 
board and a waiver for informed consent was obtained. 150 patients who 
underwent Gd-EOB-DTPA-enhanced MR imaging at 3.0T (Discovery, General 
Electric) were evaluated with breath-hold T2-weighted images and volumetric 
three-dimensional Gd-EOB-DTPA-enhanced T1-weighted GRE MR images 
acquired in the arterial (25s), portal venous (60s), equilibrium (180s),and 
hepatobiliary phase (20min). Two readers retrospectively reviewed the MR 
images in consensus for small HAPE-only nodules. The final study group 
included 31 patients aged 23-82 years with a total of 47 HAPE-only lesions. 
Qualitative analysis of MR enhancement features during the hepatobiliary 
phase was related to pathology reports or imaging follow-up (at least 6 
months). Sensitivity, specificity and positive and negative predictive values 
with corresponding 95% confidence intervals (CIs) were determined.
Results: Of the 47 HAPE-only lesions, 34 (72%) were hepatocellular carcinoma 
(HCCs). The remaining 13 (28%) lesions were considered definite pseudolesions. 
The sensitivity and specificity of Gd-EOB-MR imaging during the hepatobiliary 
phase for depicting HCCs was 93% (31 of 33) and 85% (11 of 13), respectively. 
The positive and negative predictive values of gadoxetic acid MR imaging 
were 94% (31 of 33) and 85% (11 of 13), respectively.
Conclusion: Gadoxetic acid-enhanced MR imaging during the hepatobiliary 
phase has high specificity and sensitivity for the characterization of small 
HAPE-only lesions in cirrothic patients.
SS 1.05
The value of gadoxetic acid-enhanced hepatospecific 
phase MR imaging for characterization of hepatocellular 
nodules in the cirrhotic liver
R. Cianci, A. Filippone, F. Sabatino, V. Bianco, A. Tartaro, 
A.R. Cotroneo; Chieti/IT
Purpose: To retrospectively assess the value of adding hepatospecific phase 
images of gadoxetic acid-enhanced MR imaging to unenhanced and dynamic-
enhanced MR images for the characterization of dysplastic nodule (DN) and 
hepatocellular carcinoma (HCC) in cirrhotic livers.
Material and Methods: Thirty-four patients with 39 HCCs and 15 DNs were 
enrolled and all lesions were pathologically proved except for 16 HCCs. Patients 
underwent gadoxetic acid-enhanced MR examination, including dynamic and 
20 min hepatospecific phase imaging using a 1.5 Tesla system. Two radiologists 
independently reviewed two sets of MR images: set A, unenhanced and 
gadoxetic acid-enhanced dynamic images; set B, unenhanced and gadoxetic 
acid-enhanced dynamic images plus 20 min hepatospecific phase images. For 
each set and each observer, the diagnostic accuracy was compared using ROC 
analysis (Az). Sensitivity and specificity values were also calculated.
Results: For both observers, Az values for the diagnosis of HCC resulted to be 
higher with the addition of hepatospecific phase images, with a significant 
improvement for the less experienced observer (p = .045). Similarly, sensitivity 
values significantly increased with the addition of hepatospecific phase images 
for both observers (p = .044 for observer 1 and p = .025 for observer 2). No 
significant differences were observed for specificity values.
Conclusion: Adding the hepatospecific phase to unenhanced and dynamic 
gadoxetic acid-enhanced MR images helps to differentiate HCC from DN.
11:15 -12:45 Palagalileo
Scientific Session 1
HCC: diagnosis and treatment response 
(Liver 1)
SS 1.01
Low-voltage arterial phase scanning for the detection of 
hypervascular lesions of the liver
G.A. Zamboni, M.C. Ambrosetti, R. Pozzi Mucelli; Verona/IT
Purpose: To test a low-voltage protocol for arterial phase scanning in patients 
with hypervascular focal liver lesions (hFLL) to exploit the k-edge of iodine and 
reduce patient dose.
Material and Methods: We compared two groups of 20 patients with liver 
disease, who underwent multiphasic MDCT of the abdomen on a 64-row 
scanner. In the test group, the arterial phase was performed at 80 kVp and 370 
mAs, while in the control group it was performed with 120 kVp and automatic 
tube current modulation; all other scan parameters were kept constant. Scans 
were compared for quantitative imaging parameters (attenuation and standard 
deviation in the liver, aorta and in the largest hFLL) and for dose parameters 
(CTDI, DLP) using an unpaired t-test.
Results: Mean attenuation was significantly higher in the test group than in the 
control group for the aorta (512.12 ± 159.98 vs 277.80 ± 54.08HU), liver (77.47 
± 13.05 vs 59.01 ± 10.85HU) and hFLL (150.27 ± 33.35 vs 103.22 ± 19.56HU) 
(all: p < 0.0001). Radiation dose was significantly lower in the test group than 
in the control group (CTDI 6.64 ± 0 vs 12.12 ± 4.37mGy; DLP 212.61 ± 25.25 
vs 404.54 ± 137.16mGyxcm; p < 0.0001). Conspicuity of the hypervascular 
FLLs was significantly higher in the test group (72.71 ± 39.17 vs 44.21 ± 
16.42HU; p = 0.0112).
Conclusion: The use of 80 kVp arterial phase scanning for abdominal CT 
increases the conspicuity of hFLL may help in their identification and, at the 
same time, gives a significant lower dose to the patient.
SS 1.02
Comparison of gadoxetate disodium-enhanced MRI and 
triple-phase MDCT for the detection of small ()3 cm) 
hepatocellular carcinoma
Y.E. Kim, M. Kim, Y.E. Chung, M. Park, K.W. Kim; Seoul/KR
Purpose: To retrospectively compare the diagnostic accuracy of gadoxetate 
disodium-enhanced magnetic resonance imaging (EOB-MRI) and multidetector 
computed tomography (MDCT) for the detection of small hepatocellular 
carcinoma (HCC) in patients with chronic liver disease.
Material and Methods: Seventy-three patients (63 men, 10 women; mean 
age, 56 years; range, 30–72 years) suspected having small ()3cm) HCC 
underwent EOB-MRI and triple-phase MDCT within one month. Final diagnosis 
was confirmed surgically (n = 35) or clinically (n = 38). Two radiologists 
independently and randomly reviewed the MDCT and EOB-MRI. The diagnostic 
accuracy was compared using areas (Az) under alternative free response 
receiver operating characteristics (ROC) analysis. Sensitivity and positive 
predictive value (PPV) were compared.
Results: Ninety-five HCCs were confirmed in 61 patients. The Az values on 
EOB-MRI (0.94 for both readers) were significantly higher than those on MDCT 
(0.84 and 0.80 for reader 1 and 2, respectively) for both observers (p < .002). 
Sensitivities were significantly higher with EOB-MRI (90.5% and 89.5%) than 
with MDCT (74.7% and 35.8%) for both observers (p <.001). PPV was 
significantly higher with EOB-MRI than with MDCT for reader 1 (95.6% vs 
61.2%, p < .001), but was comparable between EOB-MRI and MDCT for 
reader 2 (98.8% vs 100%, p = 1.00).
Conclusion: EOB-MRI allows higher accuracy than MDCT for the detection of 
small HCC in patients with chronic liver disease.
SS 1.03
Additional value of gadoxetic acid-DTPA-enhanced 
hepatobiliary phase MR imaging in the diagnosis of 
early-stage hepatocellular carcinoma: comparison with 
dynamic triple-phase multidetector CT imaging
H. Haradome, K. Al Manea, T. Bonaventure, L. Grazioli; 
Brescia/IT
Purpose: To assess the value of hepatobiliary phase gadoxetic acid (EOB)-
enhanced MRI for the diagnosis of early-stage hepatocellular carcinoma (HCC) 
()3cm) compared to triple-phase dynamic multidetector CT (MDCT).
Material and Methods: 52 patients with 60 pathologically proven HCCs 
underwent both EOB-enhanced MRI and triple-phase dynamic MDCT. Two 
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contrast during the dynamic phase was noted. 28 patients developed 
recurrence of HCC. These patients had significant more often microvascular 
invasion and a moderate or poor differentiated tumour. Moderate and poor 
differentiated HCC showed more wash-out compared to well differentiated 
HCC (p < 0.001). HCC with microvascular invasion showed significant more 
wash-out (p = 0.032). The shape of the time intensity curve (TIC) did not differ 
significantly between the three differentiation grades, presence of microvascular 
invasion, nor predicted recurrence.
Conclusion: Differentiation grade and microvascular invasion are predictors of 
long-term survival of HCC. Moderate to poor differentiated HCC and 
microvascular invasion are significantly associated with the presence of wash-
out demonstrated on dynamic contrast-enhanced MRI.
SS 1.09
Three-dimensional contrast-enhanced ultrasound versus 
conventional two-dimensional contrast-enhanced 
ultrasound in the evaluation of therapeutic response of 
hepatocellular carcinoma after local therapies
T.V. Bartolotta, A. Taibbi, G. Brancatelli, L. Tortorici, M. Galia, 
G. Lo Re, M. Midiri; Palermo/IT
Purpose: To investigate diagnostic performance of three-dimensional contrast-
enhanced ultrasound (3D-CEUS) compared with 2D-CEUS in the assessment of 
therapeutic response of hepatocellular carcinoma (HCC) treated with local therapies.
Material and Methods: Twenty patients (mean age: 65.6 years) with 20 
HCCs (mean size: 2.8 cm) treated by radiofrequency ablation (n = 8), 
transarterial chemoembolization (n = 7), combined treatments (n = 3), 
alcoholization (n = 1) and wedge resection (n = 1) underwent one-month 
follow-up by 2D-CEUS and 3D-CEUS. Two readers reviewed by consensus 
both examinations considering in the arterial phase: 1) complete response 
(CR): the absence of enhancing portion within or at the margin of the treated 
zone and 2) residual tumour (RT): a portion of treated HCC showing persistent 
hypervascularity. MRI (n = 15) and CT (n = 5) provided final diagnosis. The 
influence of both methods on clinical outcome was evaluated on a 3-point 
scale. Intermodality agreement was calculated too.
Results: Either 2D-CEUS or 3D-CEUS correctly identified RT in 11/20 (55%) cases 
(mean size: 3.3 cm) and CR in the remaining eight (40%) (mean size: 2.3 cm). 
3D-CEUS did not depict RT in one (5%) (size: 2 cm) deeply located lesion. 
Intermodality agreement was excellent (k = 95%) with no statistically significant 
differences in diagnostic performance and influence on clinical outcome (p < 0.001).
Conclusion: 3D-CEUS showed similar diagnostic value when compared with 
conventional 2D-CEUS in the detection of RT in HCCs treated with local therapies.
SS 1.10
Tumor enhancement at contrast-enhanced CT and 
Gd-enhanced MRI for the assessment of treatment 
response of hepatocellular carcinoma (HCC) after sorafenib
A. Furlan1, G. Salvaggio2, G. Cabibbo2, L. Giannitrapani2,  
D. Marin3, F. Agnello2, R. Lagalla2, G. Brancatelli2; 
1Pittsburgh, PA/US, 2Palermo/IT, 3Durham, NC/US
Purpose: To investigate whether arterial enhancement of advanced HCC 
during pre-treatment and follow-up contrast-enhanced CT (CECT) or Gd-
enhanced MRI (Gd-MRI) can be used to predict tumor response to sorafenib.
Material and Methods: Seventeen patients (12M, 5F; mean age: 69 years) 
receiving sorafenib for inoperable HCC between 2007 and 2010 were included. 
Median interval time between pre-treatment and follow-up CECT or Gd-MRI was 
160 days. Tumor arterial enhancement was measured at baseline and follow-up: 
(tumor attenuation/intensity on arterial phase – tumor attenuation/intensity on 
unenhanced images)/(tumor attenuation/intensity on unenhanced images) x 
100. Response was assessed according to modified RECIST (mRECIST) criteria 
(one-dimensional measurement of viable tumor). Mann-Whitney-U test was 
used to assess significance of difference of tumor enhancement at baseline, 
change in tumor enhancement at follow-up, and tumor response.
Results: Three (18%) patients had progressive disease (PD), 3 (18%) partial 
response (PR), and 11 (64%) stable disease (SD) according to mRECIST. Mean 
tumor enhancement at baseline was significantly higher in PD (281.6% ± 
166.1) compared to SD (112.8% ± 50.7) or PR (141.4% ± 90.1) (p = 0.007). In 
patients with PR, the decrease in mean tumor enhancement at follow-up 
(-76.1% ± 13.6) was significantly larger than in patients with SD (8.8% ± 148.4) 
or PD (-32.9% ± 7.4) (p = 0.013).
Conclusion: Higher tumor enhancement at baseline CECT or Gd-MRI can 
predict response after treatment with sorafenib in patients with advanced 
HCC. Larger decrease in tumor enhancement at follow-up correlates with 
response according to mRECIST criteria.
SS 1.06
Accuracy of diffusion-weighted MR imaging for 
hepatocellular carcinoma compared with liver explantation
A. Hardie; Charleston, SC/US
Purpose: The goal of this study was to assess the diagnostic accuracy of 
diffusion-weighted (DW) MRI for HCC using liver explant pathology from 
patients who had undergone liver transplantation.
Material and Methods: 43 patients who had undergone liver transplantation 
and had had respiratory-triggered, single-shot, echo-planar DW-MRI were 
evaluated by 2 independent, blinded observers for HCC and comparison made 
with explanted specimens. Apparent diffusion coefficient (ADC) values for 
each visualized lesion were measured.
Results: On pathology, 30 HCC (mean largest diameter 2.2 cm) were identified in 
21 patients and 17 benign lesions. Based on qualitative assessment, sensitivity and 
specificity for reader 1 was 60% and 89% and for reader 2 50% and 100% (Kappa 
0.64, “substantial” agreement). For all visible liver lesions, ROC curve analysis of 
the ADC values was performed to assess the ability to characterize lesions based 
on a cut-off value of 1.5 x 10-3 mm2/s. For reader 1, sensitivity for identifying HCC 
was 100% and specificity 90%, with Az = 0.972. For reader 2, sensitivity of 
identifying HCC was 100% and specificity was also 100%, with Az = 1.
Conclusion: DW-MRI had only a moderate sensitivity for identifying HCC in a 
cirrhotic population and thus is not recommended as a stand alone sequence. 
However, the high specificity of DW-MRI for HCC in cirrhotic patients suggests 
it likely has value as part of a routine liver MRI evaluation.
SS 1.07
Enhancement pattern of hepatocellular carcinoma 
(HCC) at contrast-enhanced US, MDCT, and MRI: 
intermodality agreement and comparison of diagnostic 
sensitivity between 2005 and 2010 American Association 
for the Study of Liver Diseases Guidelines
A. Furlan1, D. Marin2, P. Cabassa3, F. Agnello4, A. Taibbi4,  
E. Brunelli3, M. Midiri4, G. Brancatelli4; 1Pittsburgh, PA/US, 
2Durham, NC/US, 3Brescia/IT, 4Palermo/IT
Purpose: To evaluate agreement between CEUS, MDCT, and MRI for the 
assessment of enhancement pattern of HCC; and to compare sensitivity for 
the diagnosis of HCC between 2005 and 2010 AASLD guidelines.
Material and Methods: We prospectively included (Jan-08 to Dec-09) cirrhotic 
patients with newly diagnosed 10-20 mm HCC imaged at two contrast-
enhanced imaging techniques among CEUS, MDCT, and MRI. Images were 
reviewed by two radiologists to assess enhancement pattern. Intermodality 
agreement was determined calculating percentage of cases with concordant 
findings and Cohen coefficient (k). McNemar’s test was used to compare 
sensitivity between 2005 and 2010 AASLD guidelines.
Results: Population included 91 patients (69M; 22F; mean age 68 years) with 
96 HCCs (15.2 ± 3.8 mm). Lesions were studied with a combination of CEUS 
and MDCT (n = 59), CEUS and MRI (n = 26), or MDCT and MRI (n = 11). 
Intermodality agreement for assessment of tumor enhancement pattern was 
67% (k = 0.294, p = 0.001). Typical enhancement pattern (hypervascularity and 
washout) was detected coincidentally at two imaging modalities in 50 (52%) 
HCCs. Sensitivity increased significantly using 2010 AASLD criteria compared 
to 2005 AASLD criteria (84% vs. 52%, p < 0.001).
Conclusion: Typical tumor enhancement pattern was detected coincidentally at 
two contrast-enhanced imaging techniques in 52% of cases. Sensitivity for the 
diagnosis of HCC increased significantly to 84% when the visualization of typical 
enhancement pattern was required in one imaging modality (AASLD 2010).
SS 1.08
Long-term survival of HCC predicted by dynamic 
contrast-enhanced MRI
C.D.M. Witjes, F.E.J.A. Willemssen, J. Verheij, S.J. van der Veer, 
B.E. Hansen, C. Verhoef, R.A. de Man, J.N.M. Ijzermans; 
Rotterdam/NL
Purpose: Differentiation grade and presence of microvascular invasion 
predicts long-term survival of HCC after surgery. We examined whether pre-
operative MRI characteristics can predict HCC differentiation grade and 
presence of microvascular invasion.
Material and Methods: All histological slides of the resected specimen of HCC 
patients and the pre-operative MRI were prospectively analysed. Clinical, pathological 
and imaging findings were evaluated in univariate and multivariate analyses.
Results: Between January 2000 and December 2008, 87 patients with 104 
HCCs were detected. 55 lesions (53%) showed microvascular invasion, 15 
lesions (14%) were well differentiated, 50 lesions (48%) moderate differentiated 














readers blindly reviewed all MR images for the presence of the liver-vessel 
cancellation sign. Cross-reference of patients with biopsy-proven steatosis 
and MRI within one month was performed (n = 54, 25 males, 29 females; 
mean age: 41.0 ± 18.9), with a population of 6 patients with UHLFC (1 male, 
5 females, 15.5 ± 11.2). Performance diagnostic tests, including sensitivity 
and specificity were performed.
Results: Liver vessel cancellation sign was present in all patients with UHLFC 
but in none of the remaining patients. Calculated sensitivity and specificity for 
the detection of UHLFC with this sign were 100% (95% CI: 69.1-100%) and 
100% (95% CI: 98.4-100%), respectively.
Conclusion: The presence of phase cancellation artifact around intra-hepatic 
vessels is a feature of UHLFC.
SS 2.04
The influence of lipid droplets on MRI diffusion 
parameters: results in phantoms and patients with 
liver steatosis
H.S. Leitão1, S. Doblas2, P. Garteiser2, G. D’Assignies2,  
J. Daire2, V. Vilgrain2, R. Sinkus2, B.E. Van Beers2;  
1Coimbra/PT, 2Clichy/FR
Purpose: To assess if lipid droplets in lipid-based phantoms and patients with 
liver steatosis influence the diffusion parameters measured with diffusion-
weighted MR imaging (DWI).
Material and Methods: Lipid-based phantoms with different concentrations 
of fat, and thirty-three patients with or without liver steatosis were evaluated 
with DWI. All patients had previous liver biopsy. Multi-b, free-breathing DWI 
images were obtained at 1.5T with a spin-echo EPI sequence (TR/TE = 305/56 
ms, 3 transverse slices, 4mm slice thickness, b = 0, 10, 20, 30, 40, 50, 75, 100, 
150, 300 and 500 s/mm2, scan duration of 3 min 30s). Measurements of 
perfusion fraction (DCfast), pure diffusion fraction (DCslow), pure diffusion 
coefficient (ADCslow) and conventional ADC (ADCconv) were blindly performed 
by one observer for each DWI acquisition.
Results: In the phantom evaluation, we observed a strong correlation between 
ADCconv and the lipid fraction (p < 0.0001, r = -0.972). Patients with steatosis 
had significantly lower ADCslow than non-steatotic patients (with steatosis: 
ADCslow 0.959 x 10-3 mm2/s; without steatosis: 1.101 x 10-3 mm2/s; p = 0.024).
Conclusion: Lipid droplets restrict the apparent diffusion in lipid-based 
phantoms and in patients with liver steatosis.
SS 2.05
Fat-fibrosis correlation with acoustic radiation force 
impulse: are larger patients prone to high variability in 
elastography readings?
M. Jagtiani Sangwaiya, D. Sherman, P. Bassett, P. Shorvon; 
London/UK
Purpose: Experience with ultrasound elastography to date has indicated that 
obesity limits the usefulness of the technique. The aim of this study was to determine 
if patients with larger amounts of subcutaneous fat on ultrasound (and thus, large 
body habitus) are more prone to variable elastography scores with the more recent 
introduction of acoustic radiation force impulse (ARFI) ultrasonography.
Material and Methods: Sixty-four consecutive patients scanned for chronic liver 
disease from January 2010 through July 2010 by ARFI (24 females:40 males, 
mean age 49 years, age range 22-81 years) were identified retrospectively. For 
each patient, the age, gender, mean ARFI fibrosis score and standard deviation 
and subcutaneous fat depth were recorded. Statistical correlation tests were 
performed to assess correlation (if any) between the variability of reading with the 
depth of the patient’s subcutaneous fat and also the depth of measurement.
Results: Correlation between the mean ARFI score and subcutaneous fat is 
0.001. The r value for correlation between the standard deviation of ARFI score 
and subcutaneous fat was 0.13, while the r value for correlation of depth of 
measurement and standard deviation of ARFI was 0.1. However, the depth of 
measurement and subcutaneous fat depth were correlated by a r value of 0.55.
Conclusion: No correlation was identified between the variation of 
elastography score (standard deviation) and the subcutaneous fat depth 
while measuring liver stiffness by ARFI.
11:15 -12:45 Sala Perla
Scientific Session 2
Diffuse liver disease (Liver 2)
SS 2.01
Liver iron concentration quantification by MRI: are 
recommended protocols accurate enough for clinical 
practice?
J.M. Alústiza1, A. Castiella2, J.I. Emparanza1, E.M. Zapata,2, 
A.B. Costero3, M.I. Díez3; 1San Sebastián/ES, 2Mendaro/ES, 
3Alcala de Henares/ES
Purpose: To assess the quantification of liver iron concentration (LIC) by MRI 
using the Rennes University (URennes) algorithm.
Material and Methods: In 1999-2006 the LIC calculated with URennes model 
in 171 patients was compared to the LIC values obtained by liver biopsy.
Results: According to the biopsy, 107 patients had no overload (<37 µmol 
Fe/g), 38 had moderate overload (37-79 µmol Fe/g), and 26 had 
hemochromatosis (>79 µmol Fe/g). There is a correlation between the LIC 
estimated with MRI and the measurement obtained with a biopsy (r = 0.86). 
MRI correctly classified 105 patients in the various levels of LIC. Diagnostic 
accuracy is 61.4%, with a tendency to overestimate: 43% of patients with no 
overload were diagnosed as overloaded, and 44.7% of patients with moderate 
overload were diagnosed as having high overload. The sensitivity of the 
URennes method for high overload is 92.3%, and the specificity for absence 
of overload is 57.0%. The MRI estimated values >170 µmol Fe/g revealed a 
PPV for hemochromatosis of 100% (n = 18); concentrations <60 µmol Fe/g 
had a NPV of 100% for hemochromatosis (n = 101). The 44 patients with 
intermediate values remain in uncertainty.
Conclusion: The assessment of LIC with URennes is useful in 74.3% of the patients 
included in to rule or to identify patients with high iron overload. The method has a 
tendency to overestimate overload, which limits its diagnostic performance.
SS 2.02
Diffusion-weighted imaging for quantification of hepatic 
iron deposition in patients with thalassemia major: 
comparison with multi-echo T2*-weighted imaging
G. Restaino1, M. Occhionero1, S. Roiati2, A. Caulo2,  
M. Missere1, A. Pepe3, G. Sallustio1; 1Campobasso/IT, 
2Rome/IT, 3Pisa/IT
Purpose: Multi-echo MRI GRE sequence has been fully established in clinical 
practice for liver iron overload assessment in severe conditions like 
hemochromatosis and thalassemia major.  Diffusion weighted imaging (DWI) is 
very sensitive to susceptivity effects from iron deposits.  Purpose of the study 
is to determine the diagnostic performance of DWI for hepatic iron quantification 
in patients with thalassemia major.
Material and Methods: 53 patients with thalassemia major and 20 healthy 
volunteers underwent liver MRI with 1.5T scanner. Liver T2* was assessed with 
a multi-echo GRE sequence. ADC values were measured in the same hepatic 
region with EPI-DWI sequence with 2 different b-values (600 and 1000). 
Subjects were classified, according to liver T2*, into 4 groups: (I)no iron 
overload, (II)borderline, (III)slight, and (IV)moderate/severe overload. ADC 
values were compared in the groups with ANOVA with Dunnett’s adjustment.
Results: All volunteers resulted in iron burden group I; amongst the patients, 9 
were in group I, 24 in group II, 8 in group III, and 12 in group IV. In both DWI 
acquisitions it was impossible to differentiate the group I from II and the group 
III from IV because of overlapping of ADC values. Conversely, there was no 
overlap between ADC values after grouping I-II groups and III-IV groups.
Conclusion: DWI with b = 600 and b = 1000 had excellent performance for 
differentiating subjects with absent or borderline iron overload from subjects 
with slight to severe iron overload.
SS 2.03
Liver vessel cancellation artifact on in-phase and out-of-
phase MRI imaging: a sign of ultra-high liver fat content
V. Heredia, M. Ramalho, R.O. Campos, B. Dale, R. Azevedo, 
J. Woosley, R. Semelka; Chapel Hill/US
Purpose: To describe a new MRI sign on in-phase and out-of-phase gradient-
echo sequences related to ultra-high liver fat content (UHLFC) (>90%) by 
qualitative histology, the liver-vessel cancellation artifact.
Material and Methods: Institutional review board approval was obtained 
for this retrospective HIPAA compliant study with waived informed consent. 
Patients with liver steatosis were searched on MRI (n = 195) and pathology 
(n = 116) databases between January 1, 2008 and June 20, 2010. Two 
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SS 2.09
Pattern analysis of spontaneous volume changes of 
well-compensated cirrhotic liver: CT volumetry 
evaluation with laboratory correlations
M.J. Park, Y. Kim, H. Kim, S.J. Lee, H.K. Lim; Seoul/KR
Purpose: To elucidate the pattern of spontaneous parenchymal volume 
changes of well-compensated cirrhotic livers using CT volumetry and to 
evaluate which liver function test significantly reflects such changes.
Material and Methods: Twenty patients (M:F = 16:4, mean age 54.1) with 
Child-Pugh class A, biopsy-confirmed liver cirrhosis who underwent long-term 
MDCT follow-up (>4 years and >3 times/year) were retrospectively enrolled. 
We performed 340 CT volumetric measurements of hepatic parenchyma 
(excluding IVC and hepatic vessels >5mm) using semi-automatic segmentation 
method and analyzed their patterns. We also investigated correlations between 
volume changes and liver function tests (within 3 days of CT) by performing the 
analysis using mixed model to consider random effects between subjects.
Results: CT follow-up period was 59.7 ± 5.0 (49.7-68.1) months with 3.7 ± 0.6 
(1.6-5.3) months intervals. Hepatic parenchymal volume measured from all CTs 
was 1208.0 ± 213.0 mL. All livers showed undulating patterns of volume 
change (cycle 13.2 ± 4.6 months; maximum amplitude 240.5 ± 94.7mL [19.9 ± 
7.2% of mean volume]). At the end of evaluation period, liver volume decreased 
in 40% (8/20, -61.2 ± 55.3 mL from baseline), however increased in 60% 
(12/20, 145.2 ± 125.5 mL). Among liver function tests, only serum total bilirubin 
(p = 0.003) revealed to be inversely correlated with liver volume changes.
Conclusion: Volume of well-compensated cirrhotic liver undulates with a cycle 
of approximately one year. Liver volume does not always decrease over a long-
term follow-up. Among liver function tests, only serum total bilirubin reflected 
such undulating volume changes significantly.
SS 2.10
MR imaging in patients with extrahepatic biliary atresia 
and Kasai hepatoportoenterostomy: a prospective 
cohort study
F.E.J.A. Willemssen1, R. Reinhard2, I. Pieters2, R. Houwen3, 
R.A. de Man1; 1Rotterdam/NL, 2Amsterdam/NL, 3Utrecht/NL
Purpose: Extrahepatic biliary atresia is characterized by complete fibrotic 
obstruction of the extrahepatic bile ducts. Kasai hepatoportoenterostomy 
(HPE) is the initial treatment of choice. The long-term morbidity of patients 
without liver transplantation is yet unknown. The aim of our study was to 
evaluate the extend of hepatic changes using MR imaging.
Material and Methods: Between 1977 and 1986, HPE was performed in 71 
children nationwide, of which 28 patients were alive in 2006. Sixteen patients 
(22.5%) did not undergo liver transplantation. These patients were contacted 
for participation, and 8 patients (5 females, 3 males) consented. Clinical 
analysis including serum blood samples and dynamic contrast-enhanced 
MR imaging were performed.
Results: Mean age was 21.8 years (20-24 years). All patients had elevated liver 
enzymes. MRI demonstrated extensive macronodular liver cirrhosis in all 
patients, with severe portal hypertension in 7 patients. Intrahepatic bile duct 
dilation was noted in 4 patients. In one patient a large focal lesion (10.2 cm) 
was detected, with imaging characteristics consistent with HCC. This patient 
was successfully treated by liver transplantation.
Conclusion: MR imaging is the imaging modality of choice in the evaluation of 
patients with Kasai hepatoportoenterostomy, since the spectrum of hepatic 
changes consists of extensive cirrhotic changes including portal hypertension, 
intrahepatic bile duct dilation and hepatocarcinogenesis.
SS 2.06
Cross-validation of MR elastography and ultrasound 
transient elastography in liver stiffness measurement
U. Motosugi1, T. Ichikawa2, H. Sou2, K. Sano2, A. Muhi2,  
F. Amemiya1, N. Enomoto1, T. Araki2; 1Yamanashi/JP, 2Chuo/JP
Purpose: To evaluate individual differences in liver stiffness measurement 
using both magnetic resonance elastography (MRE) and ultrasound transient 
elastography (UTE) in patients with chronic liver disease.
Material and Methods: This study included 80 patients with chronic liver disease 
who underwent both UTE and MRE. MRE and UTE were performed using a 
pneumatic driver (60 Hz) and an ultrasound probe with a vibrator (50 Hz), 
respectively. Liver stiffness data measured using the 2 techniques (µUTE and µMRE) 
were compared with respect to shear modulus. The patients were subdivided into 
4 quartiles on the basis of average of the µUTE and µMRE values for each patient.
Results: The analysis of the 4 quartile groups revealed that µUTE was significantly 
higher than µMRE in the 2 most stiff liver groups: µUTE vs. µMRE, 7.5 (1.2) vs. 6.0 
(0.72) kPa for the group with [µUTE + µMRE]/2 of 5.6 –8.0 kPa; 15.1(4.2) vs. 6.7 (1.4) 
kPa for the group with >8.0 kPa. However, in the least stiff liver group (i.e., the 
group with [µUTE + µMRE]/2 < 3.2 kPa), µUTE was significantly lower than µMRE.
Conclusion: The shear modulus measured by UTE and MRE are not 
equivalent, especially in patients with stiff livers.
SS 2.07
Elastography immediately prior to biopsy: comparison 
of acoustic radiation force impulse scores with histology
M. Jagtiani Sangwaiya, D. Sherman, P. Bassett, P. Shorvon; 
London/UK
Purpose: Studies comparing elastography with liver biopsy often use data not acquired 
at the same time or from the same liver site. The aim of this study was to compare 
acoustic radiation force impulse (ARFI) scores in patients with chronic liver disease and 
concomitantly acquired biopsy specimen scores from the same liver position.
Material and Methods: As part of an ongoing study, patients (n=32; F:M 
11:21) who underwent ultrasound-guided liver biopsy for chronic liver diseases, 
performed by a consultant radiologist with a specialist interest in liver imaging, 
were assessed. All patients underwent ARFI scoring immediately prior to 
biopsy in the same anatomical region. All histopathologic reports were queried 
for pathological scoring of the acquired specimen. Any correlation between 
ultrasound and pathology scores was evaluated.
Results: Data for 24 (F:M 8:16, mean age 47 ± 12 years) patients were available 
at the time of submission of this abstract. The mean elastography score was 2 
± 0.8. Mean depth of readings was 3.7 ± 0.75 cm and the mean subcutaneous 
fat depth was 1.9 ± 0.55 cm. The r value for correlation between pathology 
(ISHAK) and ARFI score was 0.37.
Conclusion: A weak correlation between the pathology and ARFI scores was 
calculated. Ultrasound may be used as an adjunct to histopathology and serum 
investigations. Histopathology as a gold standard should be used with caution. A 
larger study is required to compare ARFI results with same sitting biopsy results.
SS 2.08
Are T2*, MR elastography and 31P MR spectra surrogate 
markers for liver fibrosis staging in hepatitis C infection?
E.M. Godfrey1, N.H. Peters2, R.J. Black1, A.N. Priest1,  
I. Joubert1, A.S. Krishnan1, G.J. Alexander1, M.E. Allison1,  
S. Davies1, N.M. Griffin1, W. Gelson1, D.J. Lomas1; 
1Cambridge/UK, 2Utrecht/NL
Purpose: To assess whether hepatic T2* measurements, MR elastography 
stiffness and 31P spectra correlate with fibrosis stage determined on 
histopathological analysis of liver biopsy samples and can therefore be used 
as non-invasive methods for liver fibrosis staging.
Material and Methods: Twenty-six patients underwent an MRI examination 
(including multi-echo gradient echo, MR elastography and 31P MR spectroscopy 
sequences) and liver biopsy on the same day. An experienced liver pathologist 
provided fibrosis staging using the Ishak fibrosis score (0–6). The T2* measurements 
of the liver, MR elastography stiffness data and the 31P spectra were plotted versus 
the ISHAK fibrosis stage in scatter plots from which r2 values were calculated.
Results: Histopathological analysis of the biopsy samples showed the following 
results: ISHAK stage 0: 3 patients, stage 1: 3 patients, stage 2: 8 patients, stage 
3: 7 patients, stage 4: 2 patients, stage 5: 2 patients and stage 6: 1 patient. We 
found a good correlation between MR elastography stiffness and fibrosis stage 
(r2: 0.67); no apparent correlation was found between the T2* (r2: 0.04) or 31P 
spectra (PME/PDE ratio) (r2 < 0.001) and the fibrosis stage.
Conclusion: Our results show that liver stiffness measured by MR 
elastography is the most promising non-invasive marker of liver fibrosis in 















between ADC values and CEA levels and tumor-to-fascia distance at primary 
staging was investigated. Differences between the mean tumor ADCs of the 
following pre-treatment groups were tested: CEA <5mg/mL vs. *5mg/mL and 
cT1-2 vs. cT3-4; cN0 vs. cN+; CRM-free vs. CRM-invaded (as determined on 
primary staging MRI). Differences in tumor ADCs of the following histological 
subgroups were also investigated: lymphovascular invasion (LVI) absent vs. LVI 
present; differentiation grade (DG).
Results: Pearson coefficient (r) was -0.191 (p = 0.208) and 0.374 (p = 0.019) 
for the correlation between pre-treatment ADC values and CEA levels and 
tumor-to-fascia distance, respectively. Mean tumor ADCs were significantly 
different between cN0 vs. cN+ (p = 0.011), CRM-free vs. CRM-invaded (p = 
0.013) and DG (p = 0.025).
Conclusion: A profile of higher tumoral aggressiveness was associated with lower 
ADC values. Significant correlations were found between ADC and CRM status, 
tumor-to-fascia distance, N-stage and histological differentiation grade. ADC has 
the potential to become a non-invasive marker of rectal cancer aggressiveness.
SS 3.04
Changes in tumor oxygenation in primary rectal cancer 
using intrinsic susceptibility weighted-MRI
V. Goh1, N.J. Taylor2, A. Khan1, I. Simcock1, J. Stirling2,  
R. Glynne-Jones2, A. Padhani1; 1Northwood/UK, 2Middlesex/UK
Purpose: Intrinsic susceptibility weighted (ISW)-MRI informs on the hypoxic 
blood volume and may be used to assess tumor oxygenation alterations 
induced by treatment. The aim was to assess changes in R2* with 
chemoradiation in rectal cancer.
Material and Methods: Following IRB approval, 10 prospective patients with 
rectal cancer underwent multiecho ISW-MRI at 1.5-tesla (Avanto, Siemens) 
before and after chemoradiation: TR 100ms, TE 4.76 to 61.93ms. NEX2, 
FOV260, matrix256, 6 slices, SW 5mm. R2* values were derived by ROI 
analysis using proprietary software (ICR, London, UK). Signal changes on ISW-
MR images were used to calculate intrinsic T2* relaxivity. R2* values were 
calculated on a pixel-by-pixel basis from a straight line fitted to a plot of signal 
intensity against TE using a least squares approach; the gradient is -R2*. 
Voxels with either negative or zero values were excluded. R2* values were 
compared using t-test; significance at 5%.
Results: Mean (SD) tumor R2* was 26.17 (5.36) sec-1 before and 23.37 (3.31) 
sec-1 immediately after chemoradiation, a mean reduction of 12.6% (p = 0.07), 
indicating a reduction in hypoxic blood volume with treatment, unlike the 
increases seen with chemotherapy. In 4 patients there was a 25% or greater 
reduction in R2*. 1 patient had a 15% increase in R2*, not related to artefact.
Conclusion: ISW-MRI demonstrates a decrease in R2* with chemoradiation. This 
may reflect improvement in tumor oxygenation and/or oedema following treatment.
SS 3.05
Dynamic contrast-enhanced mr evaluation of rectal 
cancer before, during and after neoadjuvant treatment
R. DelVescovo, V. Di Paola, S. Battisti, F. D’ Agostino,  
I. Sansoni, R.F. Grasso, B. Beomonte Zobel; Rome/IT
Purpose: To identify the effects of chemoradiation therapy on tumour vascularization 
performing dynamic contrast-enhanced magnetic resonance (D-CE-MR).
Material and Methods: We enrolled 18 patients (pts) with locally advanced 
rectal cancer. For each patient D-CE-MR was obtained before, during and after 
the neoadjuvant treatment by 1.5 T system. Computer-aided quantitative 
analysis was performed by a system developed in MATLAB for the contrast 
enhancement analysis. Basing on MR findings pts were divided into two 
groups: pts who underwent downstaging (responders), and pts who did not 
undergo downstaging (non-responders).
Results: The analysis of numerical values of the local peak intensity (LPI) 
provided by the software according to the area under curve (AUC) showed the 
same statistical significant difference before, during and after treatment in 
healthy and pathological tissue. An increase of LPI was observed during 
treatment as compared to the pre-treatment phase, for healthy and for 
pathological tissue; on opposite, LPI in both healthy and pathological tissue 
showed a post-treatment decrease as compared to pre-treatment and during 
treatment LPI. The responders group showed 48% increase of LPI with respect 
to LPI before treatment; on opposite, the non-responders group showed 18% 
decrease of LPI compared to LPI before treatment.
Conclusion: Tumor response more likely occurs in pts who report higher LPI 
values on D-CE-MR analysis during treatment with respect to pre-treatment.
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SS 3.01
Can we identify the peritoneal reflection at rectal MRI?
M.J. Gollub1, M. Maas2, M. Weiser1, G. Beets2, K. Goodman1, 
L. Berkers2, R. Mehsen2, R.G.H. Beets-Tan2; 1New York, NY/US, 
2Maastricht/NL
Purpose: To assess the ability of readers to identify the PR, an important 
landmark in treatment decisions, on rectal MRI.
Material and Methods: This retrospective, IRB approved, two-center study 
included 207 randomly chosen patients with rectal cancer undergoing pelvic 
MRI. Two experienced GI radiologists independently analyzed sagittal and 
axial T2 weighted MR images to identify the anterior PR and its distance from 
the anorectal junction (ARJ) on a five-point confidence scale. Tumor sizes and 
distances from the ARJ and the PR were also recorded.
Results: Two-hundred seven MRI were analyzed. The PR was confidently seen 
in between 75 and 83% cases. The mean distance to the PR from the ARJ was 
68.3 mm (Reader 1) and 66.7 mm (Reader 2, intra-class correlation coefficient 
[ICC] = 0.833). Mean tumor length was 55.0 mm (Reader 1) and 53.1 mm (Reader 
2, ICC = 0.868). Readers 1 and 2 agreed more on tumor distance from the PR (k 
= 0.706), than on the distance of tumor from the ARJ (k= 0.424).
Conclusion: The peritoneal reflection was identified by 2 experienced GI 
radiologists in the majority of rectal MRI. Greater agreement was found in the 
relationship between tumors and the PR than in their distance above the anorectal 
junction, likely reflecting intrinsic anatomic variation between patients.
SS 3.02
Reproducibility of dynamic contrast-enhanced magnetic 
resonance imaging (MRI) and dynamic contrast-enhanced 
computed tomography (CT) of primary rectal cancer
N.J. Taylor1, A. Khan2, I. Simcock2, J. Stirling1,  
R. Glynne-Jones1, A. Padhani2, V. Goh2; 1Middlesex/UK, 
2Northwood/UK
Purpose: Dynamic contrast-enhanced (DCE)-MRI and DCE-CT may both assess 
tumor angiogenesis. No direct comparison of reproducibility has been undertaken 
to date. The aim was to evaluate their reproducibility in primary rectal cancer.
Material and Methods: Following ethical approval, 12 patients underwent 
DCE-MRI and vDCE-CT to derive Ktrans, ve, and AUGC60 (DCE-MRI); and BF, BV 
and FE (vDCE-CT). Imaging was repeated within 48 hours, and analysed by 
two readers. Reproducibility was assessed using Bland-Altman statistics.
Results: DCE-MRI: Ktrans mean difference, 95% limits of agreement, and wCV for 
repeat studies were 0.0066, -8.47 to 9.25, and 11.7 (Reader One); 0.0115, -9.3 
to 10.3, and 13.0 (Reader Two). ve mean difference, 95% limits of agreement, 
and wCV were 0.16, ï‚±10.4 and 12.9 (Reader One); and -0.04, ï‚±9.1 and 11.4 
(Reader Two). AUGC60 mean difference, 95% limits of agreement, and wCV were 
-0.58, -9.2 to 10.2 and 12.9 (Reader One); and -0.28, -10.1 to 11.2, and 14.2 
(Reader Two). DCE-CT BF: mean difference, 95% limits of agreement, and wCV 
for repeat studies were 1.48, -6.57 to 7.04, and 8.5 (Reader One); 4.27, ï‚±9.3, 
and 11.1 (Reader Two). BV mean difference, 95% limits of agreement, and wCV 
were -1.74, ï‚±15.6, and 18.6 (Reader One); -1.29, ï‚±21.0, and 25.2 (Reader 
Two). FE mean difference, 95% limits of agreement, and wCV were 5.36, -15.7 
to 18.6, and 22.6 (Reader One); 6.49, -17.8 to ,and 21.6 (Reader Two).
Conclusion: Reproducibility was similar for both modalities.
SS 3.03
Diffusion-weighted magnetic resonance imaging in 
rectal cancer: apparent diffusion coefficient as a 
potential non-invasive marker of tumor aggressiveness
L. Curvo-Semedo1, D.M.J. Lambregts2, M. Maas2,  
T. Thywissen2, R.G. Riedl2, G. Beets2, F. Caseiro-Alves1, 
R.G.H. Beets-Tan2; 1Coimbra/PT, 2Maastricht/NL 
Purpose: To assess the usefulness of diffusion-weighted imaging (DWI) as a 
potential non-invasive marker of aggressiveness in rectal cancer, by analyzing 
the relationship between the apparent diffusion coefficient (ADC) values of 
tumors and several prognostic clinical and histological parameters.
Material and Methods: Fifty rectal cancer patients underwent primary staging 
MRI including DWI (b0, 500, 1000). All received surgery with histological 
analysis of the surgical specimen. Oval-shaped ROIs were placed over the 
tumor ADC map to obtain mean pre-treatment ADC values. Correlation 
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Results: AUCs for identification of CR based on pre-volume, post-volume and 
volume were 0.54, 0.68 and 0.79 for T2W versus 0.64, 0.91 and 0.91 for DWI, 
respectively. Diagnostic performance for post-CRT volume was significantly 
better for DWI (p = 0.03) than for T2W. The ICC between tumor volume on T2W 
and DWI was 0.98 and 0.32 (pre- and post-CRT, respectively).
Conclusion: MR volumetry based on high b-value DWI, specifically the volume 
reduction measurements (у volume) after CRT and volume measurements on 
post-CRT DWI, is very accurate and superior to those performed on T2W for 
identification of a complete response after CRT for locally advanced rectal cancer.
SS 3.09
Apparent diffusion coefficient for assessment of post-
treatment tumor response in locally advanced rectal 
cancer 8 weeks after chemoradiotherapy
F. Sabatino, A. Filippone, R. Cianci, E. Pace, A. Tartaro,  
A.R. Cotroneo; Chieti/IT
Purpose: To evaluate apparent diffusion coefficient (ADC) as a marker of response 
to neoadjuvant chemoradiotherapy (CRT) in patients with rectal cancer.
Material and Methods: Twenty-eight patients with non-mucinous rectal 
adenocarcinoma treated with CRT and surgery were enrolled. All patients 
underwent pre and 8-week after CRT 3.0T conventional MRI plus DWI (six b 
values from 0 to 1000 s/mm2). Pre- and post-CRT ADC values were compared. 
Pathologic reports (Mandard’s classification) served as reference standard. 
Patients with tumor regression grade (TRG) of I or II were considered as 
responders, whereas patients with TRG of III, IV, or V as non-responders.
Results: After CRT, the mean ADC significantly increased in all patients, 
irrespective of tumor response (P = 0.001). Before CRT, the mean ADC of 
responders was lower than those of non-responders (P = 0.33). After CRT, the 
mean ADC of responders was significantly higher than those of non-responders 
(P = 0.003). The mean %ADC increase in responders (77.2) was significantly 
greater than that of non-responders (36.0) (P = 0.05). The best post-CRT mean 
%ADC increase cut off to differentiate responders from non-responders with 
ROC curve analysis was 29.5%. Negative correlation was observed between 
mean %ADC increase rate and TRG after CRT (rho = -0.69; P = 0.0063).
Conclusion: 8-week post-CRT ADC can reliably assess tumor response. The 
mean %ADC increase rate seems to be a reliable tool to differentiate 
responders from non-responders.
SS 3.10
Assessment of texture changes in primary rectal cancer 
following neoadjuvant chemoradiation
D. Banerjee1, A. Khan1, B. Ganeshan2, A. Gogbashian3,  
I. Simcock1, J. Stirling3, V. Goh1, R. Glynne-Jones3, K. Miles2; 
1Northwood/UK, 2Brighton/UK, 3Middlesex/UK
Purpose: CT texture provides information on tumor heterogeneity. The aim was to 
assess the changes in tumor texture following chemoradiation in rectal cancer.
Material and Methods: Following IRB approval, 14 prospective patients (10 
males, 4 females, mean age 67.1 years) with rectal cancer underwent contrast-
enhanced CT (dual source CT, Siemens Definition). Texture parameters 
(entropy (irregularity) and uniformity (distribution of gray level)) were determined 
at mid rectal tumor level using proprietary software (TexRAD, University of 
Sussex). Filter levels (unfiltered, 1.0, (fine) 1.5, 1.8 (medium) , 2.0 and 2.5 
(coarse texture) were applied and normalized to define features at different 
spatial scales. Mean (SD) for entropy and uniformity was recorded. Texture 
changes were compared using t-test; statistical significance at 5%.
Results: 12 of 14 patients had a post-treatment CT. Baseline mean (SD) of entropy 
and uniformity were 1.02 (0.74), 1.27 (0.39), 1.38 (0.37), and 1.81 (0.77); and 1.17 
(0.25), 0.87 (0.10), 0.82 (0.09), and 0.73 (0.06), respectively, at the following filter 
ratios: 1.0/1.5, 1.0/1.8, 1.0/2.0, and 1.0/2.5. Following chemoradiation, mean 
entropy and uniformity changed by +1.97, -1.17, -0.34, +4.04%; and +2.29, -2.58, 
-4.03 and -9,77%, respectively, at same filter ratios. This was statistically lower for 
uniformity at 1.0/2.5 filter ratio (p = 0.0088) but not for entropy.
Conclusion: CT uniformity but not entropy decreases following chemoradiation. 
SS 3.06
Clinical impact of imaging for restaging rectal cancer 
after preoperative chemoradiation
F. Pomerri, S. Pucciarelli, S. Corradin, I. Maretto, D. Nitti, 
P.C. Muzzio; Padua/IT
Purpose: To determine the accuracy of different imaging techniques in 
predicting local staging and the circumferential resection margin (CRM) status 
of rectal cancers (RC) after preoperative chemoradiotherapy (CRT).
Material and Methods: We prospectively assessed 132 patients with locally 
advanced mid-to-low RC using CT, MRI and endorectal ultrasound (ERUS). 93 
patients were studied with both MRI and ERUS. Post-CRT local staging and 
infiltration of CRM were compared with histopathology.
Results: The overall concordance rate between CT (n = 98) and histopathology 
findings was 33%. Because of these disappointing results, this part of the 
study was discontinued. Unfortunately, the accuracy of T staging was low also 
using MRI (35%) and ERUS (33%). Grouping mural stage into ypT)3 and ypT4 
categories imaging showed high specificity and negative predictive value 
(NPV); particularly MRI achieved 92% specificity and 95% NPV. The accuracy 
of N staging was 67% and 65% for ERUS and MRI, respectively; the 
corresponding NPV were 75% and 78%. The specificity and NPV for the CRM 
involvement were 80% and 96%, respectively, for MRI.
Conclusion: Current imaging techniques are unreliable for RC restaging purposes 
after CRT, but are useful in predicting T) 3 RC and RC with negative nodes and 
CRM. These findings may be of clinical relevance for planning less invasive surgery.
SS 3.07
Accuracy of gadofosveset-enhanced 3D T1W MRI for 
T-stage prediction after chemoradiation for rectal cancer
M. Maas, G. Beets, D.M.J. Lambregts, U. Lalji,  
R.G.H. Beets-Tan; Maastricht/NL
Purpose: Accurate selection of a rectal tumour confined to the bowel wall after 
CRT (ypT1-2) could select patients for local excision without compromising the 
risk for local recurrence. Goal of this study was to evaluate diagnostic 
performance at gadofosveset-enhanced T1W-MRI for selecting ypT1-2 
tumours compared to T2W-MRI.
Material and Methods: 50 patients with locally advanced rectal cancer underwent 
2DT2W-FSE-MRI (in 3 planes) and axial gadofosveset-enhanced 3DT1W-GRE-
MRI before and 6-8 weeks after CRT. All patients underwent surgery after the 2nd 
MRI. An abdominal radiologist predicted yT-stage at T2W-MRI and at ce-T1W-
MRI (after a 2-week interval). After another 2-week interval the T2W and ce-T1W 
images were scored simultaneously. With the ce-T1W-images multiplanar 
reformatting was used. Patient order was randomised between every reading. 
Likelihood of yT1-2 was scored using a confidence level score (0 = definitely 
outgrowing wall to 4 = definitely confined to wall). Histology was gold standard. 
ROC-analyses were performed to compare diagnostic performance.
Results: Area under the ROC-curve (AUC) was 0.68 (0.53-0.83) at T2W, 0.70 
(0.55-0.85) at ce-T1W and 0.75 (0.61-0.90) at T2W+ce-T1W images. 
Corresponding sensitivity and specificity are: 61% and 62% for T2W, 82% and 
57% for T1W and 86% and 52% for ce-T1+T2W.
Conclusion: The addition of gadofosveset-enhanced 3DT1W GRE imaging 
improved radiologist’s performance for selecting tumors limited to the bowel 
wall after CRT. Strikingly, ce-T1W images only already achieve similar accuracy 
as T2W alone. Enhancement with gadofosveset might help to more accurately 
select tumours confined to the rectal wall after CRT.
SS 3.08
Response of rectal cancer to preoperative chemoradiation 
therapy: a comparison between MR volumetry assessed 
on T2-weighted and diffusion-weighted images
L. Curvo-Semedo1, D.M.J. Lambregts2, M. Maas2,  
R. Mehsen2, G. Lammering2, G. Beets2, F. Caseiro-Alves1, 
R.G.H. Beets-Tan2; 1Coimbra/PT, 2Maastricht/NL
Purpose: To assess whether volume measurements on diffusion-weighted images 
(DWI) are accurate for the assessment of complete response (CR) after chemoradiation 
treatment (CRT) in patients with locally advanced rectal cancer (LARC) and to 
compare them with conventional T2-weighted (T2W) MR volumetry (MRV).
Material and Methods: Fifty patients with LARC underwent pre- and post-
CRT MRI. Histology (ypT0) was the standard reference. Free-hand ROIs were 
used to calculate pre-CRT tumor volume, post-CRT tumor volume and tumor 
volume reduction rate (у volume) on both datasets (T2W and b1000 DWI). 
ROC curve analysis evaluated their accuracy in detecting CR and differences 
were analyzed by comparing areas under the ROC curves (AUC). The intraclass 
correlation coefficient (ICC) between measurements on T2W and DWI was 















Material and Methods: Forty-two patients after Roux-en-Y gastric bypass 
(RnYGB) were considered for secondary surgery due to insufficient weight-
loss (n = 21, group 1) or late complications (n = 21, group 2). These patients 
underwent abdominal CT after application of oral contrast and an antiperistaltic 
agent. Thin-slice datasets were evaluated for pouch volume, area of the 
gastroenterostomy, and volume of the proximal Roux-limb. A multidisciplinary 
team (MDT) decided on further surgical treatment.
Results: With 67.7ml compared to 32.2ml and 5.7cm2 compared to 2.9cm2 
pouch volume and the area of the gastroenterostomy were significantly higher 
in group 1, respectively (p < 0.05). Eighteen patients from group 1 were 
subjected to secondary surgery. In 5 patients gastric restriction was fortified by 
banded RnYGB; 10 patients received malabsorptive secondary procedures. 
Banded RnYGB patients exhibited larger pouches (148.6ml vs. 52.3ml; p = 
0.006) but normal dimensions of the Roux-limb, whereas malabsorption was 
commonly introduced in patients who showed a combined dilation of the 
gastroenterostomy and the Roux-limb.
Conclusion: Pouch dilation and widening of the gastroenterostomy are 
common findings in cases of insufficient weight-loss after RnYGB. Extreme 
pouch dilation combined with normal dimensions of the Roux-limb might 
support an MDT decision for further restrictive treatment options.
SS 4.04
320-row CT virtual gastroscopy: differential diagnosis 
between benign and malignant ulcers
M. Moschetta, A.A. Stabile Ianora, F. Cazzato, V. Lorusso,  
A. Scardapane, G. Angelelli; Bari/IT
Purpose: This study aims to assess the diagnostic accuracy of virtual 
gastroscopy obtained by 320-row CT examination in differentiating benign 
from malignant gastric ulcers.
Material and Methods: 29 patients (18 M, 11 F, mean age 58.4) with 
endoscopic and histological diagnosis of gastric ulcer underwent CT 
examination. A hypotonizing drug was administered and gastric walls were 
distended by air in order to perform virtual endoscopy. Basing on morphological 
features, gastric ulcers were subdivided into benign or malignant forms by two 
blinded radiologists. Interobserver agreement was evaluated using Cohen’s 
kappa (k) test. CT results were then compared with endoscopic and histological 
findings, having the latest as the reference standard.
Results: 21 out of 29 patients (72%) were affected by malignant ulcers, while in 
the remaining 8 cases diagnosis of benign gastric ulcer was made. Virtual 
gastroscopy shown diagnostic accuracy, sensitivity and specificity values of 93%, 
90% and 100%, respectively, in differentiating benign from malignant ulcers. 
Almost perfect agreement between the two readers was found (k = 0.86).
Conclusion: CT virtual gastroscopy improves the identification of gastric 
ulcers and allows to differentiate benign from malignant forms.
SS 4.05
Diagnostic performance for gastric cancer detection of 
three different reconstruction techniques using MDCT 
compared with 2D axial CT
J.H. Kim, H.W. Eun, S.S. Hong, J.K. Han, B.I. Choi; Seoul/KR
Purpose: To assess diagnostic performance for gastric cancer detection of 
three different reconstruction techniques compared with 2D axial CT.
Material and Methods: During 7 months, we performed CT of 104 patients 
with gastric cancer (EGC = 63) and control group (n = 35). Two radiologists 
retrospectively and independently interpreted the axial CT and three different 
reconstruction techniques; multiplanar reformation(MPR), transparent 
image(TI), and virtual gastroscopy(VG). They graded the presence or absence 
of gastric cancer and, if present, assess its location. Diagnostic performances 
were compared using the area under the ROC curve (Az) in gastric caner and 
EGC. Sensitivity and specificity were also calculated. The  statistics was used 
to determine interobserver agreement.
Results: The diagnostic performances for gastric cancer detection were as 
follows: 2D-axial (Az = 0.858); MPR (Az = 0.879); TI (Az = 0.873); VG (Az = 
0.928). VR was better in performance than 2D axial CT (p = 0.016). The 
sensitivity and specificity were as follows: 76.7% and 82.9% in 2D-axial; 
79.6% and 85.7% in MPR; 91.3% and 80% in TI; 95.1% and 74.3% in VG. The 
interobserver agreement showed substantial (  = 0.67-0.75). In EGC, the 
diagnostic performances for detection were as follows: 2D-axial (Az = 0.777); 
MPR (Az = 0.811); TI (Az = 0.825); VG (Az = 0.896). VR was better in performance 
than 2D axial CT (p = 0.006) and MRP (p = 0.038). The sensitivity and specificity 
were as follows: 62.9% and 82.9% in 2D-axial; 67.7% and 85.7% in MPR; 
85.5% and 80% in TI; 91.9% and 74.3% in VG.
Conclusion: Among three different reconstruction techniques, virtual 
gastroscopy accurately detects gastric cancer, especially useful for EGC, 
compared with 2D axial CT.
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SS 4.01
Role of MR-fluoroscopy with high-speed kinetic 
sequences in multiple swallowing disorders of oro-
esophageal tract and gastro-esophageal junction
I. Sansoni, R. Alloni, C.L. Piccolo, C.A. Mallio, I. Di Giampietro, 
R. DelVescovo, R. Coppola, B. Beomonte Zobel; Rome/IT
Purpose: To evaluate the capability of high-speed kinetic MR sequences in 
defining upper and lower swallowing disorders.
Material and Methods: 33 patients (10 M, 23 F) with various oro-esophageal 
and gastrooesophageal disorders underwent MR examination on 1.5 Tesla 
magnet equipped with high performing gradients. Anatomical BH GRE unspoiled 
T1-w and HASTE T2-w sequences were acquired on multiple planes in order to 
define the anatomic details (f.e. Nissen fundoplication position above or below 
diaphragmatic plane). We evaluated visualization of oesophageal bolus transit, 
bolus transit-time, peristalsis, gastrooesophageal junction patency and 
competency during oral administration of contrasted yogurt.
Results: MR-fluoroscopy provided useful information regarding bolus propulsion 
from oesophagus to stomach. MR-fluoroscopy imaged swallowing abnormalities 
in 31/33 patients: 3 upper motility disorder, 8 achalasia, 1 megaoesophagus, 2 
para-esophageal Hjatal Hernia, 7 gastro-esophageal reflux (2 of those with 
sliding Hiatal Hernia), 12 after Nissen-fundoplication, 1 after gastrectomy. MR 
findings well correlated with other different instrumental examination findings.
Conclusion: High-speed kinetic MR-fluoroscopy is a useful and complementary 
tool for evaluating oro-esophageal deglutition process and gastro-esophageal 
junction alterations. In symptomatic subjects after Nissen fundoplication, it can 
detect antomic and motility alterations, providing additional information useful in 
diagnostic work-up. MR-fluoroscopy is radiation-free able to evidence swallowing 
disorder, with no time of observation limit characteristic of tools employing ionizing 
radiations. It is simple, non-invasive, rapid and well-tolerated for diagnosing GE 
reflux or motility disorders, but deserves further investigations.
SS 4.02
Agreement of ultrasound with endoscopy for evaluation 
of upper GI pathology
A. Mishra, E.F. Ehtuish; Tripoli/LY
Purpose: Ultrasound is a promising, non-invasive, readily available imaging 
technique for evaluation of hollow viscera like stomach. Agreement of 
ultrasound vs. the current ‘gold standard’ - endoscopy – has not been 
evaluated for assessing gastroduodenitis yet.
Material and Methods: 460 patients with epigastric pain underwent ultrasound 
and endoscopy. Both operators were blinded to the respective findings. The 
findings were tabulated in a standard format. Stomach was adequately distended 
with oral water prior to ultrasound. Gastric antral wall >5 mm was assumed 
thickened which was evaluated for symmetry as circumferential/asymmetric and 
focal/diffuse distribution. Gastric body and fundus were not assessed on ultrasound. 
The results were compared to assess agreement coefficient between two modalities. 
All ultrasound and endoscopy examinations were performed by same personnel.
Results: Diffuse circumferential gastric antral wall thickening was seen in 78.2%(n 
= 360). Focal symmetric thickening was seen in antrum (18.4%) and pylorus 
(16%). Focal asymmetric thickening was seen in 2.8% patients which were 
biopsied during endoscopy. Duodenal wall thickening was seen in 58.4% (n = 
269) patients. Non-neoplastic pathology (gastritis/ulcer/fibrosis) was diagnosed 
in 71.3% (n = 328) on endoscopy and duodenitis in 54.6% (n = 251). 3 patients 
were proven gastric cancer after biopsy. The sensitivity, specificity, PPV and NPV 
for ultrasound were 92.1%, 76.5%, 91.1% and 78.8%, respectively.
Conclusion: Ultrasound and endoscopy show excellent agreement for evaluation 
of gastric/duodenal wall thickening indicating upper GI pathology provided the 
viscus is adequately distended, albeit a steep learning curve for ultrasound.
SS 4.03
The role of computed tomography with volumetric 
analysis in secondary treatment planning after gastric 
bypass surgery
T. Baumann, G. Pache, E. Kotter, S. Küsters, W.K. Karcz,  
M. Langer; Freiburg/DE
Purpose: Bariatric surgery is a rapidly growing field. Secondary surgical 
procedures, however, are sometimes necessary to achieve sufficient weight-
loss. It was the purpose of this study to evaluate the role of computed 
tomography (CT) in surgical treatment planning.
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Results: The overall sensibility of MDCT in relapse detection was 78%, the 
specificity 85%; for CE-PET/CT 85% and 94%; specificity in identification of 
liver metastasis modifications was higher (95vs83%) for CE-PET/CT. In 12 
patients the CE-PET/CT never determined therapy changes, while it modified 
the therapy in 21 patients considering 49 examinations in 36 months. MDCT 
modified therapy in 14 cases only.
Conclusion: The CE-PET/CT is a reliable examination in GIST evaluation and 
follow-up. It improves the peritoneal lesions detection, their characterization during 
therapy and it allows an effective evaluation of the liver parenchyma. The CE-PET/
CT is more effective than MDCT alone in GIST monitoring during the follow-up.
SS 4.09
Comparison of the new Choi CT response patterns to 
the RECIST criteria with CT and MR in pts affected by 
GIST during molecular targeted therapy
S.V. Setola1, A. Messina2, G. Cardone2, V. Granata1,  
R. Carbone1, M. Barretta1, A. Gallipoli1, E. de Lutio1; 1Naples/IT, 
2Milan/IT
Purpose: Correlate new tumor response criteria (Choi criteria) to Recist in 
patients with GIST undergoing imatinib mesylate therapy (peculiar response 
with no decrease in size) These criteria have been demonstrated to correlate 
with patients’ outcomes better than Recist criteria.
Material and Methods: 37 pts with advanced GIST underwent therapy with 
imatinib mesylate. All pts performed CT (16 slice) and MR (1,5T system) 
examinations at baseline and then at 2, 4, 6, 8, 10 and 12 months during the 
treatment. The radiological patterns that we used were: 1) changes in tumor 
size (according to RECIST criteria). 2) Tissue characteristics and changes in 
vascularization (according to Choi Criteria). MR/CT pattern in responsive 
patients, according to RECIST criteria, was tumor decrease in size. MR/CT 
pattern in responsive patients, according to the new Choi criteria, was the 
descrease of vascularization >15% on contrast enhanced evaluation.
Results: CT and MR show the same results. On morphologic evaluation, using 
dimensional criterion, 18/37 pts had a RECIST “partial response” , 9/37 pts 
had a RECIST “stable disease” and 10/37 pts had a RECIST “progression 
disease”. On vascular evaluation 24/37 pts had “partial response pattern, 7/37 
had “stable disease” pattern and 6/37 had “progression disease” pattern.
Conclusion: In GIST, new response assessment criteria proposed by H. Choi, 
incorporating not only tumor size but also changes in tumor density and 
vascularization following contrast enhancement, were shown to predict 
prognosis better than RECIST.
SS 4.10
Tumour response and clinical outcome in metastatic GI 
stromal tumour under sunitinib therapy: comparison of 
RECIST, Choi and volumetric criteria
N. Schramm, M. Schlemmer, C. Becker, M.F. Reiser,  
F. Berger; Munich/DE
Purpose: Purpose of the study was the comparison of RECIST, Choi and 
volumetric radiological response in GIST-patients under 2nd-line-sunitinib-
therapy with correlation to disease-specific survival (DSS).
Material and Methods: 20 patients with baseline-CT of the abdomen under 
imatinib obtained follow-up-CTs 3 months and 1 year after change to sunitinib. 
Therapy response was evaluated according to RECIST, Choi and volumetric 
criteria (PR: decrease *40%, PD: increase *33%). The response categories, 
respectively, were: partial response (PR), stable disease (SD) and progressive 
disease (PD). Response according to the different assessment systems was 
correlated to the DSS of the patients.
Results: The mean DSS (in months) of the response groups 3 months after 
therapy change was: RECIST: PR (0/20); SD (17/20): 29.2 (months); PD (3/20) 11.6 
Choi: PR (10/20) 27.9; SD (8/20) 26.4; PD (2/20) 13.5. Volumetry: PR (4/20) 29.7; 
SD (11/20) 28.4; PD(5/20) 17.2. Reponse groups after 1 year of sunitinib showed 
the following mean DSS: RECIST: PR (3/20) 33; SD (9/20) 28.2; PD (8/20) 20.3. 
Choi: PR (10/20) 21.3; SD (4/20) 39.6; PD(6/20) 23.9. Volumetry: PR (6/20) 27.0; 
SD (5/20) 35.9; PD (9/20) 19.3. Patients classified as PR after 1 year according to 
Choi and volumetry had a shorter DSS than patients classified as SD.
Conclusion: In our GIST-patient collective Choi and volumetric criteria could 
detect responders with prolonged survival time under sunitinib only in the early 
follow-up but not in the later course of disease. These results have to be 
verified in larger patient cohorts.
SS 4.06
Clinical application of dynamic 320-row multidetector 
computed tomography for identifying preoperative 
staging of gastric cancer
N. Gagarina, M. Nagornyy, E. Mukhammatullina, V. Levkin, 
A. Egorov, E. Fominykh; Moscow/RU
Purpose: To evaluate accuracy of the novel dynamic scanning technique using 
320-detector-row CT to determine the preoperative staging of gastric cancer.
Material and Methods: 49 patients with gastric cancer were included. MDCT 
was performed on 320-detector-row scanner (AquilionONE,Toshiba) with 16-
cm width detector and the possibility of volume scanning (obtaining images of 
whole stomach in the dynamic mode). After native scanning 18 volumes at 3-4 
seconds interval (total 53sec) with administration of 90ml Omnipaque 
350mgI/m were performed with slice thickness 0.5mm, 100kV, 250mA. 
Postprocessing included multiplanar reformation and construction of dynamic 
video. All patients underwent surgery.
Results: The sensitivity (SE) of MDCT in detecting gastric cancer was 96%, 
specificity(SP) 100%. Accuracy in determining the T-stage was on average 
63% (14-77% for T1-T4stage). In 2 cases T1-tumor was not been detected. 
The gastric wall thickness is closely correlated with depth of invasion (r = 0.54, 
p = 0.0001). The SE of MDCT in detecting metastatic lymph nodes was 96%, 
SP91%. Accuracy for N-staging was 78%. The highest accuracy was detected 
for contrast-enhancement nodes (area under ROC-curve (AUC) 0.92, SE91%, 
SP91%), and size over 12mm (AUC0.82, SE63%, SP86%). In 5 patients tumor 
invaded the surrounding organs, which was accurately determined by MDCT.
Conclusion: MDCT-dynamic study provides a good opportunity to 
preoperative staging of gastric cancer.
SS 4.07
The value of gastric adenocarcinoma length by MDCT 
and MRI and correlation with clinical staging
R. Mateus Marques, L. Fernandes, C. Leal, P. Mendonça,  
L. Costa, J. Esteves, F. Cabrita, J. Guedes da Silva,  
A. Caldeira Fradique; Lisbon/PT
Purpose: Tumoral length is considered an important prognostic factor in 
gastric adenocarcinoma (GA) and MDCT and less commonly MRI have been 
used to stage the disease. The purpose of this study is to compare gastric 
cancer length (GCL) by MDCT and MRI, with the gold standard of pathologic 
evaluation and to clinical staging (CS) of GA.
Material and Methods: Sixty pathologic specimens of operated GA were 
reviewed between October 2008 and November 2010. To compare GCL by 
MDCT and MRI, a T-student test with data of 32 patients was performed. The 
comparison of GCL by pathology with MDCT and MRI was done with the 
Bland-Altman Test (21 and 30 patients, respectively). Finally, GCL by pathology 
was compared to the CS by histograms.
Results: Student’s t test with a p-value of 0.705 excluded a statistical evidence 
of disparity between GCL by MDCT or MRI. With the Bland-Altman test the 
bias for GCL by MRI and MDCT vs pathology were - 4 mm and - 7mm, with 
limits of agreement of ±27 mm and ±18 mm, respectively. The histograms 
revealed that GCL larger than 5 and 8 cm corresponded, respectively, to a 
minimum CS of 2 and 3; GCL smaller than 2 cm had a CS inferior to 2.
Conclusion: GCL by MRI and MDCT are not statistically different and both are 
useful tools in the measurement and CS of GA.
SS 4.08
What you need to know in clinical use of contrast-
enhanced PET/CT for GIST evaluation and follow-up
E. Biscaldi, D. Comandini, M. Iacozzi, A. Piccardo,  
G.A. Rollandi; Genova/IT
Purpose: To evaluate the effectiveness of contrast-enhanced (CE)-PET/CT 
(MultidetectorCT, 16 rows) in GIST management, after 6 years of a retrospective 
experience with a group of patients in follow-up at our oncologic centre.
Material and Methods: We studied 33 patients (aged 44-81, mean 64), 
affected by GIST. In 14 a MultidetectorCT (MDCT, 16 rows) study discovered 
the pathology at the beginning, in 19 a pretherapy CE-PET/CT was performed, 
in all patients the CE-PET/CT was used in follow-up after imatinib, sunitinib 
and in the absence of a targeted therapy. 22 patients were operated, at the 
onset and/or after relapses. 7 died after three years. The MDCT study alone 
was used in follow-up, every two negative PET/CTs. We compared MDCT and 
CE-PET/CT sensibility and specificity in detection of peritoneal relapses, of 
response during therapies (5 years), in liver metastases identification and 
monitoring. We evaluated when the CE-PET/CT modified the therapy of the 















readers identified 74% (95%CI: 66-80%) of patients with at least one lesion 
*6mm while CAD-FR SE was 76% (95%CI:69-83%; p = .5). All masses were 
identified with both paradigms; 37 polyps correctly prompted by CAD were 
dismissed by at least one reader. SP was 94% (95% CI: 91-97%) and 92% 
(95%CI: 88-95%) without and with CAD-FR, respectively (p = .3). No differences 
were reported also between AUCs (p > .05). CAD-FR reporting time was 
significantly shorter than the unassisted read (p = .0001).
Conclusion: Diagnostic performances of CAD-FR are not different from those of 
unassisted interpretation. However, with the former reading times are reduced.
SS 5.04
Observer variability: comparing a computer aided 
detection in a first reader paradigm to unassisted read
G. Iussich1, L. Correale2, F. Iafrate3, A. Laghi4, E. Neri5, F. Cerri5, 
S. Del Santo2, A. Bert2, C. Senore2, N. Segnan2, D. Regge1; 
1Candiolo/IT, 2Torino/IT, 3Rome/IT, 4Latina/IT, 5Pisa/IT
Purpose: To compare observer variability of CAD as a first reader (FR) 
versus unassisted reading.
Material and Methods: The database contained 155 CT colonography studies, 
with a total of 89 * 6 mm lesions. The reference standard was built by 2 unblinded 
radiologists. Three experienced radiologists read the datasets, randomized 
between CAD-FR and unassisted reading. Datasets were reread with the 
opposite paradigm after 6 weeks. For both reading strategies, readers recorded 
lesions and classified patients according to the CRADS criteria. Data were 
analyzed with Fleiss-kappa-statistic to characterize the agreement among the 3 
radiologists and the accuracy of the study readers’ diagnoses was assessed 
against the reference standard. Accuracy was defined as the percent of the 
reference standard CRADS classifications correctly identified by readers.
Results: Average intra-observer agreement within 4 diagnostic categories 
(C1-C4) was good (k = 0.67 [95% CI: 0.60-0.74]). Inter-observer agreement 
was substantial for both unassisted and CAD-assisted reading (k = 0.67 
[95%CI: 0.60-0.73] vs k = 0.62 [95%CI: 0.55-0.68]). The accuracy of the 
CRADS classification with respect to the reference standard was quite high for 
both reading strategies (k = 0.67 vs k = 0.63). However, in both reading 
conditions, the level of agreement between readers and reference standard in 
identifying C2 cases was low (k = 0.42 vs k = 0.35).
Conclusion: There was good agreement between unassisted read and 
CAD-assisted reading. However, our results suggest that the description of 
patients with 6-9 mm polyps does not yield reproducible results, 
independently from the used reading paradigm.
SS 5.05
CT colonography for nonpolypoid colorectal lesions: 
CAD-assisted versus unassisted reading by radiologists 
with different level of experience
M. Ciolina1, P. Baldassari1, A. Pichi1, M. Iannitti1, A. Stagnitti1, 
F. Iafrate1, A. Laghi2; 1Rome/IT, 2Latina/IT
Purpose: To determine sensitivity of CT colonography interpreted by four 
readers with different levels of experience with and without applying CAD 
software for flat lesions.
Material and Methods: A database of 94 patients was interpreted by four 
readers with different levels of experience. 50 patients (control group) and 44 
patients had 47 flat lesions. Data were first interpreted on a dedicated 
workstation. After 1 month interval same datasets were randomly interpreted 
using a CAD software in a second reading paradigm. Sensitivities and 
specificities with and without CAD software were assessed. Mean reading time 
and number of CAD false-positive findings were evaluated.
Results: Sensitivities of human readers for nonpolypoid lesion without CAD 
was, respectively, 51% and 57% for novice readers, 65% for intermediate 
reader, 74% for expert reader. Using CAD as second reader sensitivities were, 
respectively, 51%, 72%, 75% and 84% for novices, intermediate and expert 
readers. CAD sensitivity for nonpolypoid lesion was 89%. Specificities were, 
respectively, 90% and 91% for novices, 94% and 96% for intermediate and 
expert reader. FP were 6. Mean reading time was 9 min and 10 min for novice 
readers, 8 for intermediate and 6 for expert.
Conclusion: CTC after applying CAD software showed a promising high 
sensitivity for flat lesions. The use of CAD software as second reader seemed 
to improve sensitivity of readers with different levels of experience.
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SS 5.01
Dose optimization in CT colonography
G. Boehm, W. Schimetta, M. Gschwendtner; Linz/AT
Purpose: CT colonography is a modern imaging technique for colon 
assessment. To keep the radiation exposure as low as possible, low dose 
protocols are used for optimization.
Material and Methods: In our retrospective analysis 700 patients were included 
who received a CT colonography (CTC) for evaluation of colon polyps or tumors. 
All examinations were performed according to the same low dose protocol (120 
kV, 80mA, 16x1 mm, 0.5 sec. rotation time, supine and prone position). The dose 
length product (DLP) of each patient was documented. For comparison, the DLP 
of 100 patients who received an abdominal CT in routine diagnosis was used. 
The study parameters were equivalent to a normal dose protocol using a CT 
automatic exposure control. For comparison, the maximum value for abdominal 
CT in the Austrian Radiation Protection Ordinance has been invoked.
Results: The DLP was determined with the average of 339.8 (285-380)mGy.cm 
in CTC and 548.9 (198-1277)mGy.cm in the abdominal CT. The DLP-values in 
CTC (two series) were significantly lower (p < 0.001) compared to abdominal CT. 
The highest collected DLP of CTC reached only 32% of the maximum DLP value 
(1200 mGy.cm) for abdominal CT in medical radiation protection regulations.
Conclusion: Despite recording two series in CTC, the radiation exposure is 
significantly lower than for a routine abdomen CT and does not reach the maximum 
value of DLP for abdominal CT in medical radiation protection regulations by far.
SS 5.02
Optimisation of CT colonography dose protocols:  
a District General Hospital experience
M. Jagtiani Sangwaiya, A. Marcus, J. Edwards, J. Lovell,  
M. Train, J. Berger; London/UK
Purpose: To assess radiation administered to patients undergoing CT colonography 
at Barnet General Hospital. Subsequent re-evaluation of dose achieved.
Material and Methods: Patients undergoing CTC in 01/2010 were identified. The 
dose parameters (CTDI, CT dose index and DLP, dose length product) were 
documented; note was also made when the dose sheet was not sent to PACS. 
Conservative reduction in the dose was attempted, keeping in mind local scanner 
limitations. The CT protocol was changed to include the dose sheet on PACS as 
a mandatory step of scanning. Patients scanned from 09/2010 were evaluated.
Results: In 01/2010, 50 consecutive patients (F:M 33:17; mean age 70) were 
assessed. The CTDI (supine) was 14.8 ± 2.1; corresponding DLP 690 ± 129. The 
CTDI (prone) was 7.8 ± 0 and DLP 372 ± 36. No dose sheet was sent to PACS in 
14 patients. Corresponding measurements in 09/2010, 50 consecutive patients 
(F:M 28:19; mean age 72) were assessed. The CTDI(S) was 11.4 ± 3.2; DLP was 
516 ± 158. Also, the CTDI and DLP(P) were 4.8 ± 1.7 and 222 ± 81, respectively. All 
dose sheets were archived in PACS. Overall dose reduction from a CTDI vol of 11.3 
± 4.9; DLP of 531 ± 224 to CTDI vol of 8.1 ± 1.1; DLP of 369 ± 53 was achieved.
Conclusion: Optimisation of CT dose up to 30% can be safely achieved in a 
District General Hospital setup. Changes in the Departmental protocol can 
improve compliance with the IRR99. Precautions must be taken to minimise 
dose in CT colonography.
SS 5.03
CT colonography with computer-aided detection (CAD) 
using a first reader paradigm: effect on reader performance
L. Correale1, G. Iussich2, F. Iafrate3, A. Laghi4, E. Neri5, F. Cerri5, 
L. Morra1, A. Bert1, C. Senore1, N. Segnan1, D. Regge2;  
1Torino/IT, 2Candiolo/IT, 3Rome/IT, 4Latina/IT, 5Pisa/IT
Purpose: To assess the diagnostic performance and reporting time of CAD 
as a first reader.
Material and Methods: 155 colonoscopy CTC exams were interpreted by 3 
experienced radiologists twice, 6 weeks apart, using both unassisted reading 
and CAD as a first reader. Reading paradigms were randomized on a per-case 
basis. Performance was compared to an annotated reference standard created 
by 2 experienced radiologists unblinded to colonoscopy. Per-patient sensitivity 
(SE), specificity (SP), reporting time and diagnostic confidence without and 
with CAD were compared using paired exact and Student’s t tests, respectively. 
For both reading strategies, areas under the curves (AUCs) were calculated.
Results: 57 of 155 cases (37%) were positive for a total of 89 lesions *6mm, 
and 10 masses. CAD stand-alone detected 91% (81/89) (71 polyps and all 
masses). Per-patient CAD SE was 91.2% (52/57). On average unassisted 
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significant differences were found between the learning curve of the assisted 
and unassisted sessions. Less experienced readers were faster when assisted 
by CAR but no significant differences were found on mean reading time for all 
readers (p = 0.5/0.07). Both readers decrease false positive when assisted.
Conclusion: Our study demonstrated that the learning process of less 
experienced readers was not influenced by the assistance of the CAR software.
SS 5.09
Systematic review: the effect of manipulating clinical 
context on studies of diagnostic test accuracy
D. Boone1, S. Halligan1, S. Mallett2, S.A. Taylor1, D. Altman2; 
1London/UK, 2Oxford/UK
Purpose: We performed a systematic review of diagnostic accuracy imaging 
studies investigating the effect of, (A) blinding observers to population 
information and, (B) reporting intensity and recall bias.
Material and Methods: We searched the biomedical literature during March 
2010 using 3 discrete strategies. Inclusion criteria: imaging studies that 
quantified the effect on diagnosis of modifying the context of observers’ 
interpretations, in terms of varying disease prevalence, blinding to population 
characteristics, reporting intensity, and recall bias.
Results: 11247 abstracts were reviewed, 201 full texts examined, and 12 
included in our systematic review. There were 5 to 9520 patients and 2 to 129 
observers per study. Interpretation rate varied from 5 per day to 3208 over 18 
months. 9 studies investigated clinical review bias of population level 
information. Only 3 studies investigated prevalence, 2 of which investigated 
maximum enrichment well below levels often used by researchers. We 
identified no research specifically directed at observer knowledge of prevalence 
or that specifically addressed the duration of washout. Available research 
found no evidence of recall bias on study results.
Conclusion: Potential sources of bias central to design imaging diagnostic 
test accuracy studies are poorly researched and there is little evidence to 
guide study design. Research is needed urgently to investigate the impact of 
potential sources of bias on imaging studies, particularly observers’ knowledge 
of prevalence and the effects of recall bias, especially in screening contexts.
SS 5.10
Chronic diverticulitis versus colorectal cancer: findings 
on CT colonography
S.E.H. Cremers1, S. Gryspeerdt2, P. Lefere2, S. Houterman3, 
G. Slooter3, M.L. Verhulst3, P.T.J. Cremers3; 1Rotterdam/NL, 
2Hooglede/BE, 3Veldhoven/NL
Purpose: In CT colonography chronic diverticulitis (CD) can mimic colorectal 
cancer (CRC) masses. In order to distinguish these two entities several 
findings were analysed.
Material and Methods: 371 symptomatic patients consecutively underwent CT 
colonography between June 2008 and November 2010. All patients with pathologic 
confirmation of CD (10) and CRC (28) on surgical specimens were included. The 
images were analysed by a consensus of two reviewers. Length of the mass, 
diverticula included in the mass, growth pattern, luminal narrowing, presence of 
perilesional lymph nodes and mesenteric fat stranding were evaluated.
Results: There was a significant difference in median length of the mass between 
CD and CRC, 98 and 49 mm, respectively (p < 0.001). Diverticula included in the 
mass were visible in all patients with CD, but in none of the patients with CRC (p 
< 0.001). A curved growth pattern of the mass was noted in all but one patient 
with CD versus three out of 28 patients with CRC (p < 0.001). There were no 
significant differences between the groups with respect to median luminal 
narrowing (84 vs 83%, p = 0.3), presence of perilesional lymph nodes (p = 0.3) 
and presence of perilesional mesenteric fat stranding (p = 0.3).
Conclusion: To differentiate CD and CRC masses, the length of the mass, 
inclusion of diverticula and growth pattern are important discriminating factors.
SS 5.06
Learning and training in virtual colonscopy: difficulty 
and facility in recognizing findings by expert and 
unexpert examiners
G. Guzzetta, M. Guzzetta, B. Barusco, A. Biagioli, G. Feltrin; 
Padova/IT
Purpose: To choice the best method reporting the cancer findings in virtual 
colonscopy (CCT), we compared two different models of learning and 
training through the conventional findings of barium enema and without their 
previous experience.
Material and Methods: We compared the accuracy in reporting made by an 
expert radiologist (A) who has experience with barium enema studies and the 
results obtained by a beginning radiologist (B), as resident, in recognizing the 
same findings in the same cases. Both results were also compared with CAD 
of the system (PEV-Leonardo, Siemens).
Results: The A results are more accurate in recognizing the protruding and flat 
cancers compared with B readers (sensitivity 90% vs 68%). The CAD system 
is useful for flat lesions, which easily could be missed by A observer and more 
easily by B reader. Usually the CAD is highly sensitive and it could be useful, in 
particular way with the less prominent lesions.
Conclusion: The great experience derived by barium enema is not much 
improving the accuracy in reading by the expert reader (A) because it increases 
also the FP results. Therefore, in the other hand, it is more useful for the 
unexperienced reader (B). A previous experience with traditional study is not 
recommended for young radiologist, even a learning of cancer findings with 
the barium enema studies appears less useful. More aid could be achieved by 
A and B readers using CAD system.
SS 5.07
CT colonography: comparison of visual search patterns 
in experienced and novice readers
D. Boone1, S. Halligan1, P. Phillips1, S. Mallett2, D. Altman2, 
S.A. Taylor1, A. Gale3, D. Manning4; 1London/UK, 2Oxford/UK, 
3Loughborough/UK, 4Carlisle/UK
Purpose: Diagnostic accuracy can vary between observers due to differences 
in ability to detect and characterise lesions. Eye tracking technology has been 
used to explore visual search during plain radiographic interpretation but not 
complex 3D tasks. We compared search strategies of novice and experienced 
readers interpreting CT colonography.
Material and Methods: Endoscopically validated CTC datasets, containing 8 
lesions reported by experienced readers in a prior study were selected (mean polyp 
size = 10mm; range 5-25mm). Video clips (mean = 26s) were interpreted by faculty 
members (n = 10) or participants (n = 19) during 3 CTC workshops. Case order and 
polyp appearance time were randomised. Visual search was recorded using a Tobii 
X150 eye tracker and observers indicated potential polyps with a mouse click.
Results: Visual search patterns were recorded satisfactorily. Of 5 true positive 
lesions, novices indicated a median of 3 lesions (range 1 to 5) and experienced 
readers indicated a median of 4 lesions (range 2 to 5), giving good accuracy 
calibration data for the development of new eyetracking metrics. Both novices 
and experts identified true positive lesions at a median of 3.3 seconds after the 
lesion was first visible, although times varied by lesion.
Conclusion: Visual tracking during 3D interpretation is technically feasible. 
Experienced readers on average identified more lesions, although both novices 
and experts took on average similar times to indicate polyps. Further studies 
will assess the effect of training on visual search pattern.
SS 5.08
Effect of training on different experienced readers with 
and without the assistance of a CAR software when a 
primary 3D flythrough approach is used
F. Vecchietti1, M. Rengo2, F. Iafrate2, D. Caruso1, M. Maceroni1, 
A. Laghi1; 1Latina/IT, 2Rome/IT
Purpose: To investigate the learning process of two inexperienced readers 
when a primary 3D flythrough approach is used with and without the 
assistance of a CAR software.
Material and Methods: Two readers evaluated 50 patients with 100 endoscopically 
proved polyps (ranging from 3 mm to 40 mm) and different colonic preparations 
(fluid tagging and full cathartic preparation) with and without the assistance of a 
CAR softaware. Datasets analysis was performed during 10 sessions (5 assisted 
and 5 unassisted). Per-polyp sensitivity, learning curve for both approaches, 
mean reporting time and false positive were evaluated for each approach.
Results: Both readers increased progressively per-polyp sensitivity, 
respectively, from 75% and 61% for 3D analysis to 86% and 74% for primary 














Results: In 18 cases (72%), CT depicted peripancreatic and perianastomotic fluid 
collections with air bubbles (9, one patient with mild amylase drainage content 
was septic for hepatic abscess) and homogeneously hypodense (8). Diagnostic 
confirmation was obtained with US percutaneous drainage (13), and relaparotomy 
(5). In 6 cases (28%), CT was negative for abdominal fluid collections. In one 
patient with severe and prolonged amylase drainage output, CT did not show 
abnormalities. Sensibility, specificity, accuracy , positive , negative predictive 
value for CT were 95%, 88%,93% 95% and 88%, respectively.
Conclusion: 64-scan CT is an accurate technique to evaluate patients 
underwent pancreatoduodenectomy with clinical suspicion of PF, as it depicts 
the extension of abdominal fluid collections and defines the possible treatment. 
Output through surgical drains with amylase content greater than three times 
the normal serum value, in addition to CT evidence of peripancreatic and 
perianastomotic fluid collections enables to diagnose PF.
SS 6.04
At war with the clinicians. Should we still perform erect 
abdominal radiographs just because the clinicians 
request them?
D.D. Cokkinos, E. Antypa, P. Tserotas, V. Kostaras,  
A. Parlamenti, K. Stefanidis, F. Lazarioti, Z. Zafiraki,  
D. Kitsos, E. Tavernaraki, P. N. Piperopoulos; Athens/GR
Purpose: According to various international radiological references and 
guidelines, erect abdominal radiographs are not part of routine abdominal 
imaging, but in most cases have been replaced by supine X rays. However, 
clinicians still ask for them, especially for the assessment of bowel obstruction 
and pneumoperitoneum. We examine if this practice is warranted.
Material and Methods: We retrospectively review abdominal radiographs 
requested by clinicians from 334 patients and performed for the detection of 
obstruction, pneumoperitoneum, appendicitis, abdominal pain, cholecystistis, 
nausea/vomiting, pancreatitis, Crohn’s disease, haematemesis and calculi. We 
examine the patients’ position as requested by the clinician (erect or supine). 
We compare abnormal findings in the two positions.
Results: In 220/334 patients (65.9%) abdominal radiographs were performed 
in the erect position. Of these, 34 (15.5%) were abnormal. Supine radiographs 
were performed in 114/334 patients (34.1%). Of these 45 were abnormal 
(39.5%). Supine radiographs revealed abnormal findings in more cases in 
comparison to erect (p < 0.0001-Fischer’s exact test).
Conclusion: Erect abdominal radiographs do not reveal pathology more often 
than supine. They are also more difficult to perform in obese and debilitated 
patients. Recent medical literature and guidelines do not include them in routine 
imaging assessment. Except for very few indications, they should be abandoned.
SS 6.05
Sensitivity and specificity in identifying cocaine drug mules 
by computed tomography, plain radiograph and Lodox
P.M. Flach, S. Ross, G. Hatch, U. Preiss, T. Ruder,  
M.J. Thali, M.A. Patak; Bern/CH
Purpose: To retrospectively evaluate the specificity and sensitivity of multi-
detector computed tomography (MDCT), digital radiography (DR) and low-
dose linear slit digital radiography (LSDR, Lodox) in the detection of 
incorporated cocaine containers.
Material and Methods: 50 patients suspected of having incorporated cocaine 
drug containers (45m, 5f, 16-45yrs) were included in the study. All underwent 
radiological imaging: MDCT n = 27, CR n = 50, LSDR n = 12. A total of 89 
exams were performed. Radiological findings were compared with the written 
record of evidence recovered from the feces of each detained suspect in the 
hospital-affiliated custody ward. Image analysis was performed prior to 
knowledge of the gold standard: cocaine packs from feces. Sensitivity and 
specificity for drug concealment were calculated for each modality.
Results: There were 43 drug mules. Seven patients did not incorporate any drug 
containers. In the 27 MDCT exams, 18 were true positive (TP), 8 true negative 
(TN), 1 false positive (FP) and no false negative (FN). For CT, sensitivity was 
100%, specificity 88%, positive predictive value (PPV) 95% and negative 
predictive value (NPV) 100%, respectively. In 50 DR exams, 21 were TP, 14 TN, 
6 FP and 9 FN showing a sensitivity of 70%, specificity 93%, PPV 77% and NPV 
60%, respectively. LSDR (total number of 12) showed 6 TP, 3 TN, 2 FP and 1 FN 
with a sensitivity of 85%, specificity 60%, PPV/NPV 75%, respectively.
Conclusion: The detection of incorporated cocaine drug packs should be performed 
by MDCT, rather than by DR or LSDR, in order to provide 100% sensitivity. In the 
future for radiation protection, low-dose protocols need to be implemented for 





Quantification of adipose tissue on abdominal CT: a new 
biomarker for the severity of acute pancreatitis? 
Preliminary results
A. Furlan, G. Papachristou, B. Park, K.T. Bae; Pittsburgh, PA/US
Purpose: To quantify abdominal fat volumes on CT images of patients with acute 
pancreatitis (AP), and to correlate them with patient’s BMI and severity of disease.
Material and Methods: Study cohort included 26 patients (16M, 10F; mean age, 
54 years – BMI: 19-40kg/m2; mean, 26kg/m2) with AP and available MDCT scan. 
Abdominal fat was segmented and measured from unenhanced CT images using 
semi-automated segmentation program. Abdominal total adipose tissue (TAT) 
was quantified from diaphragm dome to pelvis and further divided into visceral 
adipose tissue (VAT) and subcutaneous adipose tissue (SAT). Severity of 
pancreatitis was defined as development of multi-system organ failure (OF). 
Pancreatic necrosis was determined from contrast-enhanced MDCT. Correlation 
between BMI, SAT, VAT, and TAT was assessed using Pearson’s coefficient (r). 
Association between the mean values of fat measurement and development of 
pancreatic necrosis and OF was assessed with Student’s t-test.
Results: BMI strongly correlated with TAT (r = .767, p < .001), VAT (r = .662, p< .001) 
and SAT (r = .654, p < .001). 8/26 (31%) patients had pancreatic necrosis: mean 
BMI and TAT in patients with pancreatic necrosis (30.3 ± 5kg/m2, and 14.6 ± 5.2L) 
were significantly larger than those without necrosis (25.2 ± 5.4kg/m2, and 9.7 
±4.7L). 9/26 (35%) patients developed OF; mean VAT was higher in patients with 
OF than without (5.9 ± 3.5L vs.4.4 ± 2.4L).
Conclusion: High BMI and TAT were associated with increased pancreatic 
necrosis. VAT tended to increase in patients with OF.
SS 6.02
Severe acute pancreatitis requiring drainage therapy: 
findings on computed tomography as predictor of 
patient outcome
P. Heiss, T. Bruennler, B. Salzberger, C. Stroszczynski,  
O.W. Hamer; Regensburg/DE
Purpose: To evaluate whether morphologic features on computed tomography 
(CT) correlate with outcome of patients with severe acute pancreatitis.
Material and Methods: 80 patients with severe acute pancreatitis requiring 
percutaneous drainage therapy were retrospectively analyzed. Twelve CT 
features beyond the CT severity index (CTSI) were studied. Endpoints for patient 
outcome were patient death, length of hospital and ICU stay. The twelve features 
and the CTSI score were correlated with mortality using Kaplan-Meier estimator 
and correlated with length of hospital and ICU stay using Chi-square test. A 
p-value of )0.05 was considered statistically significant.
Results: Two CT features exhibited a significant correlation with mortality: (1) 
the number of parts of pancreas (head/corpus/tail) that exhibited areas of 
necrosis and (2) the presence of distant fluid collections (posterior pararenal 
space and/or paracolic gutter). Mortality was 42% (21 of 50 patients) and 20% 
(6 of 30 patients) if two/all three parts or none/one part of the pancreas 
exhibited necrosis, respectively. Mortality was 46% (18 of 39 patients) and 
22% (9 of 41 patients) if distant fluid collections were present or absent, 
respectively. Based on these two features, we propose a new simple CT score 
to stratify patient risk. All other imaging features including the CTSI showed no 
significant correlation with patient outcome.
Conclusion: We identified that two morphologic features on CT might be helpful 
to predict prognosis of patients suffering from severe acute pancreatitis.
SS 6.03
Role of 64-scan CT in the detection of pancreatic fistula 
after pancreatoduodenectomy
M.C. Gibertini, A. Pecchi, M. De Santis, G. Della Casa,  
F. Di Benedetto, P. Torricelli; Modena/IT
Purpose: To evaluate the role of 64-scan CT in the detection of pancreatic 
fistula (PF) after pancreatoduodenectomy.
Material and Methods: Between September 2004 and September 2009, 63 
patients (37 males, 26 females, mean age 64.5 years), underwent 
pancreatoduodenectomy. During postoperative period, 25/63 patients with 
abdominal pain, fever, leucocytosis and output through operatively placed 
drains with amylase content greater than three times the normal serum value 
were evaluated with 64-scan CT before and after intravenous contrast medium 
administration in precontrastographic, arterial and venous phases.
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Material and Methods: 33 patients with IBD were studied blindly and consecutively 
with CEUS just after colonoscopy with biopsy. The routine histological exam was 
completed by the count of the vessels in 10 optical fields with high magnification 
(40x) after haematoxylin and eosin stain and CD34. The data considered were the 
features usually considered in the study of these diseases: type of IBD, presence 
or absence of symptoms, therapy, CPR value, endoscopic, histological and 
ultrasound disease degree. We added the count of vessels and the enhancement 
quantitative evaluation (PEAK%, TTPs, RBV, RBF, MTTs) (Qontrast, e-AMID/
BRACCO). Statistical analysis was performed with T-test study.
Results: 21/33 patients (Group 1) resulted affected by active disease at the 
endoscopic, histological and US/CEUS study; and 12/33 patients (Group 0) 
showed quiescent disease. The count of vessels at the histopathologic 
examination demonstrated a significant different range between the two 
groups: from 265 to 396 (mean 349) vessels in Group 1 and from 136 to227 
(mean 148) in the Group 0. All the results were statistically significant respect 
to the number of vessels, in particular a strictly correlation was demonstrated 
between quantitative evaluation and vessels within the bowel wall. The 
statistical analysis permits to demonstrate a cutoff value of Peak%. TTPs, and 
RBF in order to distinguish active or non-active disease.
Conclusion: The study demonstrates high accuracy of this quantitative analysis 
of the enhancement to evaluate the activity degree of the IBD disease.
SS 6.09
Superior mesenteric artery embolism: imaging markers 
of bowel necrosis using MDCT angiography
A. Huete, C. Besa, P. Bächler; Santiago/CL
Purpose: To retrospectively correlate superior mesenteric embolism (SME) 
morphology and patterns of abnormal bowel wall (aBW) with bowel necrosis 
(BN), using MDCT angiography.
Material and Methods: 31-patients were diagnosed with SME (2001-2010; age: 
45-94yo). Biphasic MDCT angiography was performed. Images were reviewed 
using advanced vessel analysis software. Distance of SME from ostium and 
presence of occlusive clot were recorded. Patterns of aBW included: thin-wall 
without arterial and venous enhancement (wAV), thin-wall without arterial 
enhancement (wA), “target”-thickening (wT), homogenous-thickening (wH) and 
hyperEnhancement (wE). Ileus was defined as small-bowel diameter >2.5cm. 
Medical records were reviewed for surgical correlation and patient outcome.
Results: Twenty-patients underwent surgery. BN was found in thirteen (42%). 
Mortality was 29%, all with BN. SME-distance from ostium was not correlated 
with neither BN nor mortality. Occlusive clot was associated with BN (p < 0.05) 
but not with mortality. Normal bowel was seen in 9 patients, with no BN or 
mortality in this group. BN and mortality were strongly associated with wAV 
(76.9% vs. 15.0%, p < 0.001, and 88.9% vs. 13.9% p < 0.001, respectively) 
and ileus (93.3% vs. 22.2%, p < 0.001, and 100% vs. 31.8%, p < 0.01). wAV 
had 77% (95% CI: 46%-94%) sensitivity, 94% (71%-100%) specificity, 91% 
PPV, 85% NPV, and 13.8 +Likelihood-ratio for diagnosing BN. Ileus reported 
92% (62%-100%) sensitivity, 78% (52%-93%) specificity, 75% PPV, 93% 
NPV, and 4.2 +Likelihood-ratio to identify BN in patients with SME.
Conclusion: MDCT angiography optimally depicts markers of BN in SME. 
Ileus and wAV pattern both correlate strongly with BN and mortality.
SS 6.10
Diagnosis of intestinal traumatic lesions: 
contribution of CT
E. Danse, T. Van Drogenbroeck; Brussels/BE
Purpose: To evaluate the role of MDCT in the diagnosis of bowel traumatic 
lesions, and to identify CT signs contributive for the optimal treatment option.
Material and Methods: Retrospective analysis of our database and selection of 
patients with a final diagnosis of bowel trauma. 11 cases were identified in whom 
the following CT signs were noted: focal bowel wall changes (disruption, thickening, 
modified enhancement), pneumoperitoneum, iodine extravasation in the 
mesenteric folds, infiltration or haematoma into the mesentery, free fluid, abdominal 
wall changes. We compared the CT findings with surgery or the clinical evolution.
Results: 10 cases were operated with a favorable outcome. Surgery was 
required for bowel rupture (complete in 8 and superficial in 2). The non-
operative patient had a duodenal haematoma. Free fluid was noted in 10 , 
infiltration of the mesentery in 8, focal wall thickening in 8, focal disruption of 
the gut in 8, intraperitoneal gas in 7, reduced enhancement of the gut in 5, 
haematoma into the meso in 5, abdominal wall changes in 5, bowel pneumatosis 
in 2 and extravascular iodine contrast in the mesentery in 1.
Conclusion: The most frequent CT signs of bowel trauma include focal 
disruption of the bowel wall, extradigestive gas and focal reduced enhancement 
of the gut. A larger series are need to identify the best CT sign helping for the 
choice for an optimal treatment.
SS 6.06
MRI features associated with acute appendicitis  
(pilot study)
M. Leeuwenburgh1, M. Thieme2, B. Wiarda2, S. Bipat1,  
P.M. Bossuyt1, M. Boermeester1, J. Stoker1; 1Amsterdam/NL, 
2Alkmaar/NL
Purpose: To identify MRI features associated with appendicitis.
Material and Methods: Radiological signs expected to be associated with 
acute appendicitis were recorded by sixteen readers (9 radiologists, 7 
residents) in 82 abdominal MRI scans of patients with suspected appendicitis. 
Previously, the readers were trained to appraise MRI examinations for 
appendicitis with 20 scans, receiving direct feedback. An expert panel assigned 
acute appendicitis as final diagnosis in 36 of 82 patients based on 
histopathology and follow-up. Associations between imaging features and 
acute appendicitis were evaluated with logistic regression analysis.
Results: We evaluated 1291 MRI readings. Seven evaluated MRI features 
were associated with acute appendicitis in multivariable analysis: thickened 
appendix (>6mm), peri-appendiceal fat infiltration, peri-appendiceal fluid, 
appendicolith, restricted diffusion of the appendiceal wall, the appendiceal 
lumen and of focal fluid collections. The probability of appendicitis was at least 
89% if two of these MRI features were present, 91% if three MRI features were 
present. The combination of peri-appendiceal fat infiltration and presence of 
an appendicolith on MRI had the highest probability of appendicitis (99%, 
95% CI 94-100%). In the absence of any of these features appendicitis was 
present in 7% (95% CI 5-10%) of patients.
Conclusion: Presence of a thickened appendix (>6mm), peri-appendiceal fat 
infiltration, peri-appendiceal fluid, appendicolith, restricted diffusion of the 
appendiceal wall, the appendiceal lumen and focal fluid collections on MRI are 
associated with acute appendicitis.
SS 6.07
Does additional diffusion weighted imaging improve the 
detection of acute appendicitis in MRI?
M. Leeuwenburgh1, M. Thieme2, B. Wiarda2, S. Bipat1,  
P.M. Bossuyt1, M. Boermeester1, J. Stoker1; 1Amsterdam/NL, 
2Alkmaar/NL
Purpose: To evaluate if additional diffusion weighted imaging (DWI) increases 
the detection of acute appendicitis in MRI.
Material and Methods: Sixteen readers (9 radiologists, 7 residents) examined 
82 abdominal MRI scans of patients with suspected appendicitis. Previously, 
these readers were trained to appraise diffusion weighted images for appendicitis 
with 20 scans, receiving direct feedback. Presence of appendicitis was first 
recorded after viewing T2 weighted images (coronal and axial HASTE with and 
without fat saturation) and secondly after viewing diffusion weighted images 
(coronal and axial). An expert panel assigned acute appendicitis as final 
diagnosis in 36 of 82 patients based on histopathology and follow-up. Mean 
sensitivity and specificity were calculated for the first and second diagnoses.
Results: We evaluated 1291 MRI readings. Mean sensitivity of the readers 
increased from 83% (95%CI 80-86%) to 88% (95%CI 85-91%, p < 0.001) after 
viewing the additional DWI, whereas specificity decreased from 91 (95%CI 
88-93%) to 87 (95%CI 84-89%). Readers’ accuracy did not improve 
significantly between the first and the last set of 20 scans. The addition of DWI 
reduced the percentage of inconclusive findings from 24% (95%CI 22-26%) to 
11% (95%CI 9-12%). Readers assigned the correct diagnosis in 157 out of 
309 inconclusive scans after viewing DWI. The additional DWI was indicated 
as helpful in 64% of all examinations.
Conclusion: Addition of DWI increased sensitivity for acute appendicitis in 
MRI significantly and reduced the percentage of inconclusive results.
SS 6.08
The quantitative analysis of the enhancement of the 
bowel wall with contrast-enhanced ultrasound in the 
evaluation of activity degree in patients with 
inflammatory bowel diseases correlated to the 
histopathologic features
L. Romanini1, M. Passamonti2, M. Navarria3, F. Calliada4,  
L. Grazioli1, R. Maroldi1; 1Brescia/IT, 2Lodi/IT, 3Como/IT, 4Pavia/IT
Purpose: In order to demonstrate the accuracy of the semi-quantitative 
analysis of the enhancement of the bowel wall after CEUS in patients with 
inflammatory bowel disease (IBD), as objective evaluation, the results were 
related to an objective “quantitative” histopathologic analysis of same bowel 
wall: the count of vessels after haematoxylin and eosin stain and CD34, 
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Material and Methods: Sixty-two consecutive patients with 159 FLLs 
underwent EOB-enhanced MRI during the hepatocyte phase at 5, 10, 15, and 
20 minutes, with both low (10°) and high (30°) FAs. Two blinded radiologists 
independently and randomly reviewed the two image sets using a four-point 
rating scale. Receiver operating characteristic (ROC) analysis was performed, 
and sensitivities and specificities were calculated. Lesion-to-liver contrast 
ratio (LLC) on all hepatocyte phase images was measured.
Results: The area under the ROC curve for the detection of all FLLs at 5 and 
10 minutes with high FA was significantly higher than that with low FA, for both 
readers (P < 0.01). The sensitivities with high FA for small ()10mm) malignant 
FLLs were significantly higher than those with low FA, at all time points, for 
both readers (P < 0.05). LLCs with high FA were significantly higher than those 
with low FA at all time points (P < 0.001).
Conclusion: Hepatocyte phase EOB-enhanced MRI with high FA can 
significantly increase LLC and improve the detection of FLLs, particularly 
small malignant lesions.
SS 7.04
Characteristics of hepatocellular adenomas in Gd-EOB-
enhanced MRI
C. Grieser, I.G. Steffen, C.M. Perez Fernandez, L. Stelter,  
D. Schnapauff, J.H. Rothe, B. Hamm, T. Denecke; Berlin/DE
Purpose: To retrospectively evaluate MRI characteristics with hepato-
specified contrast media (Gd-EOB-DTPA) of histopathologically confirmed 
hepatocellular adenomas (HCA).
Material and Methods: Thirteen patients who underwent liver MRI (1.5 T) and 
subsequently histologically proven HCA were retrospectively included. The 
examination protocol contained: T1-in-and opposed-phase; T2-w, and fs T1w 
sequences before and after Gd-EOB-DTPA application (arterial (ap), portal 
venous (pv), venous (vp), and hepatobiliary phase (hbp; 20 minutes delay)). 
Standard of reference was surgical exploration (n = 11) or diagnostic puncture 
(n = 2). Two blinded radiologists analyzed the MR images in consensus (criteria: 
size; shape; texture; fat; haemorrhage and intensity of HCA and liver). 
Furthermore, relative dynamic signal intensity (SI) values in comparison to the 
pre-contrast SI-values were recorded (liver, muscle, and HCA).
Results: In total, 31 HCA were evaluated. All HCA showed a strong contrast 
uptake in the ap (56.8 (±58.9)%; p < 0.001); 13 HCA showed “wash out” in the 
vp and all adenomas presented a relative contrast uptake in the hbp (51.4 
(±40.8)%; p < 0.001). Visually, 5 HCA were iso-/hyperintens compared to the 
surrounding liver parenchyma in the fs T1w images of the hbp; all of these were 
found in only 2 patients with prominent fatty livers.
Conclusion: All HCA showed a significant contrast uptake in the hbp, however 
significantly less than the surrounding liver parenchyma. In case of distinctive hepatic 
steatosis, a hyperintensity of HCA on fs T1w images can be seen in the hbp.
SS 7.05
Gadolinium-EOB-DTPA-enhanced MRI in differentiating 
focal nodular hyperplasia from hepatocellular adenoma
M. Bieze, J.W. van den Esschert, C. Yung Nio, R.B. Reitsma, 
T.M. van Gulik, S.S.K.S. Phoa; Amsterdam/NL
Purpose: We assessed the accuracy of Gadolinium-EOB-DTPA compared to 
conventional gadolinium-enhanced MRI in differentiating FNH from HCA, with 
histological outcome as standard of reference.
Material and Methods: In this prospective study, 55 consecutive patients 
suspected of FNH or HCA underwent a gadolinium-EOB-DTPA MRI of the liver. 
Conventional series included dynamic contrast-enhanced T1-weighted FS 
series, T1 in/out of phase, T2, and diffusion, followed by delayed hepatobiliary 
phase. The two imaging studies were stored separately and evaluated by two 
blinded abdominal radiologists. Diagnosis on conventional imaging was based 
on lesion characteristics (bleeding, central scar, shape) and enhancement 
pattern. In addition, diagnosis based on the hepatobiliary phase was regarded 
diagnostic for FNH if accumulation of contrast was seen and diagnostic for 
HCA without accumulation. Imaging results were compared to histological 
outcome as standard of reference (SOR) and obtained by biopsy or resection.
Results: SOR revealed HCA 23 and FNH 32. The conventional MRI showed a 
sensitivity of 52.2% for HCA with a positive predictive value (PPV) of 92.3% 
and for FNH of 56.3% (PPV 94.7%). The hepatobiliary phase showed a 
sensitivity for HCA of 95.7% (PPV 92.7%) and for FNH of 93.8% (PPV 96.8%). 
Features with significant predictive value for diagnosis included bleeding for 
HCA (p = 0.040) and a central scar for FNH (p = 0.001).
Conclusion: The hepatobiliary phase of the Gd-EOB-DTPA contrast 
significantly increases the sensitivity of MRI in differentiating FNH from HCA.
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SS 7.01
Characterization of incidental liver mass: comparison of 
multidetector CT versus gadoxetate disodium-enhanced 
MR imaging
Y.E. Chung, M. Kim, Y.E. Kim, M. Park, J. Choi, S. Baek,  
W. Chung, J.S. Lim, K.W. Kim; Seoul/KR
Purpose: To retrospectively compare the accuracy of contrast-enhanced 
multidetector-CT (MDCT) and gadoxetate-disodium-enhanced MRI (EOB-
MRI) for characterization of incidental liver masses.
Material and Methods: 127 incidental liver masses (94 benign and 33 malignant: 
hemangioma, 24 lesions; focal nodular hyperplasias [FNH] 27; eosinophilic 
abscess, 15; focal fat deposition, 3; angiomyolipoma, 3; schwannoma, 1; 
hepatocellular carcinoma, 24; cholangiocarcinoma, 6; inflammatory 
pseudotumor, 2; and embryonal sarcoma, 1) found in 80 (M:F = 45:35) patients 
without primary extrahepatic malignancy or chronic liver disease were included. 
All patients underwent EOB-MRI and MDCT. Two radiologists reviewed EOB-
MRI and MDCT independently. Area under the ROC (Az) values were calculated 
to compare the diagnostic performance for differentiation of benign and 
malignant (B/M) lesions. The accuracy for the differentiation of B/M lesions and 
for the specific diagnosis of diseases were also compared.
Results: The accuracy for the differentiation of B/M lesions was significantly higher 
with EOB-MRI (94.5%) than with MDCT (74.0%) for reader 2 (R2, P < 0.001), but was 
comparable for reader 1 (R1, EOB-MRI: 97.6%; MDCT: 92.9%; P = 0.050). Az values 
for differentiation of B/M lesions with MDCT (R1, 0.963; R2, 0.988) and EOB-MRI 
(R1, 0.977; R2, 0.975) were comparable (R1, P = 0.621 and R2, P = 0.504). For the 
diagnosis of FNH, accuracy was significantly higher with EOB-MRI (R1, 96.3%; R2, 
77.8%) than with MDCT (R1, 66.7%; R2, 22.2%). Diagnosis rates of the remaining 
diseases were comparable between EOB-MRI and MDCT for both readers.
Conclusion: For characterization of incidental liver masses, EOB-MRI may 
provide higher accuracy than MDCT for the differentiation of B/M lesions. 
Specific diagnosis of focal nodular hyperplasia can be significantly improved 
with EOB-MRI than with MDCT.
SS 7.02
Gadolinium-ethoxybenzyl-diethylene triamine penta-
acetic acid-enhanced magnetic resonance imaging of 
the liver: timing of T1 and T2-weighted sequences
N. Hersey1, R. Musson2, A. Blakeborough2; 1Derbyshire/UK, 
2Sheffield/UK
Purpose: To compare the signal intensity and relative enhancement of liver parenchyma 
at set time intervals following injection of gadolinium-ethoxybenzyl-diethylene triamine 
penta-acetic acid (Gd-EOB-DTPA) in both T1 and T2-weighted breathhold sequences.
Material and Methods: We performed a retrospective analysis of all patients at our 
institution during an 18-month period undergoing gadolinium-ethoxybenzyl-diethylene 
triamine penta-acetic acid (Gd-EOB-DTPA)-enhanced liver MR imaging. All patients 
with repeat imaging or abnormal liver function tests were excluded. Each patient 
underwent T1- and T2-weighted breathhold sequences at 3, 6, 10 and 20 minutes post-
injection of Gd-EOB-DTPA, as well as pre-contrast imaging. Signal-to-noise ratio was 
determined for each patient at each time interval and relative enhancement calculated.
Results: 101 patients were eligible for the study with a mean age of 51 years. 
The relative enhancement increased incrementally at each time interval on the 
T1-weighted imaging, with a 64% mean increase by 20 minutes. Between 10 
and 20 minutes post-contrast, the relative enhancement increased by 20%. 
There was negative relative enhancement of the liver parenchyma on all post-
contrast T2-weighted sequences with a mean reduction of 13.5%.
Conclusion: Only a modest negative relative enhancement of liver parenchyma 
was observed following Gd-EOB-DTPA administration on T2-weighted imaging. 
Liver enhancement on T1-weighted imaging increases incrementally up to 20 
minutes. In contrast, timing of post-contrast T2-weighted imaging is less critical.
SS 7.03
Improved focal liver lesion detection on gadoxetic acid 
disodium-enhanced hepatocyte phase MRI with 
increasing the flip angle protocol
H. Haradome, K. Al Manea, T. Bonaventure, L. Grazioli; 
Brescia/IT
Purpose: To determine whether hepatocyte phase gadoxetic acid disodium 
(EOB)-enhanced MRI using a high flip angle (FA) improves focal liver lesion 
(FLL) detection compared to using a standard low FA.
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Results: For both readers, the Az values were higher when dealing with the 
20-min hepatospecific phase images, but differences were not significant. The 
sensitivity values were higher in session B (92.12 vs 94.78 for reader 1 and 
95.65 vs 96.52 for reader 2), without significant differences. On the other hand, 
when considering the detectability of lesions )1cm, the less experienced 
reader’s confidence was significantly higher when assessing the 20-min 
hepatospecific phase images (p = 0.001).
Conclusion: When dealing with the detection of colorectal metastases in 
non-cirrhotic liver we can save up 10 min of examination time for Gd-EOB-
DTPA-enhanced MR imaging.
SS 7.09
Diffusion-weighted MR imaging of the liver after 
administration of different gadolinium contrast agents: 
is it still reliable?
S. Kinner, L. Umutlu, S. Blex, G. Antoch, T.C. Lauenstein; 
Essen/DE
Purpose: Diffusion-weighted imaging (DWI) is an emerging technique for 
abdominal MRI. DWI is usually performed before intravenous contrast injection. 
However, it may be necessary or time-saving to acquire DWI data after 
gadolinium administration. We aimed to compare DWI before and after the 
administration of different gadolinium compounds.
Material and Methods: 15 patients with known HCC underwent liver MRI at 
1.5T (Magnetom Avanto, Siemens) including DWI on day 1 before and after 
administration of gadobutrol (Gadovist®) and on day 2 after administration of 
EOB-gadolinium-DTPA (Primovist®). Signal to noise ratios (SNR) and contrast to 
noise ratios (CNR) of HCC lesions and liver parenchyma were determined for all 
acquired DWI data sets. Furthermore, ADC values were calculated and compared 
using a Wilcoxon test. A p-value <0.05 indicated statistical significance.
Results: There were no statistically significant differences regarding SNR pre-
contrast (mean: 43.3), after gadobutrol (43.2) or after EOB-gadolinium-DTPA 
(46.5). Similarly, significant differences were found neither for CNR (average 
values: 34.7 vs. 32.1 vs. 35.7) nor for ADC values (1.5 vs. 1.4 vs. 1.5 x 10-3).
Conclusion: There is no significant difference regarding DWI of HCC before 
and after intravenous injection of a liver-specific agent (EOB-gadolinium-DTPA; 
Primovist®) as well as a highly concentrated compound (gadobutrol; 
Gadovist®). Hence, it is feasible to run DWI after gadolinium either as an 
alternative for unsuccessful pre-contrast DWI or as a gap filler to spare time in 
EOB-gadolinium-DTPA imaging.
SS 7.10
Does diffusion weighted imaging add diagnostic 
confidence in characterizing focal lesions if included in 
contrast-enhanced magnetic resonance imaging (MRI) 
of the liver?
R. Girometti, M. Del Pin, S. Pullini, L. Cereser, C. Zuiani,  
M. Bazzocchi; Udine/IT
Purpose: To investigate whether DWI improves the diagnostic confidence in 
focal lesions characterization when added to contrast-enhanced liver MRI.
Material and Methods: One experienced abdominal radiologist, blinded to 
clinical information, reviewed thirty-six focal liver lesions (11 benign, 25 
malignant) in 23 patients who underwent MRI on a 1.5T magnet. Pre- and 
post-i.v. Gd-BOPTA sequences were reviewed without (set 1) and with single-
shot echo-planar DW images and apparent diffusion coefficient (ADC) maps (b 
= 50, 400, 800 sec/mm2) (set 2) in separate sessions. The reader recorded on 
a 1-5 score: (i) the confidence in lesion diagnosis (malignant/benign nature and 
type), for both sets; (ii) the impact of ADC vs. signal intensity (DWI images/ADC 
map) in achieving the diagnosis, for set 2.
Results: No significant difference (p > 0.01; Wilcoxon test) was found between the 
confidence scores of sets 1 and 2, both for lesions nature (mean:4.25 ± 0.8 vs. 
4.11 ± 0.7, respectively) and type (4.11 ± 0.97 vs. 4.02 ± 084). Reader attributed 
significantly greater impact to signal intensity than ADC in achieving the diagnosis 
both for lesions nature and type (scores of 4.08 ± 1.15 vs. 3.2 ± 1.42 and 
3.9 ± .1.13 vs. 2.9 ± 1.39, respectively) (p < 0.01; Wilcoxon test). Accuracy in 
characterizing lesions nature was similar without or with DWI (83.3%).
Conclusion: Expert reader relied on DWI signal intensity to characterize focal 
liver lesions. Nonetheless, DWI adds neither diagnostic confidence nor 
accuracy to contrast-enhanced MRI. Work-in-progress results will show 
whether DWI is more useful for less-experienced readers.
SS 7.06
The value of gadoxetic acid–DTPA-enhanced MR 
imaging in the differential diagnosis of hepatocellular 
adenoma and focal nodular hyperplasia
H. Haradome, K. Al Manea, T. Bonaventure, L. Grazioli; Brescia/IT
Purpose: To evaluate the utility of gadoxetic acid (Gd-EOB-DTPA)-enhanced 
MRI in the differential diagnosis of hepatocellular adenoma (HCA), and focal 
nodular hyperplasia (FNH).
Material and Methods: Seventy-five patients with pathologically proven 71 
nodules (28 FNHs and all 43 HCAs) and 40 FNHs diagnosed using typical 
imaging reference and follow-up studies were enrolled in this study. For 
quantitative analysis, contrast enhancement ratio (CER), lesion-to-liver contrast 
(LLC), and signal intensity (SI) ratio of each tumor on dynamic and hepatobiliary 
phase images were calculated. Two readers retrospectively and in consensus 
reviewed all images in terms of signal intensity features of each tumor on pre-
contrast, dynamic and hepatobiliary phase images.
Results: The mean CER of FNHs on arterial phase was significantly higher 
than that of HCAs (p < 0.01). During hepatobiliary phases, mean LLC of FNHs 
showed minimal positive value and that of HCAs demonstrated strong negative 
value. The areas under the receiver operating characteristic of hepatobiliary 
phase SI ratio for differentiation of the two tumors was 0.97, with sensitivity of 
100% and a specificity of 90% when using an optimal cutoff value of less than 
0.87. Among 6 FNHs showing atypical hypointense during hepatobiliary 
phases, the 4 FNHs had a large central scar, the one contained rich fat 
component, and the remaining one had abundant radiated fibrous septa.
Conclusion: Gd-EOB-DTPA-enhanced MRI facilitates accurate differentiation 
of FNH from HCA with potential ability of avoiding invasive biopsy.
SS 7.07
Detection of liver metastases using gadoxetate 
disodium-enhanced MR imaging: comparison of 
dynamic, 10-min, and 20-min delayed phase images
H.T. Jeong, M. Kim, M. Park, J. Choi, J.S. Choi, K.S. Kim, 
G.H. Choi, S. Shin; Seoul/KR
Purpose: To assess the incremental value of hepatobiliary phase images in 
gadoxetate disodium-enhanced magnetic resonance (MR) imaging, and to 
compare diagnostic accuracy and lesion conspicuity on 10-min and 20-min 
delayed images for the preoperative detection of hepatic metastases.
Material and Methods: Forty-six patients with 107 metastases who underwent 
surgery after MR imaging were evaluated. Four observers interpreted three sets 
of images: dynamic set, precontrast T1-, T2-weighted and dynamic images; 10-
min set, dynamic set with 10-min delayed; 20-min set, 10-min set with 20-min 
delayed. Diagnostic accuracy, sensitivity and positive predictive values were 
compared with subgroup analysis according to size and prior chemotherapy. 
Liver-to-lesion signal difference ratio (SDR) was also compared.
Results: Mean Az values and sensitivities were significantly higher for 10-min 
and 20-min sets than dynamic, with no significant difference between 10-min 
and 20-min. For small ()1cm) metastases and chemotherapy, sensitivities 
were significantly higher with 10-min and 20-min set than dynamic. The SDR 
was significantly higher on 10-min and 20-min images than precontrast and 
dynamic, with significantly higher on 20-min than 10-min.
Conclusion: Regardless of size or chemotherapy, detection of hepatic metastases 
was significantly improved by the addition of hepatobiliary phase images with no 
significant differences between 10-min and 20-min delayed images.
SS 7.08
Colorectal metastases detectability on hepatospecific 
phase of Gd-EOB-DTPA-enhanced MRI: can we save up 
10 minutes in MR examination time?
F. Sabatino, A. Filippone, R. Cianci, V. Bianco, A. Tartaro, 
A.R. Cotroneo; Chieti/IT
Purpose: To compare the conspicuity of colorectal hepatic metastases on 
hepatospecific phase MR images obtained 10 and 20 minutes after 
injection of Gd-EOB-DTPA.
Material and Methods: Fifty-four patients with non-cirrhotic liver and 
hystologically proved colorectal metastases were selected among patients who 
underwent Gd-EOB-DTPA-enhanced MR imaging. MR examinations were 
carried out at 1.5 T before and 25s, 70s, 180s, 10min, and 20min after Gd-EOB-
DTPA administration. Two readers of different experience independently evaluated 
lesion detectability according to a four-point confidence scale in two separate 
reading sessions including: A) unenhanced, dynamic and 10 min hepatospecific 
phase images; B) unenhanced, dynamic and 20-min hepatospecific phase 
images. The diagnostic accuracy (Az values), sensitivity, and confidence score of 
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Material and Methods: 58 patients who underwent preoperative CRT followed 
by radical surgery were enrolled in the study. The tumor volume before and 
after CRT was measured by a semi-automated software by two radiologists. 
The tumor volume reduction ratio, shown by MR volumetry, was compared 
with the histopathologic response and the DFS.
Results: Concordance correlation coefficient (ICC) between the two radiologist 
was 0.87 (0.76-0.93) for volumetry. The concordance correlation was 0.69 
(0.64-0.73) for both T staging. The mean tumor volume was 56cm3 +/- 7 in 
tumoral regression grade (TRG) 1-2 whereas the mean tumor volume in patient 
who showed TRG3-4 was 83 cm3+/-8. Patients with a volume reduction ratio 
of more 75% were associated with a higher DFS at 2 year (P = 0.0001).
Conclusion: Our study demonstrates that cancer volumetry is a reliable 
marker for rectal cancer prognosis. In contrary to traditional parameters (CRM, 
Downstagin), MRI volumetry might be easier to measure, faster to perform and 
predicts as well as other methods survival prognosis.
SS 8.04
Does the number of lymph nodes harvested at 
pathology in rectal cancer depend on the surgeon and 
pathologist only?
M. Maas, R.G.H. Beets-Tan, D.M.J. Lambregts, M. Berkhof, 
G. Beets; Maastricht/NL
Purpose: Prognosis of rectal cancer patients depends on the number of 
harvested nodes. Harvest depends on quality of surgery&pathology and 
patient factors. Aim was to evaluate with MRI whether there are differences in 
number&size of mesorectal lymph nodes (MRL) between patients with and 
without rectal cancer, which could influence nodal harvest.
Material and Methods: Size and number of MRL in 71 rectal cancer patients 
and in 30 controls were measured on 3DT1W-MRI with 1mm3 voxel size. 
Control patients had disease not affecting MRL. These measurements were 
compared between rectal cancer patients and controls and in subgroups of 
rectal cancer patients with and without positive nodes at pathology.
Results: Mean 16 ± 9 MRL were found per control vs. 21 ± 12 MRL per rectal 
cancer patient (p = 0.019). Mean node size for controls was 1.6 ± 0.8mm vs. 2.8 
± 1.5mm for rectal cancer patients (p < 0.0001). Number and size of MRL did not 
differ between the pN+ and pN0 rectal cancer patients: 21 ± 10 nodes/patient 
(pN+) vs. 22 ± 13 nodes/patient (pN0) (p = 0.61). Size was 3.2 ± 1.8 (pN+) vs. 2.5 
± 1.3 (pN0), p = 0.07. Number and size of rectal cancer patients with pN0 were 
significantly higher than in controls: p = 0.026 (number) and p = 0.001 (size).
Conclusion: Number and size of MRL are significantly higher in rectal cancer 
patients than in controls. This supports the literature that there might be an 
immune response to rectal cancer, leading to an increased number and size of 
nodes. Further research to evaluate the relationship between number and size 
of nodes at MRI and this immune response and prognosis is indicated.
SS 8.05
Gadofosveset-enhanced MRI for nodal staging in rectal 
cancer: predictive criteria
D.M.J. Lambregts, M. Maas, I.J.G. Rutten, W.H. Backes, 
R.G. Riedl, F.C.H. Bakers, V.C. Cappendijk, G. Beets,  
R.G.H. Beets-Tan; Maastricht/NL
Purpose: Recently we showed that MRI using a new lymph-node contrast 
agent (gadofosveset) can significantly improve accuracy for nodal staging in 
rectal cancer -- to a level that can be sufficient for clinical decision making. Aim 
of this study was to determine the most accurate predictive imaging criteria for 
lymph node assessment using gadofosveset-MRI.
Material and Methods: 33 patients underwent a 3D T1-weighted GRE sequence 
(1 mm isotropic voxels), both before and after administration of gadofosveset-
contrast. For each node the signal intensity (SI) was measured on pre- and post-
contrast MRI. Furthermore, the nodal border characteristics (“relief effect”) were 
scored. Finally, nodes were scored (using a 5-point confidence score) by an MR-
rectum expert, based on visual evaluation of SI and nodal relief. Nodes were 
drawn on an anatomical template for lesion-by-lesion histologic validation.
Results: 289 nodes (55 malignant) were analysed. On pre-contrast MRI, SI 
did not differ between benign and malignant nodes. On gadofosveset-MRI, 
SI was significantly higher in the benign nodes (p<0.0001), which resulted in 
an area under the ROC-curve (AUC) of 0.74. The combination of SI and nodal 
relief rendered an AUC of 0.88. When analysed visually, AUC for discrimination 
of metastatic nodes was 0.92.
Conclusion: Only benign nodes show uptake of gadofosveset-contrast. The 
best criteria are nodal signal intensity and a nodal relief. When analysed visually, 
these criteria provide high accuracy for discrimination of metastatic nodes.
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SS 8.01
Restaging nodal status after chemoradiation for locally 
advanced rectal cancer: predictive factors for ypN0-status
M. Maas, D.M.J. Lambregts, M. Berkhof, G. Beets,  
R.G.H. Beets-Tan; Maastricht/NL
Purpose: Restaging N-stage after chemoradiation (CRT) is more accurate 
than N-stage prediction at primary staging of rectal cancer. Aim was to identify 
predictive factors which can help a radiologist in predicting yN-stage.
Material and Methods: 39 patients with locally advanced rectal cancer underwent 
MR imaging before and after CRT. All visible nodes in the mesorectum were 
measured and recorded before and 6-8 weeks after CRT on 3DT1W-GRE-
sequence with 1mm3 voxel size. Baseline characteristics were collected and 
compared between patients with and without nodal involvement at pathology. With 
regression analyses predictive factors for nodal involvement were identified. ROC 
curves were constructed for a predictive model based on the regression analyses.
Results: 913 nodes were identified, of which 392 (43%) disappeared after CRT. 
Patients with ypN+ had larger nodes than ypN0-patients: mean 6.3 vs 3.6mm 
before CRT and 4.5 vs 2.3mm after CRT, respectively (both p < 0.0001). Regression 
analyses identified pre- and post-CRT size, T-downstaging and primary CRM 
involvement as predictive factors for ypN0. In lesion-based analyses AUCs for the 
regression-based model, pre-CRT size and post-CRT size were 0.83, 0.78 and 
0.78, respectively. On a patient-basis they were 0.84, 0.73 and 0.75, respectively.
Conclusion: Nodal size (both pre- and post-CRT), T-downstaging and CRM 
involvement at primary staging are predictors of ypN0-stage. With this 
knowledge and by use of these criteria a radiologist could select yN0-patients 
with higher sensitivity than when size is used as a single criterion.
SS 8.02
Does correlation between dynamic contrast-enhanced 
MRI and perfusion CT in rectal cancer change after 
neoadjuvant chemoradiation therapy?
G. Petralia, S. Viotti, P. Summers, L. Bonello, M. Pasin,  
R. Di Filippi, M. Bellomi; Milan/IT
Purpose: To compare the findings of dynamic contrast-enhanced (DCE) 
MRI and perfusion CT (pCT) in rectal cancer before and after neoadjuvant 
chemoradiation therapy (NACRT).
Material and Methods: Patients with locally advanced rectal cancer underwent 
DCE-MRI and pCT before and after NACRT. DCE-MRI was performed at 1.5T 
using a dynamic T1-weighted sequence after contrast administration (0.2mL/kg, 
3.5mL/s). pCT was performed with a 16-slice MDCT after contrast administration 
(40mL, 4mL/s). Using dedicated software packages (MRIWorkbench and CT 
Perfusion 3), a radiologist defined regions of interest on tumour for each modality, 
which were applied to the corresponding functional maps to extract quantitative 
parameters: Ktrans, Kep, Ve and IAUC60 for DCE-MRI; blood flow (BF), blood 
volume (BV), mean transit time (MTT) and permeability-surface (PS) for pCT. 
Correlations between quantitative parameters were calculated.
Results: Up to date, 13 patients underwent both DCE-MRI and pCT before NACRT, 
whilst 10 after NACRT. Pre-therapy values showed moderate correlation between Kep 
and BV (R = 0.64), and a trend to correlation between Ktrans and BV (R = 0.56) and 
between Ve and PS (R = 0.55). Post-therapy values showed moderate correlation 
between Ktrans and PS (R = 0.63), Kep and PS (R = 0.61) and IAUC and PS (R = 0.61).
Conclusion: DCE-MRI estimates of capillary permeability (Ktrans and Kep) 
correlated with pCT parameters estimating blood volume before NACRT and 
capillary permeability after NACRT. Ktrans and Kep may therefore exhibit 
different sensitivity to the vascular status of rectal cancer if measured before 
or after NACRT, possibly relating to the changes in the balance between flow 
and permeability limited conditions.
SS 8.03
Magnetic resonance volumetry in rectal cancer patients 
after preoperative chemoradiotherapy: impact of the 
volume reduction ratio on disease-free survival and on 
the prediction of histopathologic complete response
S. Nougaret, M. Pierredon Foulongne, P. Rouanet,  
J.M. Bruel, B.P. Gallix; Montpellier/FR
Purpose: The aim of this study was to determine the relationship between 
rectal cancer volume changes assessed by magnetic resonance (MR) 
volumetry, histopathologic tumor response and disease-free survival (DFS) in 
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CX and after CRT. TVR was compared with histological results to assess the 
chemotherapy response. Histological results were classified in two groups: 
good response: TRG 3 or TRG 4 and bad response: TRG 1 or 2.
Results: After neoadjuvant CX, regarding the tumor volume regression, 5 
patients had a favourable response (volume regression of over 75%), 9 
unfavourable response (volume regression less than 75%). These results were 
consistent with histologic findings (p = 0.003).Moreover, there was a positive 
relationship between the tumor volume, as measured in the postoperative 
specimen, and the post-treatment tumor volume after neoadjuvant CX as 
determined by MR Volumetry (r2 = 0.93).
Conclusion: Our pilot study shows that MRI volumetry after CX could predict 
histological response and could be an help for the clinician to distinguish good 
and bad responders in order to propose an individual adapted treatment to 
prevent both drawback treatment effects and recurrence.
SS 8.09
Diagnostic usefulness of proctographic and cine-
defecographic investigation in patients with chronic 
constipation
H.J. Jeon1, U.C. Park2, Y.J. Kim1, H.S. Park1, S.I. Jung1,  
S.W. Park1; 1Seoul/KR, 2ChungJu, Chungbuk/KR
Purpose: Current study was designed to assess the diagnostic usefulness of 
radiologic investigation in patients with obstructed defecation caused by 
pelvic outlet obstruction. Moreover, the clinical usefulness of combined studies 
using the proctographic and cine-defecographic images were highlighted.
Material and Methods: 555 patients with chronic constipation visited our 
clinic and anorectal physiologic studies were performed. Studies included 
proctography and cine-defecography (n = 553), anal manometry (n = 237), anal 
EMG/PNTML (n = 133), and colonic transit time study (n = 85), Age matched 
control data (n = 33) in anal manometry and sex matched control data (n = 20) 
were selected from volunteers.
Results: Patients were categorized as rectocele (Group I: n = 337; sensitivity; 
98%, specificity; 94%, accuracy; 96%, false positive rate; 6%, false negative 
rate; 2%, kappa;0.925), nonrelaxing puborectalis syndrome(Group II: n = 164; 
86%, 90%, 88%, 10%, 14%, respectively, kappa; 0.738). rectoanal 
intussusception (Group III: n = 45; 100%, 97%, 97%, 3%, 0%, respectively, 
kappa;0.826). significant sigmoidocele (Group IV: n = 9; 97%, 97%, 3%, 0%, 
respectively, kappa;0.488). As compared with combined study (proctography 
plus cine-defecography), the proctogram showed decreased diagnostic rates 
in the evaluation of rectocele (p < 0.05), nonrelaxing puborectalis (p < 0.01), 
and rectoanal intussusception (p < 0.05). Moreover, the proctogram also 
showed increased false positive rate in the evaluation of rectocele (p < 0.01), 
nonrelaxing puborectalis (p < 0.01), and rectoanal intussusception (p < 0.05).
Conclusion: Current data suggested that proctography showed a tendency to 
overdiagnosis. Therefore, the combined study of proctography with 
cinedefecography should be taken as a diagnostic tools for patients with 
obstructed defecation. This helps the clinical decision making.
SS 8.10
Dynamic pelvic floor MRI performed with a balloon 
catheter and rectal air filling: comparison with 
conventional defecography in the evaluation of 
functional pelvic floor disorders
F. Maccioni, N. Al Ansari, F. Mazzamurro, M. Martinelli,  
I. Staltari, M. Marini; Rome/IT
Purpose: Purpose of this study was to compare dynamic pelvic floor MRI (DPF-MRI) 
with conventional defecografy in a group of patients affected by pelvic floor disorders.
Material and Methods: 36 consecutive patients (33 females) aged between 
25 and 75 years (mean age 57) with pelvic floor dysfunction underwent physical 
examination and evacuation proctography before DPF-MRI. The two 
examinations were compared with regard to the following parameters: ano-
rectal angle, ARJ descent, rectocele, invagination, diskinesia, other findings.
Results: Significant correlation was found between ano-rectal angles (ARAs) 
at straining (r: 0.38, (p < 0.02), at rest (r: 0.440, p < 0.07) and in contraction (r: 
0.389 (p < 0.19); a stronger correlation (r: 0.612, p < 0.0001) was found between 
MRI and conventional defecography, with 75%sensitivity and 66.7% specificity. 
Agreement between the two examinations was obtained in 29/32 cases of 
dyskinesia and 26/36 cases of rectal invagination, with 86 and 72% of MRI 
accuracy, respectively . No significant correlation was found for cystoceles 
and enteroceles, being MRI superior to conventional defecography.
Conclusion: Standard measurements of anorectal configuration at evacuation 
proctography and dynamic MR imaging showed a significant correlation. A good 
correlation was found both for the presence and staging of rectoceles, as well as 
with the assessment of invagination. Other findings, extremely important for surgical 
planning, such as cystocele and enterocele, could be detected by MRI only.
SS 8.06
Standardized intensity ratio: a robust, effective and 
reproducible DCE-MRI semi-quantitative index to 
monitor LARC before and after preoperative combined 
radio and chemo-therapy
M. Petrillo, R. Fusco, M. Sansone, A. Gallipoli, A. Rotondo, 
R. Grassi, A. Petrillo; Naples/IT
Purpose: The aim was to investigate the relationship among standalone 
morphological MRI (mMRI), combined morphological and qualitative DCE-MRI 
(qMRI) and standalone DCE-MRI pattern analysis (paMRI) in tumor response 
evaluation, to obtain a reliable and reproducible assessment of preoperative 
radio-chemo therapy (pCRT) in locally advanced colorectal cancer (LARC).
Material and Methods: 30 patients, LARC affected, were enrolled in this perspective 
study. All patients underwent dynamic contrast-enhanced MRI examination with a 
1.5T scanner before and after pCRT. After total surgical mesorectal excision (TME), 
pathological TNM (pTNM) was obtained. mMRI and qMRI evaluation were 
performed by two blinded expert radiologists. DCE-paMRI was based on multiple 
ROIs and 14 TIC shape descriptors were computed for each selected ROI. Paired 
sample tests, Hotelling trace criterion (HTC) and ROC analysis were applied.
Results: mMRI sensibility (SEN), specificity (SPE) were, respectively, 54,2% and 
66,7%; qMRI SEN and SPE were 66,7%, 87,5%. WII*WIS+AUCWO match, 
obtained through HTC analysis provided the best statistically significant gain in 
paMRI. Cut-off value of 199,98% divided pT3 group (non-responders) by pT2 
and pT0-pT1 group (responders) with SEN of 91.7% and SPE of 100%.
Conclusion: Being WII*WIS+AUCWO based on piecewise linearly fitted 
normalized TICs, it allows a reproducible comparisons between current or 
retrospective studies. This term, named standardized intensity ratio (SIR) 
gained best values of SEN and SPE, leading to an objective and easy 
differentiation between responders and non-responders, by means of a defined 
cutoff, resulting in a reliable index for a fast clinical employment.
SS 8.07
Selection of patients with rectal cancer for local excision 
with lymph node specific contrast-enhanced MRI
M. Maas1, D.M.J. Lambregts1, J.W. Leijtens2, S.M. Engelen1, 
S.D. Ayodeji1, R.M. van Dam1, G. Beets1, R.G.H. Beets-Tan1; 
1Maastricht/NL, 2Roermond/NL
Purpose: T1-2 rectal cancer brings about 5-20% risk for N+disease, which cannot be 
accurately evaluated with standard imaging. To minimise the risk for local recurrence 
(LR), total mesorectal excision (TME) is performed in these patients. Accurate prediction 
of N0-status could make local excision (LE) feasible. Aim is to evaluate whether 
contrast-enhanced (CE)-MRI is useful in selecting patients with N0-status for LE.
Material and Methods: 38 patients who underwent LE for rectal cancer were 
included and underwent T2W and T1W-CE-MRI with ultrasmall superparamagnetic 
particles of iron-oxide (USPIO; n = 26) or gadofosveset (n = 12) to evaluate N-stage 
and residual tumour. An expert radiologist evaluated the images. In case of N0-
status, patients underwent follow-up with regular visits, endoscopy and/or MRI. 
Patients with N+status underwent TME (+/-neoadjuvant therapy).
Results: CE-MRI indicated N0-status in 35/38 patients, who underwent follow-
up. 3 patients had suspected N+status, of which 2 had surgery, which confirmed 
N+status in one patient, but refuted N+status in the other (false-positive). The 
third patient underwent chemoradiation which sterilised the nodes. These 3 
patients are disease-free and alive. Median follow-up for all patients is 31 (0-65) 
months. Three luminal and one nodal LR were found in the follow-up group. All 
recurrences were curatively treated. 2-year disease-free survival is 94%.
Conclusion: CE-MRI is useful for selecting N0-patients for LE. The low LR-rate and 
resectability of the local recurrences suggest that CE-MRI can be important in safely 
selecting T1-2N0 tumours for LE, leading to lower treatment-related morbidity.
SS 8.08
Neoadjuvant chemotherapy evaluation by 3D MRI 
volumetry in rectal cancer followed by chemoradiotherapy 
and total mesorectal excision: a pilot study
S. Nougaret, P. Rouanet, M. Pierredon Foulongne,  
J.M. Bruel, B.P. Gallix; Montpellier/FR
Purpose: 17 consecutive patients who underwent neoadjuvant chemotherapy 
(CX) before chemoradiotherapy (CRT) and surgery were enrolled in the study. 
Tumor volume regression (TVR) was studied at the first MRI, after CX and after 
CRT. TVR was compared with histological results to assess the chemotherapy 
response. Histological results were classified into two groups: good response: 
TRG 3 or TRG 4 and bad response: TRG 1 or 2.
Material and Methods: 17 consecutive patients who underwent neoadjuvant 
chemotherapy (CX) before chemoradiotherapy(CRT) and surgery were enrolled 
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criteria, 57 patients were resectable and 54 unresectable: the clinical 
interpretation of CT angiographic scans in all 111 patients had 83% sensitivity 
in the detection of resectability, 78% specificity, 77% PPV and 83% NPV. 
According to CEUS criteria, 58 patients were resectable and 53 unresectable: 
the clinical interpretation of CEUS findings in all 111 patients had 85% 
sensitivity in the detection of resectability, 78% specificity, 78% PPV and 85% 
NPV. When at least one modality confirmed resectability, sensitivity, specificity, 
PPV and NPV were, respectively, 89%, 76%, 77% and 88%.
Conclusion: MDCT angiography and CEUS are effective tools for the 
preoperative staging of pancreatic adenocarcinoma, and in an experienced 
setting provide similar results in terms of accuracy.
SS 9.04
CT perfusion can predict ductal adenocarcinoma 
pathological grading
M. D’Onofrio, A. Gallotti, A. Ventriglia, R. Pozzi Mucelli; 
Verona/IT
Purpose: The aim of this study is to analyze the correlation between the enhancement 
pattern of pancreatic adenocarcinoma at perfusion CT and its pathologic grading. 
Material and Methods: From December 2009 to June 2010, 22 patients with 
pancreatic adenocarcinoma were included in this study. They had unresectable 
carcinoma, no presence of metastases at the imaging and they had not 
previously undergone chemotherapy or palliative care. All pancreatic lesions 
were first evaluated by perfusion CT. Blood volume (BV), perfusion (P), time to 
peak (TTP) and peak of enhancement (PEI) values were obtained. All pancreatic 
lesions then received needle biopsy.
Results: 22 pancreatic lesions, average diameter of 4.58 cm, were studied. The 
lesions were pathologically classified into low-grade 8/22 (36.4%) and high-grade 
carcinomas 14/22 (63.6%). Comparing the median of the perfusion parameters of 
the low-grade lesions with the perfusion parameters of the high-grade lesions, 
the PEI was significantly different using Mann-Whitney U test (p < 0.05). The 
accuracy to identify the high-grade lesion was 84.1% with a positive predictive 
value of 95% for PEI < 20 HU and 68.2% with 100% for PEI < 15 HU.
Conclusion: PEI, among the perfusion CT parameters, seems to be accurate 
in the identification of the high-grade pancreatic ductal adenocarcinoma.
SS 9.05
18F-FDG PET/CT in pancreatic carcinoma: diagnosis 
and staging
P. Koranda, J. KysuĀan, R. Formánek, E. Buriánková,  
R. Havlík, M. MysliveĀek; Olomouc/CZ
Purpose: To evaluate the reliability of 18F-FDG PET/CT in the preoperative 
evaluation of pancreatic masses and in the assessment of the resectability 
of pancreatic cancer.
Material and Methods: 106 patients with suspected or diagnosed pancreatic 
carcinomas underwent contrast-enhanced multislice 18F-FDG PET/CT. 
Malignancy was confirmed in 72 patients (prevalence 0.679).
Results: 18F-FDG PET/CT correctly diagnosed pancreatic carcinoma in 61 
patients, 11 false negative (FN), 5 false positive (FP), 29 true negative (TN): 
sensitivity_0.847 (95% CI 0.764-0.930), specificity_0.853 (95% CI 0.734-0.972), 
PPV_0.924, NPV_0.725, LR+ 5.761, LR- 0.179. Lymph node (N) and distant 
metastases (M) staging was evaluated in the subgroup of 67 patients which 
underwent surgical exploration (42 carcinomas – prevalence_0.626). Histologically 
confirmed lymph node involvement (prevalence_0.239) was detected using 
18F-FDG PET/CT in 8 patients, 8_FN, 4_FP, 47_TN: sensitivity_0.500 (95% CI 
0.255-0.745), specificity_0.922 (95% CI 0.848-0.995), PPV_0.667, NPV_0.855, 
LR+ 6.375, LR- 0.543. 18F-FDG PET/CT revealed distant metastases 
(prevalence_0.328) in 12 patients, 10_FN, 1_FP, 44_TN: sensitivity_0.545 (95% CI 
0.337-0.754), specificity_0.978 (95% CI 0.935-1.021), PPV_0.923, NPV_0.815, 
LR+ 24.545, LR- 0.465. According to 18F-FDG PET/CT, 19 patients with pancreatic 
carcinoma were judged to have non-operable disease.
Conclusion: Contrast-enhanced multislice 18F-FDG PET/CT appears to be an 
attractive staging tool for pancreatic cancer, although the N and M staging 
sensitivity values are lower than levels of specificity. It could help to omit a 
non-indicated surgery in patients with advanced disease. This study was 
supported by IGA MZCR (NT11023-3/2010).
11:15 -12:45 Sala Feste
Scientific Session 9
Pancreas - solid and cystic lesions
SS 9.01
MR imaging versus positron emission tomography-CT 
for evaluation of pancreatic lesions
S. Belião1, A.T. Ferreira1, O. Vierasu2, D. Blocklet2,  
T. Metens2, C. Matos2; 1Lisbon/PT, 2Brussels/BE
Purpose: To retrospectively determine the diagnostic accuracy of magnetic 
resonance imaging (MRI) and combined positron emission tomography/
computed tomography (PET-CT) in the differential diagnosis of benign and 
malignant pancreatic lesions.
Material and Methods: Twenty-seven patients (15 women/12 men, mean 
age 56.5) with MR imaging and PET-CT studies performed to differentiate 
benign and malignant pancreatic lesions were identified between October 
2008 and October 2010. Both MR and PET-CT datasets were retrospectively 
and blindly evaluated by two independent readers (4 readers total) with 
different experience degrees, using a five-point visual score system. The 
results were correlated with final diagnosis obtained by histopathology.
Results: 18 patients had malignant diseases and 9 patients had benign 
diseases. Depending on the observer, sensitivity, specificity, positive predictive 
value and negative predictive values of MRI were 88-94%, 50-80%, 75-89% 
and 71-89%, respectively. Sensitivities, specificities, positive predictive 
values and negative predictive values of PET-CT were 71-79%, 56%, 71-73% 
and 56-63%, respectively. The diagnostic accuracy of MR for the differential 
diagnosis of pancreatic lesions was 74-89%, compared with 65-70% for PET-
CT. The Cohen kappa coefficient was 0.47 at MR and 0.60 at PET-CT.
Conclusion: MRI achieved higher sensitivity and specificity in the 
differential diagnosis of pancreatic lesions; however, the inter-observer 
agreement was relatively poor.
SS 9.02
Accuracy of CEUS in the characterization of focal 
pancreatic lesions
M. D’Onofrio, A. Gallotti, F. Principe, R. Malagò, E. Martone, 
R. Pozzi Mucelli; Verona/IT
Purpose: To describe the typical CEUS pattern and to evaluate the diagnostic 
accuracy of CEUS in the characterization of pancreatic lesions.
Material and Methods: All CEUS examinations of focal pancreatic masses 
performed during a period of five years were reviewed. Inclusion criteria were: 
focal pancreatic mass pathologically proved, visible at ultrasound (US) and 
studied with CEUS. All lesions were then evaluated for enhancement pattern. 
Sensitivity, specificity, positive and negative predictive values with 95%CIs 
were calculated to define diagnostic accuracy of CEUS with respect to 
pathology. Agreement was evaluated by means of k statistics.
Results: 876 pancreatic lesions were included. At CEUS the lesions were 
divided into solid (82%) and cystic (18%) masses and classified into six and 
eight categories, respectively. There were among the solid lesions, ductal 
adenocarcinomas were characterized with an accuracy of 85.8%. Among the 
cystic lesions, cystic tumors were diagnosed with an accuracy of 97.5%. Inter-
observer agreement was slightly higher for solid (k = 0.78) than cystic (k = 0.62) 
lesions. In none of the centers side effects were reported.
Conclusion: CEUS is accurate in the characterization of pancreatic lesions. 
CEUS should be considered as a complementary imaging method for pancreatic 
lesions characterization. CEUS study after US detection of an incidental focal 
pancreatic lesion will therefore improve the diagnostic accuracy.
SS 9.03
MDCT vs CEUS in the preoperative staging of 
pancreatic adenocarcinoma
G.A. Zamboni, M.C. Ambrosetti, F. Lombardo, M. D’Onofrio, 
R. Pozzi Mucelli; Verona/IT
Purpose: To compare MDCT and CEUS in the preoperative staging of 
pancreatic adenocarcinoma.
Material and Methods: MDCT and CEUS examinations performed in a two 
year period were prospectively compared with surgical notes and pathology 
reports from 111 patients with pancreatic carcinoma. Imaging findings were 
compared with surgical reports or patient follow-up. Sensitivity, specificity, 
positive predictive value (PPV), and negative predictive value (NPV) for 
resectability were calculated for the two modalities.
Results: 53 patients underwent resection, while 58 underwent palliative 
procedures because judged unresectable. According to MDCT angiographic 
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normal liver tissue from metastases (cut-off: SUVmax of the normal liver plus 
10% (VOIliver+10%), 20% (VOIliver+20%) 30% (VOIliver+30%) and SUV = 10 (VOI10SUV)).
Results: The SUVmax of the normal liver was below 10 (7.2 ± 1.3) in all patients 
and without significant changes. Overall therapy changes per patient [mean 
(95% confidence interval (CI))] were statistically significant (p < 0.01); for: ∆CgA 
= -43 (-69…-17)%, ∆SUVmax = -22 (-29…-14)%, ∆VOI10SUV = -53 (-68…-38)% 
and less significant (p < 0.05) for: ∆VOIliver+10% = -29 (-55…-3)%, ∆VOIliver+20% = 
-32 (-62…-2)% and ∆VOIliver+30% = -37 (-66…-8)%. Correlations were found 
only between: ∆CgA and ∆VOI10SUV (r = 0.595; p < 0.01), ∆SUVmax and ∆VOI10SUV 
(0.629, p < 0.01), and between SUVmax and ∆SUVmax (r = -0.446; p < 0.05).
Conclusion: Ga-68-DOTATOC PET/CT allows volumentric therapy monitoring 
via a SUV-based cut-off separating hepatic metastases from normal liver 
tissue (10 SUV recommended).
SS 9.09
Small cystic lesions of the pancreas: incidence and size 
changes in a large series population
G. Morana1, M. Fuser2, C. Cugini1, L. Cancian1, A. Dorigo1; 
1Treviso/IT, 2Padova/IT
Purpose: To evaluate the incidence and size changes of small pancreatic 
cysts in a large series population.
Material and Methods: We reviewed the reports of MR of abdomen in the 
period March 2005-March 2010. Reports positive for cystic lesions of the 
pancreas were selected and images reviewed.
Results: We evaluated 4463 patients: 394 (8.8%) patients have been selected 
with at least one cystic lesion of the pancreas <4 cm. 174 were males (44,2%), 
220 females (55.8%). 140 patients had a single lesion, with a mean diameter at 
diagnosis of 15 mm: 54 patients <10 mm, 57 with 10-20 mm, 21 with 20-30 
mm and 22 >30 mm. 86 patients were followed up at 6, 12, 24 or 36 months. 
254 patients had a multifocal lesion with a mean diameter at diagnosis of 16 
mm: 95 patients <10 mm, 106 with 10-20, 31 with 20-30 mm and 22 >30 mm. 
173 patients were followed up at 6, 12, 24 or 36 months. No differences in age 
and sex was evident between monofocal and multifocal lesions. The lesions 
did not show significant diameter increase at follow-up up to 36 months, either 
for single lesion or multifocal.
Conclusion: Small cystic lesions of the pancreas are not infrequent in daily 
practice. Follow-up is a safe procedure as there is no significant variation in 
size of the lesions. Time interval for follow up can be lengthened.
SS 9.10
Diagnostic performance of MR imaging for pancreatic 
cysts: focusing on communication with main duct and 
differential diagnosis of malignant pancreatic cysts
J.H. Kim, H.W. Eun, S.S. Hong, J.K. Han, B.I. Choi; Seoul/KR
Purpose: To assess diagnostic ability of MRI for pancreatic cyst communication with 
main duct and differential diagnosis of malignant versus benign pancreatic cysts.
Material and Methods: During 5 years, we performed MRCP and contrast-
enhanced MRI in 65 patients with pancreatic cysts who underwent ERCP or 
surgery. Among them, 36 consecutive patients confirmed communication with 
main duct and 29 patients confirmed non-communication. Among them, 51 
patients were pathologically proven. Pancreatic cysts include IPMN (n = 26), 
pseudocyst (n = 6), serous cystadenoma (n = 1), retention cyst (n = 1) in 
communication group and IPMN (n = 6), pseudocyst (n = 4), mucinous 
cystadenoma (n = 1), serous cystadenoma (n = 2), SPT (n = 1), islet cell tumor (n 
= 1), undifferentiated carcinoma (n = 1), retention cyst (n = 1) in non-
communication group. Two radiologists retrospectively and independently 
graded the cyst communication with main duct and malignancy using five-point 
scale. They also measured size of cyst and main duct. Diagnostic performances 
were analyzed using the area under the receiver operating characteristic curve. 
Sensitivity and specificity were also calculated. Mann–Whitney U test was used. 
The  statistics was used to determine interobserver agreement.
Results: Area under the ROC curve for MR diagnostic performance of cyst 
communication with main duct was 0.931 and using the cut-off points as 3, 
sensitivity was 91.4% and specificity was 89.7%. Interobserver agreement 
was excellent (  = 0.81). Area under the ROC curve for MR diagnostic 
performance of differentiate malignant from benign pancreatic cysts was 0.902 
and using the cut-off points as 3, sensitivity was 94.3% and specificity was 
75.0%. Interobserver agreement was excellent (  = 0.82). The mean size of 
malignant and benign cysts (3.98cm + 2.74: 3.17cm + 1.26, p = 0.327) and 
main duct (5.20mm + 3.22: 4.39mm + 4.12, p = 0.227) showed no statistically 
difference between malignant and benign pancreatic cysts.
Conclusion: MRI accurately assess pancreatic cyst communication with 
main duct and very useful for differential diagnosis of malignant versus 
benign pancreatic cysts.
SS 9.06
Non-functioning neuroendocrine tumors of the pancreas: 
MRI appearance and correlation with biological behavior
M. Bonatti, R. Manfredi, R. Graziani, S. Mehrabi, F. Castelli, 
R. Pozzi Mucelli; Verona/IT
Purpose: To describe MRI features of non-functioning neuroendocrine tumors 
(NF-NETs) of the pancreas, compared to histopathology and assess capability 
of MRI in predicting their biological behavior.
Material and Methods: In the period January 2003–July 2010, 130 patients 
affected by NF-NET were observed at our Institution. Inclusion criteria: surgical 
resection and histopathological examination of NF-NET, *1 preoperative MR/
MRCP examinations. Our study encompassed 45 patients. At histopathology: 
16 NF-NET were adenomas, 10 borderline neoplasm and 19 carcinomas. For 
each lesion we evaluated, maximum diameter, margins, presence of vascular 
encasement, local spread, presence of metastasis, signal intensity on T1- and 
T2-weighted images and vascularization.
Results: Evaluated MRI parameters showed an overall excellent concordance 
with pathologic findings (k = 0.88). Adenomas presented mean maximum diameter 
of 13mm, borderline lesions 32mm and carcinomas 65mm. 6,3% of adenomas 
showed irregular margins, 33.3% of borderline lesions and 63.2% of carcinomas. 
Vascular encasement was appreciable in 57.9% of carcinomas, 0% of borderline 
lesions and 6.3% of adenomas. Local spread was present in 52.6% of carcinomas, 
in 11.1% borderline lesions and in 0% adenomas. 21.1% of patients affected by 
carcinoma presented metastases, and none of the other groups.
Conclusion: Carcinomas show a significantly larger diameter than adenomas 
and borderline lesions (p = 0.001). Irregular margins, vascular encasement, 
local spread and presence of metastasis are significantly (p < 0.05) associated 
with malignant behavior. No significant differences were found in signal 
intensity and vascularization between different graded lesions.
SS 9.07
Non-functioning pancreatic endocrine tumors: 
preoperative assessment by means of contrast-
enhanced MDCT and contrast-enhanced MRI
G. Foti, N. Faccioli, G. Malleo, G. Zamboni, R. Manfredi,  
R. Pozzi Mucelli; Verona/IT
Purpose: To compare contrast-enhanced MDCT and contrast-enhanced 
MRI capabilities in the preoperative assessment of non-functioning 
pancreatic endocrine tumors (NPET).
Material and Methods: In a 4-year period, 32 consecutive patients with 
pathologically proven NPET (17 males, 15 females, mean age 49 years, range 
25-64), preoperatively studied with MDCT and MRI, were evaluated. Both MDCT 
and MRI protocols included pre-contrast (unhenanced CT and T1-w and T2-w 
MRI) and post-contrast scans (arterial-pancreatic, 45 sec; portal, 80 sec; late 
venous, 120 sec). Student’t test was used to compare enhancement patterns 
(hyper versus iso-hypovascularity with respect to normal pancreas), main 
pancreatic duct (MPD) involvement (upstream dilation vs normal MPD), vessels 
involvement (absent or operable versus inoperable), and liver metastases 
(presence versus absence). A value of p < 0.05 was considered significant.
Results: Lesion hypervascularity was depicted in 24/32 (75.0%) MDCT and 
25/32 (78.1%) MRI exams (p = 0.1). MPD involvement was present in 13/32 
(34.3%) MRI and 12/32 (37.5%) MDCT exams (p = 0.1). Vessel involvement 
was correctly evaluated in 30/32 (93.7%) cases at MDCT and 27/32 (84.3%) 
cases at MRI (p = 0.025). Liver metastases were correctly identified in 11/32 
(34.3%) cases both at MDCT and MRI (p = 0.45).
Conclusion: MDCT and MRI presented similar overall accuracy for preoperative 
assessment of NPET. However, MDCT may be slightly superior to MRI in the 
evaluation of vessel involvement because of its higher spatial resolution.
SS 9.08
Gastroenteropancreatic neuroendocrine tumors: 
standardizing therapy monitoring with Ga-68-DOTATOC 
PET/CT, using the example of somatostatin receptor 
radionuclide therapy
W. Luboldt, K. Zoephel, B. Wiedemann; Munich/DE
Purpose: To standardize therapy monitoring of hepatic metastases from 
gastroenteropancreatic neuroendocrine tumors (GEP-NETs), during the course 
of somatostatin receptor radionuclide therapy (SRRT).
Material and Methods: In 21 consecutive patients with non-resectable 
hepatic metastases of GEP-NETs chromogranin A (CgA) and Ga-68-DOTATOC 
PET/CT were compared before and after the last SRRT. On Ga-68-DOTATOC 
PET/CT, the maximum standard-uptake values (SUVmax) of normal liver and 
hepatic metastases were calculated. In addition, hepatic metastases volumes 
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Results: Bowel preparation was complete in all patients. No statistical 
significant differences for tagged fluid density, number of residue and tagging 
homogeneity between the two groups were founded. A significant higher 
patient acceptance was founded in group 2 (P = 0.02).
Conclusion: The preparation based on the combination of a laxative and a 
fluid tagging agents was better accepted. Adding a laxative agent to a fluid 
tagging preparation did not improved image quality but was associated with 
an higher patient acceptance. Moreover, if a laxative agent is added to a fluid 
tagging bowel preparation the amount of iodine can be reduced.
SS 10.04
CT colonography: development and validation of a novel 
registration algorithm to align prone and supine scans
D. Boone, H. Roth, S. Halligan, J. McClelland, T. Hampshire, 
S.A. Taylor, M. Hu, D. Hawkes; London/UK
Purpose: Despite colonic cleansing prior to CT colonography, prone and 
supine acquisitions remain necessary to differentiate pathology from luminal 
content. Observers must therefore match endoluminal locations between 
prone and supine studies, a process that is complicated by considerable 
colorectal deformation between acquisitions. We developed and validated a 
novel algorithm that establishes endoluminal spatial correspondence 
between prone and supine CT acquisitions.
Material and Methods: Ethical approval was obtained to use anonymised 
CT colonography data from 24 patients randomised into 12 development (13 
polyps) and 12 validation sets (13 polyps). A radiologist (experience > 500 
validated datasets), indicated the polyp volumes in both prone and supine 
CTC scans using separate multiplanar reformats. These polyps were masked 
from the algorithm to avoid biasing registration and used as reference points 
for validation. To perform registration, a triangulated mesh of the endoluminal 
colonic surface was first extracted from segmented colonic data. Surface 
parameterisation was then achieved using the Ricci flow method followed by 
non-rigid 2D B-spline registration to recover the deformations.
Results: Using the development set, 8 of the 13 polyps were registered 
successfully (62%) with a mean error of 6.6mm +- 4.8. In the validation set, 10 
of the 13 polyps were registered successfully (77%) with a mean error of 6.7mm 
+- 4.6.
Conclusion: This novel algorithm allows accurate registration of prone and 
supine datasets and may ultimately simplify the interpretative task in CT 
colonography.
SS 10.05
Patient acceptability of CT colonography compared with 
double contrast barium enema: results from a 
multicentre randomized controlled trial
S. Halligan, C. von Wagner, S. Smith, A. Ghanouni,  
S.A. Taylor, J. Wardle, W. Atkin and the SIGGAR 
INVESTIGATORS; London/UK
Purpose: To determine the acceptability of barium enema (BE) or CT 
colonography (CTC) via a randomized controlled trial for patients being 
investigated for symptoms of colorectal cancer.
Material and Methods: After ethical approval, 921 consenting patients with 
symptoms of colorectal cancer who had been randomly assigned and 
completed either BE (N = 606) or CTC (N = 315) received a questionnaire to 
assess experience including bowel preparation, the primary randomized 
procedure and post-test complications. An adapted version of a previously 
validated patient acceptability scale rated overall satisfaction (10-70), worry 
(6-42) and discomfort (13-91). Higher scores indicated more positive 
experiences. Non-parametric methods assesed differences between the 
randomized procedures and patient characteristics.
Results: Patients undergoing BE were significantly less satisfied (median 61, 
interquartile range [IQR] 54-67 vs. median 64, IQR 56-69; p = 0.003) and experienced 
more physical discomfort (median 64, IQR 52-75 vs. median 68.5, IQR 57-79; p < 
0.001) than those undergoing CTC. Post-test, BE patients were significantly more 
likely to experience ‘abdominal pain/cramps’ (68% vs. 57%; p = 0.007), ‘soreness’ 
(57% vs. 37%; p < 0.001), ‘nausea/vomiting’ (16% vs. 8%; p = 0.009), ‘soiling’ (31% 
vs. 23%; p = 0.034), and ‘wind’ (92% vs. 84%; p = 0.001) and in the case of ‘wind’ 
to also rate its intensity as severe (27% vs 15%; p < 0.001).
Conclusion: CTC is associated with modest albeit significant and consistent 
improvements to patient acceptability, both during, and immediately after, the 
diagnostic episode. These data support calls for CTC to replace BE.
11:15 -12:45 Sala Mosaici 1
Scientific Session 10
CTC 2 - bowel preparation & screening
SS 10.01
Bowel preparation for CT colonography with reduced 
volume polyethylene glycol-based preparation and 
low-osmolar non-ionic iodinated contrast agent
D.A. Tiferes, C.A. Matsumoto; São Paulo/BR
Purpose: To evaluate the efficacy of CT colonography bowel preparation 
using primarily a reduced PEG–based preparation (1.5 L) and low-osmolar 
non-ionic iodinated contrast agent.
Material and Methods: 312 consecutive patients undergoing CT colonography 
were evaluated. Bowel preparation consisted primarily of a reduced volume 
PEG-based preparation (1.5 L) and a 50 mL dose of low-osmolar non-ionic 
iodinated contrast agent (iobitridol) for fecal and fluid tagging. Liquid diet and 
low-dose bisacodyl (10 mg) were also used. Two radiologists prospectively 
scored the colon for the amount of residual stool and fluid using a 4-point scale 
and classified tagging of residual fluid and stool as adequate or inadequate.
Results: Stool-free segment or only minimal particles (<5mm) was seen in 
90.4% of colonic segments. Residual fluid occupying less than 50% of 
lumen was seen in 94.2% of segments. Tagging of residual fluid and stool 
was considered adequate in 95.8% and 88.0% of the cases, respectively. 
No immediate complications related to the bowel preparation were seen.
Conclusion: The use of reduced volume PEG–based preparation and low-
osmolar non-ionic iodinated contrast agent resulted in adequate bowel 
preparation for CT colonography in the vast majority of patients.
SS 10.02
CT colonography with iodinated enema fluid tagging: 
feasibility and preliminary results
E. Neri, L. Faggioni, E. Picano, P. Vagli, F. Cerri, R. Scandiffio, 
C. Bartolozzi; Pisa/IT
Purpose: To evaluate the feasibility and effectiveness of fluid tagging in CT 
colonography (CTC) by rectal introduction of iodinated contrast material (CM).
Material and Methods: Thirty-six patients (male:female = 12:24, age 57-81 
years, mean 66 years) underwent CTC for colorectal cancer screening using a 
low radiation dose protocol. Prior to CTC, patients received a three-day low 
residue diet plus a low dose of Macrogol after each meal, beginning 3 days 
before CTC. Immediately before CTC, all patients received an enema consisting 
of 100mL diatrizoate dimeglumine diluted in 300mL of warm tap water, followed 
by automatic insufflation of 2.5-3.5L of carbon dioxide. Between rectal CM and 
insufflation, patients were asked to repeatedly turn themselves on the CT table 
to ensure homogeneous opacification of the colon. Intraluminal CT density was 
measured inside the cecum/ascending colon, transverse, descending colon, 
and in the sigmoid colon/rectum. The time required for CM enema administration 
and insufflation was measured, and patients’ satisfaction was recorded using a 
four-point score (1 = low, 2 = moderate, 3 = high, 4 = very high).
Results: Overall colonic enhancement was 726 ± 597 HU, with no significant 
difference among the various colonic segments (p = 0.3705). The time 
needed for the entire rectal tagging procedure was 13.4 ± 3.2 minutes. 
Overall patients’ tolerance after CTC was graded 3.78 ± 1.16. Neither 
complications nor adverse events occurred during and after the procedure.
Conclusion: CTC with iodinated enema allows good and homogeneous 
enhancement of the colonic lumen and is well tolerated.
SS 10.03
CT colonography bowel preparation: influence of a 
laxative agent on a fluid tagging preparation
M. Rengo1, F. Iafrate1, R. Ferrari2, A. Pichi1, M. Ciolina1,  
A. Laghi2; 1Rome/IT, 2Latina/IT
Purpose: To compare two different bowel preparations in terms of patient 
acceptance and image quality.
Material and Methods: Seventy five consecutive patients were prospectively 
randomised in two groups. Both groups followed a low residue diet for two 
days before the examination. Both preparations were based on fluid tagging, 
using a iodinate contrast medium (gastromiro). Group 1 received 180 ml of 
fluid tagging agent the day before the study. Group 2 received 100 ml of fluid 
tagging agent and 500 ml of a laxative agent (Lovol-esse) the day before the 
study. Patient acceptance was evaluated using a visual assessment scale. 
Quality of bowel preparation was evaluated using quantitative (tagged fluid 
density and number of untagged residue per segment) and qualitative (tagging 
homogeneity per segment on a 4-point scale).
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of confidence were assigned to positive findings. Reporting time, per-patient 
sensitivity for patients with adenomas or cancer *6 mm, specificity, 95% 
confidence intervals, and areas under ROC curves (AUC) were calculated for 
both reading paradigms. CC and histology were reference standards.
Results: Seventeen of the 199 enrolled individuals (8.5%) were excluded for: 
refusal to perform CC (3), unavailable histological data (4), protocol violation (3) 
and non-diagnostic image quality (7). The remaining 182 individuals included 
93 patients (51%) with at least one adenoma *6mm. Sensitivity with CAD2 and 
CAD1 was 86% (80/93) (77-92%) and 89% (83/93) (81-95%), respectively (P = 
0.5). There was no difference in specificity between CAD2 and CAD1 [89.9% 
(80/89) (81-95%) versus 91% (81/89) (83-96%)]. The mean AUCs for CAD2 
and CAD1 were similar (P = 0.09). CAD1 reading took 2 minutes less than 
CAD2 (6m versus 8m, P = 0.01).
Conclusion: CAD1 is more time efficient and has a similar diagnostic 
performance to CAD2 and should be considered for future mass screening 
programs, where cost-effectiveness may represent a key issue.
SS 10.09
A randomized controlled trial comparing participation and 
diagnostic yield in colonoscopy and CT-colonography for 
population-based colorectal cancer screening
M.C. de Haan1, E. Stoop2, T.R. de Wijkerslooth1,  
P.M. Bossuyt1, M. van Ballegooijen2, C. Yung Nio1,  
M.J. van de Vijver1, K. Biermann2, M. Thomeer2,  
M.E. van Leerdam2, P. Fockens1, J. Stoker1, E.J. Kuipers2,  
E. Dekker1; 1Amsterdam/NL, 2Rotterdam/NL
Purpose: To compare participation rate and diagnostic yield of colonoscopy 
and CT-colonography screening in a RCT trial.
Material and Methods: 8,844 Dutch citizens aged 50-74 were 2:1 randomized 
to colonoscopy or CTC. Participation rate was defined as number of invitees 
undergoing the examination divided by the total number of invitees. Colonoscopy 
was positive when advanced neoplasia was detected; CTC when a lesion >5mm 
was found. Individuals with *1 lesions 6-9mm were offered surveillance CTC and 
colonoscopy was offered for lesions *10mm. Diagnostic yield was calculated as 
number of advanced neoplasia per 100 invitees.
Results: 1,236 of 5.924 colonoscopy invitees participated (21%) compared to 935 
of 2,920 CTC invitees (32%) (p < 0.001). Yield colonoscopy participants: 91/1236 
(7%) had *1 advanced adenomas, 7 (0.6%) had a carcinoma. Yield CTC 
participants: 75/935 (8%) were offered surveillance, 70/935 (7%) were offered 
colonoscopy of which 44/935 (5%) had *1 advanced adenomas, 5 (0.5%) had a 
carcinoma. The diagnostic yield of advanced neoplasia was 8.4 per 100 
participants for colonoscopy versus 5.2 for CTC (p < 0.001); relative to the number 
of invitees, these numbers were 1.7 per 100 invitees in both arms (p = 0.909).
Conclusion: This randomized population-based CRC-screening trial demonstrated 
superior participation for CTC compared to colonoscopy, but colonoscopy 
identified significantly more advanced neoplasia. The diagnostic yield for advanced 
neoplasia per 100 invitees was comparable for both strategies.
SS 10.10
The influence of a radiographers-radiologist model on 
population screening with CT colonography for colo-
rectal cancer
C. Lauridsen1, P. Lefere2, S. Gryspeerdt2; 1Copenhagen/DK, 
2Hooglede/BE
Purpose: To assess the reduction of costs in screening for colo-rectal cancer 
(CRC) with CT colonography (CTC) interpreted by a team of radiographers 
supervised by one radiologist.
Material and Methods: In this model, CRC screening was performed by a team 
of eight radiographers and one experienced CTC-radiologist. The radiographers 
were educated in CTC based on the interpretation of 75 training cases. In this 
model each radiographer interpreted two cases per hour. The positive cases 
were submitted to the radiologist, who monitored the radiographer’s marks 
using an average reading time of 5 minutes per case. This model was compared 
with interpretation of CTC by the radiologist only.The time with the radiographers-
radiologist model versus the radiologist only model was calculated for a 
population of 100,000 patients eligible for CRC screening.
Results: Screening a cohort of 100,000 patients per year needed 9, 8 and 7 
radiographers-radiologist teams versus 19 radiologists at a ppv of 30%, 50% 
and 70%, respectively. A radiologist time reduction of 54%, 59% and 64% 
with a reduction of 10, 11 and 12 radiologist full-time equivalents at a ppv of 
30%, 50%, and 70%, respectively, was achieved. The team interpreted 49, 55 
and 62 CTC per day at a ppv of 30%, 50% and 70% respectively.
Conclusion: Population-based CRC screening with CTC interpreted by a 
team of educated radiographers under radiologist supervision is time efficient 
and reduces radiologist man power.
SS 10.06
Informed decision-making in colorectal cancer 
screening using colonoscopy or CT-colonography: a 
randomized controlled trial
M.C. de Haan1, T.R. de Wijkerslooth1, E. Stoop2,  
P.M. Bossuyt1, P. Fockens1, M. Thomeer2, E.J. Kuipers2,  
M. Essink-Bot1, M.E. van Leerdam2, E. Dekker1, J. Stoker1; 
1Amsterdam/NL, 2Rotterdam/NL
Purpose: To evaluate and compare the level of informed choice for colonoscopy 
and CT-colonography CRC screening in a RCT.
Material and Methods: 8,844 Dutch citizens (50-74yrs) were randomly invited for 
CRC screening: 5,924 to colonoscopy; 2,920 to CTC. Invitees received an information 
leaflet. All invitees received a questionnaire containing measures of knowledge and 
attitude; participants <4 weeks before the examination, non-participants 4 weeks 
after the invitation. Knowledge about CRC screening among colonoscopy and CTC 
invitees was measured by 11 and 14 statements, deemed sufficient if >50% was 
answered correctly. Attitudes towards screening were measured by four seven-point 
Likert-scales, *15 points indicating a positive attitude.
Results: Knowledge and attitude items were completed by 79% (980/1236) 
colonoscopy participants, 16% (725/4688) non-participants; 81% (762/935) of 
CTC participants and 11% (224/1985) non-participants. Of all responding 
colonoscopy and CTC participants, 977 (99.7%) and 755 (99%) had adequate 
knowledge, of which 933 (95%) and 728 (96%) had a positive attitude. Of all 
responding non-participants 700 (97%) and 212 (95%) had adequate knowledge, 
of which 184 (26%) and 35 (25%) had a negative attitude. Overall, 65% of 
colonoscopy and 77% of CTC responders made an informed decision (p = 0.001).
Conclusion: A majority of CRC screening invitees made an informed decision 
about participation. However, this concerned significantly more CTC invitees, 
suggesting additional barriers to participation in colonoscopy invitees.
SS 10.07
Individuals’ time invested in participating in colorectal 
cancer screening with colonoscopy or CT-colonography
M.C. de Haan1, L. van Dam2, T.R. de Wijkerslooth1, E. Stoop2, 
P.M. Bossuyt1, P. Fockens1, M. Thomeer2, E.J. Kuipers2,  
M.E. van Leerdam2, M. van Ballegooijen2, J. Stoker1, E. Dekker1, 
E.W. Steyerberg2; 1Amsterdam/NL, 2Rotterdam/NL
Purpose: Measure the amount of time individuals spend in population-based 
CRC screening by colonoscopy or CT-colonography.
Material and Methods: 8,844 average-risk participants aged 50-74 were 
randomly invited for CRC screening by colonoscopy (n = 5,924) or CTC (n = 
2,920). Colonoscopy was performed with 2L Moviprep and 2L clear fluid, CTC 
with 3 x 50mL Telebrix. Between February and May 2010 consecutive 
participants (eligible when able to read the Dutch language) were asked to 
participate in a diary study. Time intervals were recorded and are reported as 
median and interquartile range (IQR).
Results: 538 of 600 eligible subjects consented: 68% (240/355) of colonoscopy 
and 69% (127/183) of CTC participants completed the diary. For colonoscopy 
and CTC, median intervals between starting the preparation and leaving home 
for the examination were 17hrs (IQR15-18) and 19hrs (IQR18-20) (p < 0.001); 
between leaving home and arriving back home 4.3hrs (IQR3.5-5.0) and 2.5hrs 
(IQR2.1-3.0) (p < 0.001); between leaving home and returning to routine 
activities 6.0hrs (IQR4.0-17) and 3.2hrs (IQR2.3-6.2) (p < 0.001), between 
leaving home and feeling completely back to normal 13hrs (IQR5.1-22) and 
24hrs (IQR6.9-48) (p < 0.001), between starting the preparation and feeling 
back to normal 35hrs (IQR22-39) and 43hrs (IQR26-67) (p < 0.001).
Conclusion: The time spent in the examination itself and before going back to 
routine activities was significantly shorter for CTC than for colonoscopy. 
Despite using limited bowel preparation, time needed to feel back to normal 
was longer for CTC participants.
SS 10.08
Computer-aided detection in CT colonography (CTC): 
which CAD paradigm is best in a screening population?
G. Iussich1, L. Correale2, F. Iafrate3, A. Laghi4, E. Neri5, F. Cerri5, 
D. Campanella1, S. Del Santo2, L. Morra2, A. Bert2, C. Senore2, 
N. Segnan2, D. Regge1; 1Candiolo/IT, 2Torino/IT, 3Rome/IT, 
4Latina/IT, 5Pisa/IT
Purpose: To prospectively compare the diagnostic performance and time 
efficiency of primary and second reader CAD paradigms.
Material and Methods: Individuals participating to a CRC screening program 
and with a positive FOBT test were recruited for same-day CTC and colonoscopy. 
Two experienced radiologists independently analyzed the CTC studies following 
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were 63, 41, 30, 20 and 20% at 1, 2, 3, 4, and 5 years, respectively, in the treated 
group, while in the untreated patients, survival was 0% at 1 year (p < 0.0001).
Conclusion: RFA of both medium-sized HCCs with MPVTT significantly 
prolongs long-term survival of cirrhotic patients compared with no treatment. 
The procedure is safe, with low rate of complications and should be considered 
as a new and effective tool in the treatment of this subset of advanced HCC.
SS 11.04
Combined radiofrequency ablation and drug-eluting 
beads TACE for large hepatocellular carcinoma
E. Bozzi, F. Turini, I. Bargellini, S. Mazzeo, R. Cioni,  
R. Lencioni, C. Bartolozzi; Pisa/IT
Purpose: To prospectively evaluate the efficacy of combined radiofrequency ablation 
(RFA) and doxorubicin-eluting beads transarterial chemoembolization (DEB-TACE) in 
a series of patients with single hepatocellular carcinoma (HCC) larger than 3 cm.
Material and Methods: From September 2005 to January 2010, 34 patients 
(26 males, mean age 70 ± 7.7 years) with unresectable HCC, larger than 3 cm 
in maximum diameter (mean size 43.3 ± 15 mm, range 33-80 mm) underwent 
RFA followed by DEB-TACE, that was performed the day after RFA. Safety and 
tumor response (according to amended RECIST criteria) were analyzed.
Results: No major complications were observed. Mean follow-up was 18 ± 15 
months (range 1-51 months). At 1-month imaging follow-up, complete tumor 
response (CR) was obtained in 26 target lesions (76.5%); at 6 months, CR rate 
was 64.7% (22/34 target lesions). On follow-up, local tumor progression was 
observed in 20 (58.8%) patients with a median expected time of 14 months, 
whereas the median expected time for tumor recurrence in the non-target liver 
was 18 months. Radiological disease progression was observed in 8 (23.5%) 
patients with a mean expected time of 29 months.
Conclusion: In patients with unresectable HCC larger than 3 cm, the 
combination of RFA and DEB-TACE is safe and results in a high rate of 
sustained complete tumor response.
SS 11.05
Portal vein-thrombosis and arterioportal-shunts: effects 
on local tumor response after chemoembolization of 
unresectable hepatocellular carcinoma
O. Abdelaziz Hamada1, N.A. Nour-Eldin2, S. Ahmed1,  
H. Ackermann2, N. Naguib2, T.J. Vogl2; 1Cairo/EG, 2Frankfurt/DE
Purpose: To evaluate the effect of portal vein thrombosis (PVT) and arterioportal 
shunts (APS) on the local tumor response in advanced cases of unresectable 
hepatocellular carcinoma (HCC) treated by transarterial chemoembolization.
Material and Methods: A retrospective study included 39 patients with 
unresectable HCC, who were treated with repetitive transarterial 
chemoembolization (TACE) between March 2006 and October 2009. The effect 
of PVT (19 out of 39 patients), the presence of APS (7 out of 39), the underlying 
liver pathology, Child-Pugh score, initial tumor volume, number of tumors and 
tumor margin definition on imaging were correlated with the local tumor response 
after TACE. The local tumor response was evaluated according to the response 
evaluation criteria in solid tumors (RECIST) and MRI volumetric measurements.
Results: The local tumor response according to RECIST criteria was partial 
response in one patient (2.6%), stable disease in 34 patients (87.1%), and 
progressive disease in 4 patients (10.2%). The MR volumetric measurements 
showed that the PVT, APS, underlying liver pathology and tumor margin definition 
were statistically significant prognostic factors on the local tumor response (p = 
0.018, p = 0.008, p = 0.034 and p = 0.001), respectively. The overall 6, 12 and 18 
months survival rates were 79.5%, 37.5% and 21%, respectively.
Conclusion: TACE may be exploited safely for palliative tumor control in 
patients with advanced unresectable HCC; however, tumor response is 
significantly affected by the presence or absence of PVT and APS.
SS 11.06
Early-stage HCC patients clinically excluded from liver 
transplantation: survival after transarterial 
chemoembolization
I. Bargellini, E. Bozzi, R. Sacco, A. Cicorelli, F. Turini,  
R. Cioni, C. Bartolozzi; Pisa/IT
Purpose: To prospectively evaluate clinical outcome of transarterial 
chemoembolization (TACE) in patients with early-stage (BCLC A) hepatocellular 
carcinoma (HCC) clinically unfit for liver transplantation (LT) and excluded from 
surgical resection and percutaneous ablation.
Material and Methods: From January 2006 to May 2009, 67 patients (43 
males, mean age 70 ± 7.6 years) with unresectable early-stage HCC, within 
Milan selection criteria but clinically unfit for LT, underwent TACE. The primary 
endpoint of the study was overall survival. Secondary endpoints were: safety, 
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SS 11.01
Percutaneous microwave ablation of the liver at 2.45 
GHz: ablation zone volume achieved
P.A. Patel, M.B. Johnson, C.N. Hacking, B. Stedman,  
D.J. Breen; Southampton/UK
Purpose: There is little published data on ablation zone volume (AZvol) achieved 
in human liver following microwave ablation (MWA) at 2.45 GHz. We have analysed 
performance of percutaneous liver MWA at 2.45 GHz by correlation of AZvol 
against ablation time, total energy delivered and number of treatment stations.
Material and Methods: 12 liver tumors (HCC (5), metastases (7)) in 11 patients were 
treated by percutaneous MWA. Ablation times, total energy delivered and number of 
ablation stations were recorded prospectively. Post-procedural late arterial and 
venous phase CT was performed between 6 and 49 days post-treatment. AZvol 
was calculated using drawn regions of interest and Siemens volume software.
Results: Mean total MWA time was 376 seconds (standard deviation (SD) +/-
188.9). Mean total energy delivered was 77.9 kJ (SD +/-33.9). MWA was 
performed at 1 station (n = 9), 2 (n = 2) and 4 stations (n = 1). Mean AZvol 
achieved was 41.4 cc (SD +/-14.6). Pearson’s product correlation (r) between 
both MWA time and total energy delivered and AZvol were not significant (r = 
-0.265 and 0.330, respectively). There was significant positive correlation 
between number of ablation stations and AZvol achieved (r = 0.662, p < 0.02).
Conclusion: Early clinical liver MWA experience suggests that number of 
treatment stations significantly correlates with AZvol achieved. Increasing 
MWA time and total energy delivered shows poor correlation with AZvol. These 
results indicate that probe repositioning is a significant factor in achieving 
larger microwave liver ablation volumes.
SS 11.02
Multipolar radiofrequency ablation for the treatment of 
HCC using no touch technique
O. Seror, G. Nkontchou, N. Sellier, E. Coderc, Y. Ajavon,  
J. Trinchet; Bondy/FR
Purpose: The aim of this pilot study was to assess the effectiveness of extranodular 
no touch multipolar radiofrequency ablation of hepatocellular carcinoma (HCC).
Material and Methods: 109 patients with cirrhosis (Child-Pugh A/B: 91/18) and one 
or two (86/23) HCC (median size: 25mm (10-45mm)) were treated with no touch 
multipolar radiofrequency ablation technique, consisting of simultaneous activation 
of two to four bipolar coaxial electrodes inserted just outside the tumors.
Results: A complete ablation was obtained in 108 patients (99%) after one 
(n = 102) or 2 (n = 6) sessions. The mean number of electrodes used per tumor 
ablation was 3 (4 electrodes was used in 3 patients). More than one application 
was necessary in 5 cases, 20 to 330kJ were delivered per session (mean: 106kJ), 
during 10min to 55 minutes (mean: 27min). Two deaths occurred within three 
months after the procedure: one patient died of ascites infection 2 months after the 
procedure, the other death was not related to complication of cirrhosis (pneumonia). 
One patient experienced jaundice and another pleural effusion requiring drainage. 
After a median follow-up of 12.8 months, one local and 27 distant recurrence 
occurred. At the end point, 15 patients dead and 5 patients were transplanted. The 
2-year survival and recurrence rates were 80% and 35%, respectively.
Conclusion: Multipolar radiofrequency ablation of HCC using no touch 
technique is a very effective method in terms of local tumor control.
SS 11.03
Hepatocellular carcinoma (HCC) in cirrhosis: long-term 
results of percutaneous radiofrequency ablation of both 
the nodule and the portal venous tumor thrombus
A. Giorgio, G. de Stefano; Naples/IT
Purpose: To report 5-year survival of percutaneous radiofrequency ablation (RFA) of 
both medium-sized HCC with portal venous tumor thrombus (PVTT) in cirrhotic patients. 
Material and Methods: From January 2005 and January 2010, 672 had HCC and 
PVTT; 57 of the 672 had a single HCC with main portal vein tumor thrombus 
(MPVTT). Thirty-five patients with 35 HCC 3.7-5 cm in diameter extending into the 
main portal trunk underwent percutaneous RFA. Twenty-two matched patients 
with 22 HCC 3.6-5 cm in diameter extending into the main portal trunk refused 
RFA (control group). RFA was performed first on the MPVTT and then on the HCC 
nodule. Efficacy of RFA was defined as complete necrosis of HCC (enhanced CT 
one month after procedure) and complete recanalization of the MPV.
Results: Complete necrosis of the HCC with complete recanalization of MPV 
was achieved in 67% of cases. No patient died. The cumulative survival rates 
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SS 11.09
The value of Gd-EOB-DTPA-enhanced MRI in short-term 
prognosis of patients with orthotopic liver transplantation
A. Wibmer, S. Magnaldi, N. Bastati, D. Muin, S. Baroud,  
A. Ba-Ssalamah; Vienna/AT
Purpose: The aim of this study was to evaluate Gd-EOB-DTPA-enhanced 
MRI in terms of prediction of short time survival in patients after orthotopic 
liver transplantation.
Material and Methods: Fifty-three liver transplant recipients underwent 83 Gd-
EOB-DTPA-enhanced MRI of the liver between 2007 and 2010. T2w images, 
MRCP sequences, unenhanced and dynamic-enhanced T1w sequences (after 
25 seconds, 70 seconds, 5 minutes and 20 minutes) were performed after 
injection of 10ml Gd-EOB-DTPA. In case of delayed excretion, additional 
sequences after 60 and 180 minutes were obtained. The images were analyzed 
qualitatively by two experienced radiologists and quantitatively by measurement 
of the contrast-to-noise-ratio in the common bile duct, right and left hepatic duct 
as well as the relative enhancement of the liver parenchyma. Probability of one-
year survival was estimated by the method of Kaplan and Meier.
Results: Delayed excretion and poor relative enhancement in the Gd-EOB-
DTPA-enhanced MR images were seen in 17 cases (20.5%). Probability of 
one-year survival was significantly inferior in these patients when compared to 
those with normal relative enhancement and excretion (70.7% vs. 91.5%, p = 
0.011). Time from transplantation and age were not significantly different 
between the two groups (p = 0.45, p = 0.44, respectively).
Conclusion: Delayed or missing excretion of Gd-EOB-DTPA as well as poor 
enhancement during the hepatospecific phase is a negative predictor of one-
year survival in patients after orthotopic liver transplantation.
SS 11.10
Ischemic-type biliary lesions after liver transplantation: 
utility of Gd-EOB-DTPA-enhanced MR cholangiography
F. Donati, P. Boraschi, R. Gigoni, S. Salemi, F. Filipponi,  
C. Bartolozzi, F. Falaschi; Pisa/IT
Purpose: To evaluate the utility of contrast-enhanced MR cholangiography 
(MRC) using Gd-EOB-DTPA for identifying ischemic-type biliary lesions (ITBLs) 
in liver transplant recipients.
Material and Methods: Twenty-eight liver transplants with ischemic biliary 
changes underwent MRI at 1.5T-device. After acquisition of T1w/T2w images 
and conventional T2w MRC, 3D fat-suppressed breath-hold T1w sequence (TR/
TE, 3.6ms/1.6ms; 2.4mmthk/-1.8mmsp; matrix, 224 x 192; one NEX) was 
performed before and 15, 20, 25, 30, 35, 40 minutes after intravenous 
administration of gadolinium-EOB-DTPA (Primovist® Bayer Schering Pharma; 
10ml), followed by isotonic saline (20ml). In 9/28 cases T1w sequence was also 
obtained after 90 minutes. Depiction of intra-/extra-hepatic bile ducts, biliary 
dilation or stricture and stone/sludge were evaluated on images by consensus 
reading of two observers using a 3-point scale: 0, absent; 1, visible; 2, excellent. 
Imaging results were correlated with direct cholangiography and/or follow-up.
Results: The grading of visualization and depiction of dilation of the intra-
hepatic bile ducts was significantly superior on T2w MRC compared with Gd-
EOB-DTPA-enhanced T1w MRC; on the contrary, this latter significantly 
tended to out-perform conventional T2w MRC in delineating strictures involving 
hepatic bifurcation and extrahepatic donor bile duct (p < 0.0001). Sludge/
stone formation was correctly identified with both techniques. Biliary 
enhancement was recognized within 20 minutes post-Gd-EOB-DTPA injection 
in 6 subjects, between 25 and 40 minutes in 16, and at 90 minutes in 6.
Conclusion: Gd-EOB-DTPA-enhanced MRC may provide both anatomical 
and functional information of ITBLs in liver transplants.
toxicity on liver function, 1-month tumour response evaluated according to the 
amended RECIST criteria, time to tumour recurrence and local recurrence and 
time to radiological progression.
Results: Forty-one patients (61.2%) received conventional TACE, whereas 26 
(38.8%) were treated using drug-eluting beads. Mean follow-up was 924 ± 399 
days. Two major periprocedural complications occurred (3%). Periprocedural 
mortality rate was 1.5%. ALT and bilirubin levels significantly increased 24h 
after treatment and decreased at discharge. At 1-month follow-up, complete 
and partial tumour response rates were 67.2% and 29.9%, respectively. The 
1-, 2-, and 3-year overall survival rates were 90.9%, 85.2% and 80.8%, 
respectively. Median expected time to recurrence and local recurrence were 
480 and 364 days, respectively. Radiological disease progression was 
observed in 11 patients (16.4%) with a mean expected time of 809 days.
Conclusion: In patients with unresectable, early-stage HCC, clinically excluded 
from LT, TACE is safe and effective, with favourable long-term survival.
SS 11.07
Tumour response to transarterial chemoembolization in 
hepatocellular carcinoma before liver transplantation: 
are the amended RECIST criteria reliable?
I. Bargellini, V. Battaglia, P. Carrai, A. Cicorelli, D. Campani,  
F. Filipponi, R. Cioni, C. Bartolozzi; Pisa/IT
Purpose: To retrospectively analyse tumor response to transarterial 
chemoembolization (TACE) in a series of consecutive HCC transplanted 
patients and evaluate the agreement between amended RECIST criteria and 
percentage of tumour necrosis, assessed at pathology.
Material and Methods: From January 1996 to December 2009, 384 HCC 
patients (M/F= 336/48, mean age 55 years) underwent liver transplantation 
(LT). Among them, 201 (52%) patients (mean number of nodules 2.2 ± 1.6, 
mean diameter 46.2 ± 27.3 mm) were treated by TACE prior to LT. CT 
examinations performed 1 month after TACE were retrospectively reviewed to 
assess tumour response to TACE according to amended RECIST criteria. After 
LT, percentage of tumour necrosis was assessed on the explanted liver.
Results: 1-Month CT follow-up was available in 145/201 (72.1%) patients. 
According to amended RECIST criteria, objective response rate was 88.3%, with 
68 cases (46.9%) of complete response. In the entire series, on the explanted 
livers, mean percentage of tumour necrosis was 71.8 ± 30.7%, with 49.7% of 
patients with necrosis * 90%. A significant correspondence (p < .0001) was found 
between amended RECIST criteria and percentage of tumour necrosis; mean rate 
of necrosis was 85.5% in patients with complete response, 75.4% in patients with 
partial response and 26.2% in subjects with stable disease.
Conclusion: TACE induces >90% necrosis in about 50% of cases. Amended 
RECIST criteria, assessed by triphasic CT, nicely correlate with pathologic 
necrosis, allowing differentiation between responders and non-responders.
SS 11.08
Can psoas muscle area, as a measure of sarcopaenia, 
predict outcomes in liver transplantation?
O.S. Jaffer, D. Lewis, V. Patel, C. Kachramanoglou, N. Vidas, 
F. Gorman, J. Wendon, J. Karani, W. Bernal; London/UK
Purpose: Objective measures of disease burden, such as sarcopaenia, may 
aid clinicians when prioritising patients for liver transplant. The aim of our 
study is to determine if psoas area is a predictor of patient outcomes, such 
as mortality and hospital length of stay.
Material and Methods: The cross-sectional psoas area was measured from CT 
scans of 141 consecutive patients prior to liver transplantation. Demographic 
data and biochemical profiles were collected at initial assessment. In addition, 
anthropometric measurements were taken and Model for End-Stage Liver 
Disease (MELD) score was calculated. Multivariate regression analysis was used 
to determine the relationship between psoas area and primary (90 day and 1 
year mortality) and secondary (hospital length of stay) outcome measures.
Results: Median age was 53 years (96 males:45 females); median psoas area 
2334cm2(M):1467cm2(F). Positive correlations were observed with height (r = 0.51, 
p =< 0.0001), weight (r = 0.538, p =< 0.0001), mid-arm circumference (0.447, p =< 
0.0001), tricep skin-fold thickness (r = 0.597, p =< 0.001), mid-arm muscle 
circumference (r = 0.223, p = 0.009) and hand grip (r = 0.348, p < 0.001). Hospital 
stay had a negative correlation (r = -0.272, p = 0.008). No correlation was identified 
with sodium and albumin, or MELD. When stratified into quartiles, those in the 
lower two quartiles for psoas area had a higher rate of mortality at both 90 days (X2 
= 4.19, df = 1, p = 0.041) and 1 year (X2 = 6.059, df = 1, p = 0.14).
Conclusion: Psoas area is an easily quantifiable predictor of post-
transplant outcome measures. It correlates strongly with other 
anthropometric and functional parameters, but remains independent of 
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Results: At least one sign could be detected at CEUS in 27 of 36 (75%) 
FNHs larger than 3 cm and in 17 of 56 (30%) FNH measuring 3 cm or less 
(p < 0.0001). No statistically significant differences were noted between 
lesion depth or liver echogenicity and detection rate of these sign at CEUS 
(p > 0.05) as well as between CEUS or baseline US/CD with regard to lesion 
size, depth or liver echogenicity (p > 0.05).
Conclusion: The detection rate of the central scar and spoke-wheel sign in 
FNH at CEUS is strongly dependent on lesion size and CEUS can confidently 
diagnose the majority of FNHs larger than 3 cm.
SS 12.04
Navigator-triggered diffusion-weighted MR imaging in 
characterization of focal liver lesions compared to 
T2-weighted imaging
H. Haradome, K. Al Manea, T. Bonaventure, L. Grazioli; 
Brescia/IT
Purpose: To compare navigator-triggered diffusion-weighted imaging (DWI) 
with T2-weighted imaging (T2WI) and to determine the value of apparent 
coefficient (ADC) measurements in focal liver lesion (FLL) characterization.
Material and Methods: One hundred sixty-six consecutive patients with 
269 FLLs (153 benign and 116 malignant) were retrospectively evaluated. 
Two readers visually assessed DWI and T2WI in an independent and blinded 
manner, and ADCs of FLLs were measured. DWI and T2WI were compared 
and the value of ADC measurements was determined with respect to their 
abilities in discriminating benign from malignant FLLs, using receiver 
operating characteristic analysis. Pathologic results, consensus reading, 
and follow-up imaging were used as reference standard.
Results: The Az values of DWI were higher than those of T2WI for both 
observers, with a significant difference (P = 0.049) for the reader with the 
least experience in hepatic imaging. The Az of ADC measurements was 
0.915, and a cut-off ADC value of 1.12 ×  10-3mm2/s yielded a sensitivity of 
82.8% and a specificity of 88.9% for discriminating benign from malignant 
FLLs. The optimal cut-off ADC values of benign solid tumors showed 
moderate merit with relatively large overlap in ADCs, however, in focal 
nodular hyperplasia cases, a higher diagnostic yield may be expected when 
using a combination of visual assessment and ADC analysis.
Conclusion: Navigator-triggered DWI is more useful than T2WI in 
discriminating benign from malignant FLLs. ADC measurements could 
provide supplementary information for FLL characterization.
SS 12.05
Role of diffusion-weighted echo-planar MRI in the 
detection of hepatic metastasis in patients candidate to 
surgical resection
A. Pecchi, M.C. Righi, S. Togni, M. De Santis,  
F. Di Benedetto, P. Torricelli; Modena/IT
Purpose: The purpose of the study was to compare accuracy of diffusion-weighted 
(DW) echo-planar MRI with other MRI sequences (T2W SESS TE80, THRIVE and 
T1W FFE) and CT examination in the detection of hepatic metastasis.
Material and Methods: Sixteen patients with extrahepatic primary 
malignant tumors were studied with CT examination and hepatic MRI at 
1.5 T with the following sequences: DW, T2W SESS TE80, THRIVE and T1W 
FFE post-hepatospecific mdc (Gd-BOPTA). DWI was performed with 
triggered EPI sequence (single-shot echo-planar imaging) with 4 different b 
values, included between 0 and 1000 s/mm2. Two different radiologists 
classified the visible lesions at CT and MRI as benign or malignant according 
to contrast-enhancement and signal intensity values of the lesions. 
Sensitivity, specificity and accuracy were calculated and results were 
correlated with surgical and histopatologic findings or follow-up imaging.
Results: A total number of 75 hepatic metastasis were evaluated. Accuracy values 
and sensitivity were higher with DWI EPI (91%-95%) then with the T2W SESS TE80 
(67%-64%), THRIVE (75%-74%), T1W FFE (68%-67%) and CT (47%-37%).
Conclusion: In our study, DWI EPI was more accurate then T2W SESS TE80, 
THRIVE, T1W FFE and CT for the preoperative detection of hepatic metastasis 
in patients with extrahepatic tumors. In particular, in patient with hepatic 
metastasis candidate to surgical resection, the introduction of DWI sequence 
in the standard MRI protocol was recommended.
11:15 -12:45 Sala Perla
Scientific Session 12
Focal liver lesions (Liver 4)
SS 12.01
Decreased detection of hypovascular liver tumors with 
multi–detector row CT in obese patients: a phantom study
S.T. Schindera1, J. Charimo Torrente1, T. Ruder1, H. Hoppe1, 
R. Raupach2, B. Schmidt2, P. Vock1, Z. Szucs-Farkas1; 
1Bern/CH, 2Forchheim/DE
Purpose: To assess the impact of large patient size on the detection of 
hypovascular liver tumors with MDCT and the effect of a noise filter on image 
quality and lesion detection in obese patients.
Material and Methods: A liver phantom with 45 hypovascular tumors 
(diameters 5, 10, and 15 mm) was placed into two water containers mimicking 
intermediate and large patients. The containers were scanned with a 64-MDCT 
scanner. The CT dataset from the large phantom was post-processed using a 
noise filter. The image noise was measured and the contrast-to-noise ratio 
(CNR) of the tumors was calculated. Tumor detection was independently 
performed by three radiologists in a blinded fashion.
Results: Image noise was significantly higher in the non-filtered large phantom 
compared to the intermediate phantom (35.3 and 18.3 HU, respectively; 
P<.001). No significant difference in image noise was seen between the filtered 
large and the intermediate phantom (20.6 and 18.3 HU, respectively; P=.15). 
The CNR values of the tumors in the non-filtered and filtered large phantom 
were lower than in the intermediate phantom (P<.05). In the non-filtered and 
filtered large phantom, 24% and 19% fewer tumors, respectively, were 
detected on average compared to the intermediate phantom (P<.01).
Conclusion: The risk of missing hypovascular liver tumors with CT is 
substantially increased in large patients. A noise filter improves image quality 
and lesion detection in obese patients.
SS 12.02
Contrast-enhanced ultrasonography versus 
multidetector-computed tomography in detection of 
liver metastases from colorectal cancer. A prospective, 
blinded, patient by patient analysis
S.R. Rafaelsen, A. Jakobsen; Vejle/DK
Purpose: To compare the sensitivity and specificity of contrast-enhanced 
ultrasonography (CEUS) and multidetector-computed tomography (MDCT) in 
the detection of liver metastases in patients with colorectal cancer (CRC).
Material and Methods: In this study 271 consecutive patients with primary 
colorectal cancer were evaluated (146 males and 125 females, with a mean age of 
67.4 years, range: 34-91 years). All patients underwent combined liver ultrasonography 
and CEUS using 2.4 ml Sonovue IV. Time from injection to arrival time in the hepatic 
vein (ATHV) was noted. Contrast-enhanced MDCT in the portal phase was performed 
and interpreted blindly. In all patients intraoperative ultrasound was used as gold 
standard. Additional follow-up, MRI or biopsy was performed on all suspicious 
lesions or if there was any inconsistency in the results. When liver resection was 
performed, the pathological examination contributed to the gold standard.
Results: Liver metastases were detected in 21 patients (8%). Both CEUS and 
MDCT had sensitivity of 85.7%. Specificity of CEUS was 97.6% and MDCT 
95.6%. Compared to MDCT, CEUS tended to show a higher positive predictive 
value, 75% vs. 62%. In patients with and without liver metastases ATHV was 
18 sec. and 22 sec., respectively, p < 0.05.
Conclusion: CEUS has potential as a diagnostic alternative to MDCT in the 
detection of liver metastases. In this study, we also observed that ATHV was 
shorter in the metastatic group compared to patients without liver metastases.
SS 12.03
Hepatic focal nodular hyperplasia: contrast-enhanced 
ultrasound findings with emphasis on lesion size, depth 
and liver echogenicity
T.V. Bartolotta, A. Taibbi, L. La Grutta, C. Genova, L. Tortorici, 
M. Midiri, R. Lagalla; Palermo/IT
Purpose: To correlate contrast-enhanced US (CEUS) findings of hepatic 
focal nodular hyperplasia (FNH) with lesion size, depth and liver echogenicity 
and to compare CEUS with baseline US.
Material and Methods: Two radiologists evaluated baseline US and CEUS 
examinations of 92 FNHs (mean size: 3.1 ± 1.7 cm) in 71 patients (59 women 
and 12 men, mean age: 38.9 years), for detecting the spoke-wheel sign, 
central scar and feeding vessel. The FNHs were grouped and analyzed by 
dimension, depth and liver echogenicity.
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discriminating metastases from benign hepatic lesions for ADC and Fa value were 
0.885 and 0.731, respectively. The sensitivity-specificity of ADC and Fa were 
87.5%-84.4%, and 78.1%-57.8%, respectively. The Az value for discriminating 
cysts from hemangiomas for Fa was 0.96. The sensitivity and specificity were 
90.6% and 92.3%. The correlation between ADC and Fa was negative, weak and 
significant (r = -0.36). The interobserver agreement was very good.
Conclusion: DTI can be used to characterize hepatic metastases, 
hemangiomas and cysts. Whereas malignant lesions tend to have low ADCs 
and high Fa values, cysts have high ADCs and low Fa values and hemangiomas 
have high ADCs and high Fa values.
SS 12.09
Magnetic resonance elastography measurements of 
viscosity: a novel biomarker for human hepatic tumor 
malignancy?
M. Wagner1, S. Doblas1, P. Garteiser1, N. Haddad1, J. Daire1, 
H.S. Leitão2, V. Vilgrain1, R. Sinkus1, B.E. Van Beers1; 
1Clichy/FR, 2Coimbra/PT
Purpose: To determine the value of magnetic resonance elastography (MRE) 
with tissue elasticity (Gd) and viscosity (Gl) measurements in the differentiation 
between benign and malignant lesions.
Material and Methods: Seventy-six consecutive patients who had MRI 
examinations for the assessment of focal liver lesions were included, with 42 
benign and 37 malignant hepatic tumors. Standard MRI (including dynamic 
contrast-enhanced MRI) and MRE were performed in the same session. Gd and 
Gl maps were reconstructed by fitting a polynomial function to the local 
displacement field under physical constraints of mechanical isotropy and tissue 
incompressibility. Average Gd and Gl values were obtained after placement of 
ROIs covering the whole tumor section or the viable enhancing tumor regions.
Results: Malignant tumors were found to be significantly more viscous than 
benign lesions (global ROI: Gl = 1.97 ± 1.44 kPa and 0.99 ± 0.63 kPa ; viable 
tumor ROI: 2.13 ± 1.54 kPa and 0.98 ± 0.66 kPa, for malignant and benign 
lesions, respectively). A significant elasticity difference between malignant (Gd 
= 2.35 ± 0.75 kPa) and benign lesions (Gd = 2.02 ± 0.69 kPa) was only found 
after inclusion of cysts in the benign group.
Conclusion: MRE measurement of viscosity appears to be a promising 
biomarker for the determination of hepatic tumor malignancy. 




Clinical value of conventional follow through 
examinations compared with modern sectional imaging
L. Egger, C. Friedrich, G. Schill, C. Stroszczynski,  
A. Schreyer; Regensburg/DE
Purpose: Abdominal follow through examinations are functional radiological 
examinations to analyse the intestinal passage after application of oral contrast media 
under continuous fluoroscopy. Although ultrasound as well as other modern sectional 
imaging methods such as CT and MRI are well-established methods for intestinal 
diagnosis, conventional fluoroscopy is still requested when it comes to find out about 
uncertain abdominal conditions. The objective of our study was to assess the clinical 
value of follow through examinations compared to endoscopy and sectional imaging.
Material and Methods: We retrospectively analyzed all available data of 300 
consecutive patients, who underwent a follow through between 2001 and 
2009 in a university hospital.
Results: In 32 patients (11%) the examination was performed with complications, 
which in 6 (2%) led to an abort of the examination. 179 (60%) of 300 patients suffered 
from a malignant disease. In most cases the follow through was requested to 
exclude ileus or other not specified gastrointestinal passage problems (70%, n = 
228). 45% (n = 134) of the patients had undergone a surgical intervention at the 
abdomen, within those the examination was indicated after 8 days after the surgery. 
In 172 cases (58%) there were no specific or unconspicuous findings, in 116 (40%) 
patients the question which led to the examination was not clearly answered. 74% 
of the patients (n = 221) had been examined additionally with CT, MRI, ultrasound or 
endoscopy. Results of the follow through and other type of examinations were 
partially confirmed in 54% (n = 120) and did not match in 30 cases (13.6%). The 
average radiation of a follow through examination was 7 mSv.
Conclusion: According to the results of our study, a conventional radioscopy 
of the abdomen should be indicated very restrictivly considering the low 
explanatory power of the method and the associated exposure to radiation.
SS 12.06
Reproducibility of perfusion and pure diffusion parameters 
in multi-b diffusion-weighted MR imaging of liver tumors
M. Wagner1, S. Doblas1, J. Daire1, N. Haddad1, H.S. Leitão2, R. 
Sinkus1, B.E. Van Beers1, V. Vilgrain1; 1Clichy/FR, 2Coimbra/PT
Purpose: To investigate the reproducibility of diffusion-weighted MR imaging 
(DWI) with a multi-b, bi-exponential fitting approach in patients with liver tumors.
Material and Methods: Ten patients diagnosed with liver tumors (for a total of 
13 lesions) underwent two successive multi-b (0 to 500 s/mm2) DWI acquisitions. 
Measurements of apparent diffusion coefficient (ADC), pure diffusion coefficient 
(ADCslow), perfusion-related diffusion coefficient (ADCfast), perfusion fraction 
(DCfast), and pure diffusion fraction (DCslow) were performed by two independent 
observers in each tumor, for each acquisition.
Results: All parameter measurements were similar between acquisitions and 
between observers (p values ranging from 0.25 to 0.73 and from 0.29 to 0.71 
respectively). Measurements of reproducibility from successive DWI 
acquisitions were high for conventional ADC, ADCslow and DCslow (ICC = 
0.850; 0.831 and 0.73 and 95% limits of agreement = 29%–32%, 24%–32% 
and 15%–20%, respectively) and moderate for DCfast (ICC = 0.63; 34%-49%). 
The reproducibility of ADCfast appeared to be poor, with ICC of 0.621 and 
95% limits of agreement of 87%–98%. Inter-observer reproducibility of DWI 
data was high for any considered parameter (ICC ranging from 0.844 to 0.924 
and 95% limits of agreement ranging from 5% to 25%), except for ADCfast.
Conclusion: The reproducibility of the perfusion-related diffusion coefficient 
(ADCfast) in liver tumors was poor, whereas a maximal variation in DWI 
measurements of 49% was observed for the others parameters.
SS 12.07
Diffusion weighted MR imaging of focal liver lesions: 
qualitative and quantitative evaluation of inter-slice 
variation in apparent diffusion coefficient and its impact 
on lesion characterization
C. Schmid-Tannwald, F. Dahi, Y. Jiang, I. Sethi, A. Oto; 
Chicago, IL/US
Purpose: To evaluate inter-slice variation in apparent diffusion coefficient 
(ADC) values of focal liver lesions (FLL) and to determine impact of this 
variation on lesion characterization.
Material and Methods: 91 patients with 128FLL (>2 cm, 70 benign, 58 
malignant) were included. ADC map images demonstrating FLL without any 
partial volume effect were reviewed. Two independent observers evaluated each 
lesion to subjectively determine if there is a change in its signal among ADC 
slices. A third observer measured ADC of each FLL and neighboring normal liver 
on all included slices. ADC range for each lesion (maximum-minimum lesion 
ADC) and normal liver (maximum-minimum liver ADC) were calculated. 1. Mean 
of ADC range for benign and malignant FLL and neighboring liver and 2. mean 
ADC of slices through benign and malignant FLL were compared using t-test.
Results: Inter-slice signal variation was present in 18/70 (25.7%) and 19/70 (27.1%) 
of benign FLL and 30/58 (51.7%) and 29/58 (50.0%) of malignant FLL by observer 
1 and 2, respectively. Mean ADC range for both benign FLL (0.28 x 10-3mm2/s) and 
malignant FLL (0.26 x 10-3mm2/s) was significantly higher than mean ADC range of 
normal liver surrounding benign and malignant lesions (0.16 and 0.15 x 10-3mm2/s, 
respectively)(p < 0.01). Mean ADC of slices through benign FLL was significantly 
higher compared to malignant FLL (1.65 vs 1.45 x 10-3 mm2/s) (p < 0.01).
Conclusion: FLL demonstrate inter-slice signal variation on ADC maps 
indicating heterogeneous restricted diffusion within lesions. This variation 
limits ability of DWI to differentiate benign and malignant FLL.
SS 12.08
Characterization of Liver lesions using magnetic 
resonance diffusion tensor imaging: preliminary results
S.M. Erturk, E. Kaya, A. Ozel, O. Yapici, M. Basak,  
O. Tufaner, Z. Karpat; Istanbul/TR
Purpose: To evaluate MR diffusion tensor imaging (DTI) in the characterization 
of liver lesions using ADC and fractional anisotropy (Fa) values.
Material and Methods: Sixty-six patients with 77 lesions were examined with DTI. 
Two radiologists performed ADC and Fa measurements. The differences were 
compared using ANOVA and Tukey tests. A ROC analysis was applied; sensitivities 
and specificities were calculated. ADCs and Fa values were correlated using Pearson 
correlation. Interobserver agreement was evaluated using Bland-Altmann plots.
Results: There were 32 metastases, 13 cysts and 32 hemangiomas. The mean 
ADC value of cysts (3.30 ± 0.8 mm2/sec ) was significantly higher than that of 
hemangiomas (2.23 ± 0.5 mm2/sec) and metastases (1.62 ± 0.4 mm2/sec). 
The mean Fa value of cysts (0.2 ± 0.05) was significantly lower than 
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European Guidelines on Quality criteria for CT. Objective image noise (mean 
std dev of HU value in abdominal subcutaneous fat), CTDI(mGy)and dose 
length product (mGy-cm) for each scan was estimated.
Results: All images were considered of optimal quality. Subjective image noise 
was lower in IRIS [mean = 1.39 ± 0.72 (p = 0.29)] compared to FBP (1.72 ± 
0.58). IRIS images were rated slightly better for diagnostic quality [1.2 ± 0.38 
(p = 0.62)] over FBP (1.45 ± 0.81). Visual sharpness scores were 1.75 ± 0.56 (p 
= 0.28) for IRIS and 2.1 ± 0.37 for FBP. IRIS showed better score for image 
artifacts [1.15 ± 0.43 (p = 0.5)] over FBP 1.4 ± 0.39]. Objective image noise was 
lower (20.5% reduction) with IRIS mode [12.8 ± 5.3 (p ) 0.001)] compared to 
FBP (16.1 ± 6.7). Average CTDI and DLP in low dose CT(IRIS) and standard 
dose CT (FBP) groups were 10.1mGy, 506mGy-cm and 15.6mGy, 760mGy-cm 
with an average radiation dose reduction of 35.3% with IRIS.
Conclusion: In patients with undergoing abdominal MDCT examinations, IRIS 
enabled CT renders low dose CT images of optimal quality compared to FBP.
SS 13.05
Is low-dose CT with iterative image reconstruction an 
advantageous strategy for reducing radiation dose in 
Crohn’s disease? A prospective study
S.B. O’Neill1, S. Mcwilliams1, S. Leong1, F. O’Neill1, J. Bye2, 
O. Craig1, A. McGarrigle1, F. Shanahan1, M. Maher1;  
1Cork/IE, 2Chalfont St Giles/UK
Purpose: Crohn’s disease (CD) patients are “at risk” of significant cumulative effective 
doses (EDs) of radiation from diagnostic imaging. This study’s purpose is to examine 
the effectiveness of iterative reconstruction (IR) to reduce ED due to CT in CD patients.
Material and Methods: Following ethical approval, 50 patients with CD referred 
for clinically indicated abdomino-pelvic CT (CTAP) [40% male; mean age 37 years, 
range 17-73] consented to undergo an additional low-dose CTAP (LD) at the time 
of CTAP. Conventional and LD images were independently reviewed by two 
radiologists who calculated the Crohn’s disease activity score (CDAS) and graded 
images using image quality indices. The ED for each study was calculated.
Results: The mean ED for LD and conventional CTAP were 1.3 ± 0.9mSv and 
4.8 ± 3.2mSv, respectively, a mean dose reduction of 74% (p < 0.001). Image 
quality indices of LD images were uniformly inferior at all levels of the abdomen-
pelvis except at the iliac crest. The mean CDAS was less for LD (3.6 ± 2.7) than 
conventional CTAP (4.1 ± 2.5) (p < 0.05). However, no diagnostic finding seen 
on conventional CTAP was missed on LD.
Conclusion: IR facilitated a 74% reduction in ED with ED equivalent to that of two 
plain radiographs of the abdomen. LD images had inferior image quality and 
underestimated CDAS, yet no significant finding was missed. LD CTAP was seen 
to effectively reduce ED due to CT without compromising diagnostic yield.
SS 13.06
Comparative assessment of three image reconstruction 
techniques for image quality and radiation dose in 
patients undergoing MDCT examinations of the abdomen
G. Desai, N. Kulkarni, A. Kambadakone, A. Thabet,  
D. Sahani; Boston, MA/US
Purpose: To assess the image quality and radiation dose benefits with two 
iterative reconstruction techniques (IRIS and ASIR) and filtered back projection 
(FBP) scans in patients undergoing abdominal CT examinations.
Material and Methods: In this IRB approved study, 20 patients (11M:9F,mean age 
= 53.6yrs, mean body wt: 174.5 lbs) underwent abdominal MDCT exams with 
iterative reconstruction in image space (IRIS, Somatom Flash, Siemens), adaptive 
statistical iterative reconstruction (ASIR, Discovery CT750HD, GE) and FBP. 
Common scan parameters included 120 kVp, 55mm table feed, 5mm axial and 
3mm reconstructed coronal/saggital slices. Parameters for IRIS-160 reference 
mAs, ASIR–minimum tube current of 150mA and a maximum of 450mA, NI 36-42 
and 30%ASIR factor; FBP-200 reference mAs/NI 20-28. Randomized blinded 
review by 2 readers for image noise, diagnostic acceptability, sharpness, artifacts 
was done with European Guidelines on Quality criteria for CT. Objective image 
noise (mean std dev of HU value in abdominal subcutaneous fat), CTDI(mGy) and 
dose length product (mGy-cm) for each scan was estimated.
Results: All images were of optimal quality. Subjective image noise was lower in 
both ASIR [mean = 1.39 ± 0.62 (p = 0.29)] and IRIS [1.39 ± 0.72 (p = 0.29)] 
compared to FBP (1.72 ± 0.58). ASIR images were rated slightly better for 
diagnostic quality [1.22 ± 0.46 (p = 0.62)] over FBP (1.27 ± 0.61) and IRIS scans 
[1.50 ± 0.73 (p = 0.15)]. visual sharpness scores on ASIR = 1.27 ± 0.44 (p = 0.63), 
1.44 ± 0.64 (p = 0.28) on IRIS and 1.11 ± 0.67 on FBP. All techniques showed 
comparable score for minimal image artifacts [1.17 (p = 0.5)]. Objective image 
noise was lower with ASIR (10.64 ± 3.5 (p ) 0.001)] and IRIS [(9.97 ± 3.5 (p ) 0.001)] 
compared to FBP (16.4 ± 4.0). Average CTDI and DLP in ASIR, IRIS and FBP were 
11.8mGy, 618.6mGy-cm; 12.3mGy, 539.7mGy-cm and 16.9mGy, 747.3mGy-cm 
with average radiation dose reduction of 30.1% (ASIR) and 27.2% (IRIS).
SS 13.02
Iterative reconstruction in image space for abdominal 
multidetector CT at different tube voltages: assessment 
of diagnostic accuracy, image quality and radiation dose 
in a phantom study
S.T. Schindera1, L. Diedrichsen1, H. Muller1, O. Rusch1,  
B. Schmidt2, R. Raupach2, P. Vock1, Z. Szucs-Farkas1; 
1Bern/CH, 2Forchheim/DE
Purpose: To assess diagnostic accuracy, image quality and radiation dose of 
iterative reconstruction in image space (IRIS) compared to filtered back 
projection (FBP) for abdominal CT imaging at different tube voltages.
Material and Methods: A custom liver phantom with 45 hypovascular tumors 
was placed into a water container that mimicked an intermediate-sized patient. 
The phantom was scanned at 120, 100 and 80 kVp. The CT datasets were 
reconstructed with FBP and IRIS. The image noise was measured and the 
CNR of the tumors was calculated. The radiation dose was assessed by the 
CTDIvol. Tumor detection was independently performed by three radiologists.
Results: Compared to the FBP dataset at 120 kVp, the IRIS dataset at 100 kVp 
demonstrated significantly lower mean image noise (20.9HU and 16.7HU, 
respectively; P < .0001) and greater mean CNR values (P < .05). The IRIS 
dataset at 120kVp yielded the highest sensitivity for tumor detection, while the 
FBP dataset at 80kVp yielded the lowest. The sensitivity for the IRIS dataset at 
100 kVp tended to be greater than that for the FBP dataset at 120kVp (79.3% 
and 74.8%, respectively; P > .05). The CTDIvol decreased by 39.8% between 
the 120-kVp protocol and the 100-kVp protocol.
Conclusion: A 100-kVp abdominal CT protocol with an IRIS algorithm may increase 
image quality and diagnostic accuracy in intermediate-sized patients at a reduced 
radiation dose when compared to a 120-kVp protocol with an FBP algorithm.
SS 13.03
The effect of statistical image reconstruction on 
measured Hounsfield unit densities and noise at various 
anatomical sites: the experience with 40 patients
S.B. O’Neill1, S. Mcwilliams1, M. Breen1, F. O’Neill1, J. Bye2, 
O. Craig1, A. McGarrigle1, F. Shanahan1, M. Maher1;  
1Cork/IE, 2Chalfont St Giles/UK
Purpose: The effect of statistical iterative image reconstruction (SIR) 
methods on measured Hounsfield unit (HU) densities and objective noise 
properties of CT images is not known. Effects of algorithmic non-convergence 
may manifest as differences in absolute density which may have clinical 
impact, such as in the assessment of adrenal lesions.
Material and Methods: 40 patients with Crohn’s disease underwent low dose CT 
abdomen-pelvis for clinical indications. All were imaged on a 64-slice CT scanner 
with retrospective image reconstruction with varying amounts of SIR (0-100% in 
increments of 10%), 11 series per patient. Spherical 10mm diameter regions-of-
interest (ROIs) were drawn at 20 identical anatomical sites per series (liver, spleen, 
and femur, among others) and the mean HU and standard deviation (SD) within each 
ROI were measured. The noise index (NI) was calculated as NI = SD/mean*100.
Results: There was a significant decrease in median HU for the background 
ROI (p < 0.001); there was a trend for decreased median in all other ROIs but 
this was not significant. Higher levels of SIR led to significantly lower standard 
deviations and noise indices in all ROIs (p < 0.001).
Conclusion: Regional quantitative analysis in 40 patients showed the median 
density to drop slightly as level of SIR increased but this difference was not 
significant. There was a significant improvement in the objective noise 
properties within the regions with increasing SIR.
SS 13.04
Impact of iterative reconstruction in image space on 
image quality and radiation dose in patients undergoing 
abdominal MDCT examinations
G. Desai, N. Kulkarni, A. Abou Elias, A. Thabet, D. Sahani; 
Boston, MA/US
Purpose: To compare image quality and radiation dose exposure using low 
dose computed tomography (LDCT) with iterative reconstruction in image 
space (IRIS)and routine dose CT(RDCT) without IRIS in patients undergoing 
abdominal MDCT examinations.
Material and Methods: In this IRB approved study, 121 patients (82M:39F; 
mean age 55.6yrs, mean wt: 252.9lb) underwent CE abdominal MDCT exams 
with IRIS (Somatom Flash, Siemens). In 48 patients FBP scans were available 
for comparison. Common parameters = 120kVp, 55mm table feed, 5mm axial 
and 3mm reconstructed coronal/saggital slices, IRIS = 160 reference mAs; 
FBP = 200 reference mAs/NI = 20-28. Randomized blinded review by 2 readers 
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(HAF) were calculated for both liver lobes. The same patients were subjected 
to upper GI endoscopy for the detection of gastroesophageal varices and the 
results were correlated with the CT perfusion parameters.
Results: Data from 3 patients were excluded from the analysis since their 
results of upper GI endoscopy were equivocal for the presence of varices. 
Among the remaining 26 patients, varices were detected in 18 of them. BV 
proved to be significantly higher in both liver lobes of patients with varices (p = 
0.037 right and p = 0.044 left lobe). For the same group of patients, PS values 
were significantly higher only in the right lobe (p = 0.004) though HAF values 
proved significantly higher (p = 0.046) in left lobe.
Conclusion: There is significant correlation between certain hemodynamic 
parameters and the presence of gastroesophageal varices in cirrhotic patients. CT 
perfusion could potentially be used for the non-invasive detection of varices.
SS 13.10
3D Time-resolved qualitative and quantitative analyses of 
portal venous hemodynamics in liver cirrhosis patients
Z. Stankovic, Z. Csatari, P. Deibert, W. Euringer, S. Eggerking, 
P. Blanke, Z.A. Zadeh, M. Langer, M. Markl; Freiburg/DE
Purpose: To perform qualitative and quantitative analyses of portal venous 
(PV) hemodynamics of liver cirrhosis patients and volunteers using time-
resolved flow-sensitive 4D MRI at 3 Tesla.
Material and Methods: Our study consisted of 20 liver cirrhosis patients, 20 
age matched and 21 young volunteers. 3D flow characteristics in the portal vein 
were evaluated using time-resolved 3D MR velocity mapping at 3T MRI (spatial 
resolution: 1.6 x 2.1 x 2.4mm³, temporal resolution: 44.8ms). PV flow was 
evaluated using 3D streamlines and time-resolved particle traces originating 
from 5 emitter planes in the PV system. Quantitative evaluation included 
retrospective extraction of regional peak and mean velocities, flow volume and 
vessel area. Results were compared to the clinical reference standard US.
Results: 3D streamlines and particle traces in the PV hemodynamics were 
successfully visualized for all patients and volunteers with a small restriction in 
the left intrahepatic PV branch. Almost all results revealed a significant 
correlation with significant lower values for 4D MRI compared to US for 
maximum and mean velocities, flow volume for the intrahepatic vessels and 
significant higher values for the vessel area. Patients showed significant lower 
mean velocities in superior mesenteric vein and significant higher flow volume 
in splenic vein compared to different age group volunteers.
Conclusion: Flow sensitive 4D MRI may be a standardized method within a 
multimodal setting for liver cirrhosis patients evaluating pathological changes 
in flow characteristics or therapy monitoring.
11:15 -12:45 Sala Feste
Scientific Session 14
Pancreas and bile ducts
SS 14.01
Are diffusion-weighted imaging coefficients age-related 
or region-related in normal adult pancreas?
I. Santiago1, J. Maciel1, T. Metens2, J. Absil2, C. Matos2; 
1Aveiro/PT, 2Brussels/BE
Purpose: To determine if the diffusion of water molecules within the 
pancreas is age-related or region-related in normal adults, using MR 
diffusion-weighted imaging (DWI).
Material and Methods: 53 adults devoid of pancreatic disease (mean age: 47 
years; age range: 18-73 years) underwent DWI of the pancreas with an SS-EPI 
sequence using b factors of 0, 150, 1000 and 1600 s/mm2 at 3T. Two 
independent observers (A and B) measured the perfusion fraction (f), true 
diffusion coefficient (D) and ADC values for the head, body and tail of the 
pancreas, and these were correlated to age.
Results: No correlation was found between f, D and ADC values for the three 
different parts of the pancreas and patient age. No statistically significant 
difference was observed for the f values between pancreatic head, body and tail 
(p > 0.05 for both readers). Reader B found a low but significant difference in the 
D between pancreatic head and tail (p = 0.028), D being ~7% lower in the tail. 
Both readers found a low but significant difference between the ADC values of 
pancreatic body and tail (p = 0.006 for reader A; p = 0.011 for reader B), ADC 
being ~8% inferior in the tail. According to the Bland-Altman analysis, standard 
deviation was lower and repeatability was higher for the tail of the pancreas.
Conclusion: f,D and ADC values in adult pancreas are not correlated to age. 
ADC values are lower in the tail than in the body of normal pancreas.
Conclusion: In patients evaluated by abdominal MDCT examinations, 
iterative reconstruction techniques using IRIS and ASIR render optimal 
diagnostic quality images at 30% lower radiation dose to images acquired 
using routine dose FBP images.
SS 13.07
Body composition determinants of radiation exposure 
when automatic tube current modulation is employed 
during routine abdominopelvic CT
L.J. Chawke, S. Mcwilliams, S. O’Neill, M. Maher; Cork/IE
Purpose: With ATCM, it is assumed that patient exposure is determined by body 
mass index (BMI). However, it is unknown what determinants of BMI (body fat, organ, 
or muscle volume) are most predictive of final dose in abdominopelvic CT (CTAP).
Material and Methods: Institutional ethical approval was received. BMIs were 
recorded for 243 consecutive patients that presented for routine CTAP. All 
patients were imaged on 64-slice CT (General Electric Lightspeed VCT-XTE) at 
120kVp and 120-300mA. Dose-length-products (DLPs) were recorded from 
study dose-report. Exclusion criteria were patients with hip prosthesis or scan-
lengths not including dome of the liver to the symphysis pubis. Body 
composition parameters (BCPs) including volumes of abdominal organs, 
subcutaneous (SAT) and visceral (VAT) adipose tissue, and muscle were 
calculated using threshold-based segmentation software.
Results: DLPs ranged from 42.5 to 1363.6mGy-cm. BMIs ranged from 13.9 to 
49.1kg/m2. For all BCPs, males were significantly larger (p=0.049-p<0.001) except 
for total adipose tissue (TAT) volume where the increase did not reach significance 
(p=0.124). Using stepwise simple linear regression with DLP as the dependent 
variable, TAT volume, muscle volume, and liver volume were included (standardised 
coefficients 0.649, 0.258, and 0.097, respectively; R2=0.875, p<0.001).
Conclusion: TAT is seen as the strongest determinant of the DLP among the 
variables assessed. This information may be used to identify those patients 
at highest risk of receiving large doses from CTAP with ATCM and may help 
with refinement of ATCM.
SS 13.08
Comparison of liver tumor volume assessment using 
five different advanced visualization software platforms: 
clinical implications
M. Lubner, P.J. Pickhardt, B.D. Pooler, B. Durkee;  
Madison, WI/US
Purpose: To compare liver lesion volume measurement on five different 3D 
software platforms using a specifically constructed liver phantom.
Material and Methods: Anthropomorphic phantom was constructed with 10 
implanted liver lesions of known volume and varying sizes, attenuation, and 
morphology. Phantom was scanned on at MDCT with standard parameters 
(120 kVp, 80-440 smart mA, NI 12). DICOM data were uploaded to 5 advanced 
visualization software systems and evaluated by three independent readers. 
Tumor volumes were measured by each reader on each software platform with 
both manual and (semi)automated techniques. Actual and measured lesion 
volumes were compared for all systems and readers. Measurement time and 
subjective ease-of-use were assessed with 1-5 ranking of systems.
Results: Overall mean % volume error for manual volume technique by system was 
8.0 ± 7.5%, 16.4 ± 14.8%, 14.2% ± 15.2%, 16.9 ± 13.8%, and 13.7 ± 11.2%. 
Substantial inter-observer variability was present. More automated approaches were 
associated with much larger measurement errors. The fastest system ranked 5th (last) 
in volume error and 3rd in ease-of-use, whereas the two systems that tied for 1st in 
ease-of-use ranked 1st and 3rd in volume error and 5th and 2nd in time, respectively.
Conclusion: Accuracy, precision, and feasibility of 3D volume assessment of 
liver lesions vary considerably by software system and individual readers. 
Manual assessment is currently most accurate but is more labor intensive. 
These results underscore the need for improved automation and uniformity 
among the available software platforms.
SS 13.09
CT perfusion as a non-invasive tool for the diagnosis of 
gastroesophageal varices in cirrhotic patients
A. Karatzas, C. Triantos, M. Marsigie, E. Konstadatou,  
P. Zampakis, K. Thomopoulos, T. Petsas, C. Kalogeropoulou; 
Patras/GR
Purpose: To prospectively assess the utility of perfusion computed tomography 
(CT) in depicting the presence of gastroesophageal varices in cirrhotic patients.
Material and Methods: CT perfusion was performed in 29 cirrhotic patients 
using a 16x MDCT (LightSpeed; GE Healthcare). Obtained data were processed 
(GE Healthcare Workstation) and the blood flow (BF), blood volume (BV), mean 
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biliary tree. ROI analysis was performed to estimate the signal intensity in the 
liver parenchyma and the common hepatic duct in the EOB-MRCs and 
branching of the biliary system was classified and compared to the MRCP.
Results: The overall quality in EOB-MRC was rated as good in fa10 and fa35 
for the grade of visualization of the different anatomical biliary regions and the 
whole biliary tree. Delineation of the biliary system proved to be significantly 
better (p = <0.01) than in MRCP. Comparing the different applied flip angles in 
the post-EOB studies, the fa35 images revealed a significantly higher contrast 
of the biliary system to the liver tissue (p = <0.001) as compared to fa10 
imaging. Changes in classification of bile duct branching were made in about 
15% of the patients applying fa35 images as compared to MRCP.
Conclusion: Flip angle modulations in Gd-EOB-DTPA-enhanced magnetic 
resonance cholangiography revealed an additional diagnostic value regarding 
anatomical variations of the biliary tree as compared to MRCP. Applying a flip 
angle of 35° to the late phase post-contrast images significantly improved the 
contrast of the biliary system to the surrounding liver tissue, indicating a superior 
diagnostic assessment of anatomical and functional bile duct abnormalities.
SS 14.05
Assessment of acute cholangitis by MR imaging
J.H. Kim, H.W. Eun, S.S. Hong, J.K. Han, B.I. Choi; Seoul/KR
Purpose: To assess common MRI findings of acute cholangitis compared 
with a non acute group.
Material and Methods: During 31 months, we performed MRI in 173 patients 
with biliary abnormality. The causes of biliary abnormality include biliary stone 
(n = 85), cholangiocarcinoma (n = 47), periampullary cancer (n = 20), GB cancer 
(n = 4) and others (n = 17). Among them, 66 consecutive patients confirmed acute 
cholangitis according to Tokyo guideline and 107 confirmed non-acute group. 
The two radiologists independently assessed MR findings including cause of 
biliary abnormality, periductal T2 signal change, periductal transient attenuation 
difference, abscess, thrombosis, and ragged duct. They also measure dilated 
duct and thickened wall. Student’s t-test and Pearson Chi-square were used. The 
Kappa statistics were used to determine interobserver agreement. Logistic 
regression was used to identify the MR findings that predict acute cholangitis.
Results: MRI correctly accesses the cause of biliary abnormality in 163 patients 
(94%). The statistically common findings for acute cholangitis were as follows: 
periductal T2 signal change (n = 26, 39%, p < 0.05); periductal transient attenuation 
difference (n = 31, 47%, p < 0.05); abscess (n = 18, 27%, p < 0.05); thrombosis (n 
= 12, 18%, p < 0.05); ragged duct (n = 11, 17%, p < 0.05). Interobserver agreement 
was good to excellent in each findings (? = 0.74 to 1.000). Wall thickness showed 
statistically difference between two group (2.65mm: 2.32mm, p < 0.05); however, 
duct dilatation showed no difference. Periductal transient attenuation difference 
was independent predictor of acute cholangitis (Exp(B) = 6.389, p = 0.018).
Conclusion: By means of statistically common MR findings, MR image is very 
useful for prediction of acute cholangitis.
SS 14.06
Diagnostic work-up of segmental cholangitis using DWI 
and Gd-EOB-DTP-enhanced MRI
S. Magnaldi, A. Wibmer, N. Bastati, D. Muin, S. Baroud,  
A. Ba-Ssalamah; Vienna/AT
Purpose: To describe the MRI features of segmental cholangitis using 
diffusion-weighted imaging (DWI) and Gd-EOB-DTPA dynamic-enhanced 
MRI and distinguish it from THADs.
Material and Methods: All patients underwent a standard Gd-EOB-DTPA-
enhanced MRI of the liver including axial DWI (b = 30, 300 and 600). Patients with at 
least one wedge- or fan-shaped enhancing area in the arterial phase were selected 
for further analysis. THAD was defined as hyperenhancing area in the arterial phase 
and isointense in all remaining sequences. Segmental cholangitis was considered 
in the presence of hyperenhancing area in the arterial phase, hyperintensity in the 
DWI and hypointense in the hepatospecific phase. Blood laboratory parameters 
were compared with the Wilcoxon or the Kruskal-Wallis test.
Results: Of a total of 513 patients undergoing an enhanced MR examination 
of the liver, 42 showed at least one wedge- or fan-shaped enhancing area in 
the arterial phase. The typical appearance of a THAD was present in 12 
patients (28.6%) while 19 patients (45.3%) had signs of segmental cholangitis. 
When compared to patients with THADs, patients with segemental cholangitis 
had significantly higher mean plasma levels of alkaline phosphatase (91.9 vs. 
268.8 U/l; p = 0.015) and C-reactive protein (0.05 vs. 3.27 mg/dl; p = 0.006).
Conclusion: Segmental increased signal intensities on DWI, combined with 
segmental wash-out of hepatospecific contrast agent after administration of 
Gd-EOB-DTPA, is additional evidence of focal areas of parenchymal damage 
in the course of segmental cholangitis.
SS 14.02
Diffusion-weighted MRI of the pancreas: correlation 
with secretin-enhanced magnetic resonance cholangio-
pancreatography (S-MRCP) findings in patients with 
chronic pancreatitis
G. Restaino1, F. D’Argento2, M. Missere1, M. Occhionero1,  
G. Paolantonio2, G. Sallustio1; 1Campobasso/IT, 2Rome/IT
Purpose: To evaluate the correlation between apparent diffusion coefficient (ADC) 
values of the pancreas on diffusion-weighted imaging (DWI) and severity of chronic 
pancreatitis and pancreatic exocrine function determined by S-MRCP.
Material and Methods: Mean ADC values (b = 0, 700) derived from 3 or 2 manually 
drawn region of interest of the pancreas on DWI were measured in 15 healthy 
volunteers and in 50 patients with known or suspected pancreatic diseases 
referred for S-MRCP. S-MRCP images of the patients were evaluated for the 
diagnosis of chronic pancreatitis (Cambridge score) and assessment of pancreatic 
exocrine function (Matos score). Correlation between ADC values in volunteers 
and patients was performed using t-test for unpaired data. ADC values in patients 
were compared to Cambridge score and Matos score with ANOVA test.
Results: Mean pancreatic ADC value was 2.71 x 10-3mm2/s in healthy 
volunteers and 2.21 x 10-3mm2/s in the patients’ group, with a significant 
statistical difference in the two groups (P < .0001), even after adjusting for sex 
and age (P = .0033). There was no significant correlation between pancreatic 
ADC values and Cambridge classification or Matos score in patients with 
chronic pancreatitis, even after adjusting for sex and age.
Conclusion: Pancreatic ADC values were significantly lower in patients with 
known or suspected chronic pancreatitis than in healthy volunteers. We did not 
find any significant correlation between pancreatic ADC values and Cambridge 
classification or Matos score in patients with chronic pancreatitis.
SS 14.03
Timing of biliary excretion during Gd-EOB-DTPA-
enhanced liver MRI and its effect on T2-weighted 
imaging
R. Musson1, N. Hersey2, A. Blakeborough1; 1Sheffield/UK, 
2Derbyshire/UK
Purpose: To record the timing of biliary excretion, and subsequent impact on 
T2-W imaging of the biliary tree performed after Gd-EOB-DTPA injection.
Material and Methods: 145 consecutive patients undergoing Gd-EOB-DTPA-
enhanced MRI for known or suspected liver lesions had an examination protocol 
which included post-contrast T1-W and T2-W imaging at 3, 6, 10 and 20 minutes. 
These studies were reviewed with respect to biliary excretion of contrast agent.
Results: Five studies with incomplete data and a sub-group of 21 studies in 9 
patients with more than one examination were excluded. Of 119 patients, 
71F:48M, aged 18-85 yrs (ave. 51), 16 had a cholecystectomy, 12/93 
gallbladders had stones. Recent LFTs were available in 91 patients (57 normal). 
Biliary excretion was observed in 0/17/107/119 patients at 3/6/10/20 mins 
respectively, appearing as high signal on T1-W sequences and invariably 
producing loss of the normal high signal on the T2-W sequence. Duodenal 
opacification was noted in 0/0/4/42 cases (at 3/6/10/20 mins). Gallbladder 
opacification occurred in 0/2/29/63 (at 3/6/10/20 mins). Differences in excretion 
times did not correlate with age, sex or LFT status.
Conclusion: Biliary excretion following Gd-EOB-DTPA was not detected in any 
patient at 3 minutes, but by 6 minutes was evident in 17/119 (14%) on T1-W 
imaging with corresponding signal loss on T2-W imaging. This signal loss may 
disguise or mimic biliary pathology and we recommend T2-W sequences are 
performed either pre-contrast or early (3 minutes) post-contrast.
SS 14.04
Flip angle modulations in late phase Gd-EOB-DTPA MRI 
improve the identification of bile duct anatomy 
variations as compared to MRCP
L. Stelter, C. Grieser, C.M. Perez Fernandez, J.H. Rothe,  
B. Hamm, T. Denecke; Berlin/DE
Purpose: The additional value of flip angle modulations in late phase contrast-
enhanced magnetic resonance cholangiography (EOB-MRC) using the 
hepatocyte-specific contrast media Gd-EOB-DTPA, as compared to magnetic 
resonance cholangiopancreatography (MRCP), was estimated in this study.
Material and Methods: 35 adult patients underwent Gd-EOB-DTPA-enhanced 
MRI of the liver including an early unenhanced T2-weighted MRCP in single 
shot thick slab technique as well as late phase (20 min. post-contrast injection) 
T1-weighted THRIVE sequences applying an alternating 10° (fa10) and 35° 
(fa35) flip angle, respectively. Images were evaluated by three experienced 
observers in consensus regarding the delineation of different biliary regions, 
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class correlation coefficients. Effect of cholecystectomy, age and sex on BD 
diameter was modeled with linear mixed model analysis.
Results: Sixty-one (21.0%) patients had history of cholecystectomy. Intra-
observer agreement was 99.7% (95% confidence interval (CI): 99.7%-99.8%) 
and 98.0% (95%CI: 97.4%-98.4%). Inter-observer agreement was 93.9% 
(95%CI: 92.3%-95.1%). Cholecystectomy status and age were associated 
with statistically larger BD diameters. The average BD diameters for the non-
cholecystectomy versus cholecystectomy patients were 4,5,5mm and 5,7,7mm 
(p = 0.001) for the intra-hepatic, hepatic artery level and supra-pancreatic BD, 
respectively. Older age was also associated with larger BD diameters(p = 
0.001), irrespective of cholecystectomy status.
Conclusion: Post-cholecystectomy patients can present enlarged BD 
unrelated to cholestasis. BD diameter increases with age regardless of 
cholestasis. Hence, clinicians should rely on patient history and laboratory 
determinants to guide the necessity of further investigation.
SS 14.10
Dual-energy iodine removal for CT-cholangiography: 
virtual non-enhanced imaging effective to replace true 
non-enhanced imaging?
C.M. Sommer1, C.B. Schwarzwaelder1, W. Stiller1,  
S. Schindera2, U. Stampfl1, N. Bellemann1, M. Holzschuh1,  
J. Schmidt1, J. Weitz1, L. Grenacher1, H.U. Kauczor1,  
B.A. Radeleff1; 1Heidelberg/DE, 2Bern/CH
Purpose: To evaluate whether virtual non-enhanced imaging (VNI) is effective 
to replace true non-enhanced imaging (TNI) applying dual-energy iodine 
removal for CT-cholangiography.
Material and Methods: From April 2009 until February 2010, fifteen consecutive 
potential donors for living-related liver transplantation (nine women; mean age 
37.610.8 years) were included. All subjects underwent a two-phase CT-examination 
of the liver. The first phase consisted of a single-energy non-enhanced CT-scan 
providing TNI. After administration of intravenous cholangiographic contrast, the 
second phase was performed as a dual-energy cholangiographic CT-scan. VNI 
was reconstructed with a standard dual-energy iodine subtraction tool (Liver-VNC; 
Siemens Medical Solutions, Forchheim, Germany). Attenuation values (intrahepatic 
main ducts and liver parenchyma), objective image quality (image-noise and 
contrast-to-noise-ratio) and subjective image quality (overall image quality [1 - 
excellent; 2 - good; 3 - fair; 4 - poor; and 5 - not interpretable]) were analyzed.
Results: The long axis of the microwave-ablations with flow occlusion was 
significantly larger compared to the microwave-ablations without flow occlusion 
(41.64.0 mm versus 34.25.9 mm; P 0.01). The short axis of the microwave-
ablations with flow occlusion was significantly larger compared to the microwave-
ablations without flow occlusion (16.61.2 mm versus 12.22.1 mm; P 0.001). The 
volume of the microwave-ablations with flow occlusion was significantly larger 
compared to the microwave-ablations without flow occlusion (6.71.0 ml versus 
3.31.2 ml; P 0.001). The circularity of the microwave-ablations with flow occlusion 
was not significantly different compared to the microwave-ablations without 
flow occlusion (0.400.05 versus 0.360.07; P 0.001).
Conclusion: For CT-cholangiography, subjective image quality was comparable 
between VNI and TNI. However, from a quantitative point of view, significant 
differences exist when VNI was compared to TNI. Therefore, VNI was not 
effective to completely replace TNI.




Magnetic resonance imaging contrast-enhanced mural 
perfusion kinetics: segmental differences exist in 
endoscopicaly proven normal colon
S.A. Taylor, S. Punwani, R. Hafeez, A. Bainbridge, P. Boulos, 
S. Halligan; London/UK
Purpose: Abnormal contrast enhancement is advocated as a biomarker for 
colitis, although normal perfusion kinetics are poorly described. The purpose 
was to assess segmental enhancement in normal colon.
Material and Methods: 8 patients (mean age 61) without prior history of 
inflammatory bowel disease underwent standard MR colonography followed by 
normal same day colonoscopy. A volumetric interpolated breath hold examination 
sequence to encompass the colonic volume was performed three times prior 
(flip angles 5, 10, 35 degrees) and every 30 seconds following intravenous 
Dotarem for 210 seconds. Mural signal intensity was measured in 6 colonic 
SS 14.07
Evaluation of the bilio-enteric anastomoses with 
contrast-enhanced MR cholangiography using Gd-EOB-
DTPA: comparison with conventional T2-weighted MRC
P. Boraschi, F. Donati, S. Salemi, R. Gigoni, C. Bartolozzi,  
F. Falaschi; Pisa/IT
Purpose: To compare Gd-EOB-DTPA MR-cholangiography (MRC) with 
conventional T2-weighted MRC in patients with bilio-enteric anastomoses.
Material and Methods: Twenty-eight patients with pre-existing bilio-enteric 
anastomoses and clinical-echographical suspect of biliary pathology underwent 
MR imaging at 1.5T device. After acquisition of T1w/T2w images, conventional 
MRC was performed through thin-slab 3D FRFSE and thick-slab SSFSE T2w 
sequences. In each patient a 3D fat-suppressed LAVA sequence was performed 
before and 15, 20, 25, 30, 40 minutes after intravenous administration of 10 ml 
Gd-EOB-DTPA (Primovist®, Bayer HealthCare), and in 3/28 cases it was also 
obtained after 90-120 minutes. Visualization of each segment of the biliary tree 
and anastomotic bowel was graded by two radiologists in conference on a four-
point scale: 0, absent; 1, poor; 2, good; 3, excellent. All segments were assessed 
for the presence of ductal dilatation, stricture, bile leakage, intraductal filling 
defects and other abnormalities. MRI findings were compared to surgical findings, 
when scheduled, and/or a six months-lasting clinical-radiological follow-up.
Results: Gd-EOB-DTPA-enhanced-MRC significantly out-performed 
conventional MRC in the visualization of the extra-hepatic biliary system and 
anastomotic region and in the assessment of anastomotic strictures and 
pneumobilia (p < 0.05). The grading of visualization and depiction of dilation of 
the second and third-order intra-hepatic bile ducts was significantly superior 
on T2w MRC (p < 0.05). No significant difference was identified between the 
two techniques in the detection of biliary stones.
Conclusion: Gd-EOB-DTPA MR-cholangiography can improve the assessment 
of biliary pathology in patients with bilio-enteric anastomoses.
SS 14.08
Does Courvoisier’s sign stand the test of time?
K. Murphy, P. Mc Laughlin, B. O’Connor, M. Breen,  
C. O’Suilleabhain, P. MacEneaney, M. Maher; Cork/IE 
Purpose: Courvoisier’s sign states that in a jaundiced patient with a palpable 
gallbladder, the cause is unlikely to be gallstones. The aim of this study was 
to investigate the validity of this sign in modern practice using image analysis 
software to objectively measure gallbladder volumes at MRCP in patients 
with and without biliary obstruction.
Material and Methods: All MCRP investigations that were performed at a 
tertiary hepatobiliary and pancreatic centre over a two-year period were 
analysed. The information recorded included the presence or absence of 
gallbladder stones, common bile duct (CBD) stones or non-gallstone biliary 
obstruction. Gallbladder volume was calculated using Osirix v3.7.1.
Results: 645 MRCPs were examined, of which 398 (61.7%) were eligible for 
analysis. Mean gallbladder volumes were estimated for 4 patient groups as 
follows - no gallstones or biliary obstruction: 39.6 ml (SD 33.7), gallbladder 
stones only: 53.0 ml (SD 51.2), CBD stones: 66.7 ml (SD 58.9) and non-gallstone 
biliary obstruction: 98.7 ml (SD 62.9). A statistically significant difference exists 
between the summated obstructive and non-obstructive groups (p < 0.001). In 
addition, a significant difference exists in mean gallbladder volume between 
those with CBD stones and non-gallstone CBD obstruction (p = 0.02).
Conclusion: A significant difference was observed in gallbladder volume in the 
group with biliary obstruction from choledocholithiasis compared with the 
group with biliary obstruction due to other aetiologies. This study validates 
Courvoisier’s sign as a valuable clinical sign for suggesting aetiology of biliary 
obstruction in the jaundiced patient.
SS 14.09
Dilatation of the bile duct in post-cholecystectomy 
patients: a retrospective study
D. Landry, J. Murphy-Lavallée, A. Tang, L. Lepanto,  
D. Olivié, J. Billiard; Montréal, QC/CA
Purpose: To compare the bile duct (BD) diameters in patients with cholecystectomy 
to those without and determine the impact of age and sex on BD diameter.
Material and Methods: We retrospectively reviewed contrast-enhanced 
abdominal CT scans of 290 consecutive patients (119 males, mean age 55.9 
years; range 30-80) between June 2009 and August 2010 who presented at 
the emergency department of our institution without cholestasis, proven by 
normal laboratory values of total bilirubin and alkaline phosphatase. The BD 
diameter was measured in three locations; intra-hepatic, at hepatic artery and 
supra-pancreatic. Measurements were performed twice, at one month interval, 
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SS 15.04
Complying with NPSA. How to make the impact on 
radiology a positive one
S.J. O’Shea, A. Mort, R. Sethi, S.H. Lee; Manchester/UK
Purpose: In February 2009, the National Patient Safety Agency (NPSA) in the UK 
issued a directive to all healthcare organisations regarding potential risks associated 
with inappropriate use of oral bowel cleansing agents. To comply with the 
requirements of this document needed a major overhaul in the booking systems 
within radiology for CT colonography and barium enema examinations. All 
healthcare organisations using bowel cleansing solutions were directed to provide: 
a clinical assessment to ensure no contraindication or risks from the use of a bowel 
cleansing solution. Authorisation for use of a bowel cleansing solution at the same 
time as the investigative procedure. An explanation of the safe use of the product 
to the patient or carer. A safe system involving an authorised clinical professional 
in the supply of the medicine and written information for each patient.
Material and Methods: We describe our experience in setting up a radiology 
outpatient clinic to comply with NPSA requirements, run by specialist G-I 
radiographers, in order to review patients referred for studies requiring 
bowel cleansing agents. This allows renal function and performance status 
to be reviewed as well as bowel cleansing agents to be prescribed and both 
written and verbal instructions given.
Results: To date patient acceptability has been 100% with no complaints despite 
the requirement for an additional visit to the department prior to the radiological 
examination. We discuss our experience of obstacles to the provision of this 
service, training issues, the impact on the running of the department, cost 
implications and impact on DNA rates for time consuming investigations.
Conclusion: It is possible to set up a G I radiographer led outpatient clinic 
service in order to comply with National Patient safety requirements in the UK 
and achieve associated improvements in patient service. Such a service may 
well be required in other countries in the future. We believe our service can act 
as a role model in this respect.
SS 15.05
Assessment of colon cancer staging by water enema-MDCT
E. Sibileau1, C. Ridereau-Zins1, P.J. Valette2, N. Ibtissam 
Ashwar2, S. Bertrais1, A.H. Pavageau1, C. Casa1, C. Aubé1; 
1Angers/FR, 2Lyon/FR
Purpose: To assess the accuracy of the WE-MDCT for the staging of colon cancer.
Material and Methods: 53 patients (mean age 70) with a diagnosis of colon 
cancer were prospectively evaluated by a preoperative WE-MDCT. All patients 
were operated on. Tumors were classified with TNM staging system. The CT 
features noticed were: tumor location on the colon; aspect of tumor external 
edges; spread to the pericolic fat or to the neighbouring organs; thickening of 
retroperitonal fascia; number, size and enhancement of the peritumoral lymph 
nodes. Tumors were estimated in 2 groups: T1/T2 and T3/T4. Subgroups T3 and 
T4 were analysed separately. Lymph nodes were classified positive or negative.
Results: Tumor location on colon was always right. The agreement between 
WE-MDCT staging and pathology staging was good (k = 0.64). A stiff aspect 
of tumor external edges had excellent sensitivity for inclusion in T3/T4 group 
(Se 97.7%, NPV 85.7%). Thickening of a fascia or the abdominal wall had a 
good specificity for T4 stage (Sp 95%; NPV 91%). Enhancement over 100 
HU of at least one of the peritumoral lymph nodes was the best criteria for 
positivity (Se 86.4%; Sp 67.7%; NPV 87.5%).
Conclusion: WE-MDCT allows a good staging for colon cancer based on 
objective features.
SS 15.06
Accuracy of pre-operative MDCT staging of locally 
advanced colon cancer
V.C. Arora, S.H. Lee, S.J. O’Shea, S. McGrath; Manchester/UK
Purpose: Neo-adjuvant chemotherapy has been shown to improve survival in 
some GI malignancies. Identification of poor prognostic features in colon 
cancer can help direct therapy with the aim of down staging local disease . 
This study aims to assess the accuracy of MDCT in staging of locally advanced 
colon cancer as compared to postoperative histopathology.
Material and Methods: 29 patients were prospectively assessed by TNM 
staging for entry into the UK FOxTROT trial . Poor prognostic factors such as 
local invasion and extramural vascular invasion (EMVI) were recorded. 
Patients with distant metastatic disease were excluded. 8 patients who were 
randomized to neo adjuvant chemotherapy were excluded leaving 21 (mean 
age 72 yrs, 12M) patients for analysis.
Results: The accuracy for staging of T3/T4 colon cancer was 62%. Depth of local 
tumor invasion beyond the muscularis propria was accurately identified in 47%. 
Accuracy for EMVI and exclusion of N2 disease was 71 and 38%, respectively.
segments and colonic wall T1 calculated using a standard expression for the 
evolution of signal intensity in a spoiled gradient echo sequence and solving for 
T1. Perfusion curves (change in T1 against time averaged across all patients) 
were generated, and maximum T1 change compared across segments using 
one-way ANOVA and Tukey correction for multiple comparisons.
Results: All colonic segments demonstrated type 2 enhancement curve 
morphology. However, T1 change during the plateau phase (after 120 seconds) 
significantly differed between segments (p < 0.001). In particular, rectal T1 fall 
(mean plateau -417ms) was significantly greater that all other segments (p < 0.001 
to 0.02), whereas the caecal T1 fall (mean plateau T1 -311ms) was significantly 
less than the rectum (p < 0.001), ascending (p = 0.03), and sigmoid (p = 0.04).
Conclusion: Normal colon shows significant intersegmental perfusion 
differences. Notably, rectal enhancement is highest and caecal lowest.
SS 15.02
Image quality of MR-colonography with iodine-tagged 
limited bowel preparation and automated carbon dioxide 
insufflation for colonic distension: preliminary results
M.P. van der Paardt, F.M. Zijta, T.N. Boellaard, S. Bipat,  
A.J. Nederveen, J. Stoker; Amsterdam/NL
Purpose: To prospectively evaluate image quality of 3.0T MR-colonography 
using iodine-tagged bowel preparation and CO2 bowel distension.
Material and Methods: Twenty patients at increased risk for colorectal 
carcinoma underwent 3.0T MR-colonography using iodine-tagged bowel 
preparation and automated CO2 insufflation. Coronal FS 3D-T1-weighted 
SPGR and 2D-T2-weighted SSFSE were acquired in supine and prone (only 
T1-weighted acquisition) position. Two observers assessed image quality 
for six colon segments with regard to amount, consistency of fecal residue, 
bowel distension, artifacts and image readability, on a 3- or 4-point scale. 
Wilcoxon-signed-rank test was used for comparison.
Results: Each observer evaluated 120 segments per sequence (total evaluated 
segments = 480). In 63.8% of the segments (306/480), less than 25% of the 
lumen was filled with fecal residue. Bowel content was homogeneously 
liquefied in 94% (451/480). Overall supine distension was adequate-optimal in 
94.7% (453/480) segments. Distension was overall better in supine compared 
to prone position (84.6% versus 55.0%; P < 0.0001); prone position was 
favorable for rectal distension (92.5% (37/40) versus 67.5% (27/40); P = 0.03)). 
Overall image readability on T1-and T2-weighted (T2w) images was sufficient 
(87.9% (422/480)), although significantly lower for T1w images (P < 0.0001). 
More artifacts were found for T1w images (75.4% (181/240)) compared to T2w 
images (16.6% (40/240; P = 0.0001)); however, overall only 16 artifacts ((16/221 
(7.2%)) affected image readability (15 T1w, 1 T2w).
Conclusion: Automated CO2 insufflation is feasible for 3.0T MR-
colonography and results in adequate to optimal distension of the large 
majority of segments. Iodine tagging results in homogeneous tagging.
SS 15.03
Hydrocolonic ultrasound for colorectal cancer detection: 
technique and preliminary study in 80 cases
S. Siripongsakun, L. Charoenvisal; Bangkok/TH
Purpose: To introduce hydrocolonic ultrasound technique (HUS) that can 
complete colorectal evaluation for detecting malignant colonic lesion and 
reveal preliminary study in 80 cases when compared with colonoscopy.
Material and Methods: Technique: To eliminate retained stool, the patient 
should obtain total colonic irrigation prior the study. The irrigation system can be 
adapted from barium enema system. Scanning should be performed with 
adequate colonic distension which can be achieved by instilling of 1-2 litre of 
water. Some parts are difficult to evaluate; for example, colonic flexures behind 
the ribs or tortuous sigmoid. Most sigmoid can be assessed by changing from 
supine to lateral decubitus positions, whereas colonic flexures can be easily 
accessed by taking a deep breath to bring the flexures down below the ribs. The 
aim is to evaluate rectal area which cannot be reached by transabdominal 
ultrasound. After rectal balloon removal, transperineal approach is performed to 
complete colorectal evaluation while the retained fluid still distends the rectum. 
Total average scan time is about 15-20 minutes.
Results: Hydrocolonic ultrasound can detect all cancers and polyps >1.5 
cm(5/5 lesions), missed 1 polyp size between 1 and 1.4 cm (1/4 lesions) but 
it is insensitive in detection of polyp size less than 1 cm.
Conclusion: HUS is a cheap, tolerable, and non-invasive method for colon 
cancer detection. Without radiation exposure, hydrocolonic ultrasound can 
be a potential study for detecting early colorectal cancer, even though it is 
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range 35-68) and studied with FCTF and CF were evaluated. FCTF protocol 
included an unenhanced (UE) scan, followed by manual injection of water-
soluble contrast material under pulsed fluoroscopic guidance, and a portal 
enhanced scan (80 sec delay). For CF, the injection of contrast material was 
performed manually under fluoroscopic guidance, acquiring spot images in the 
crucial phases. The diagnostic accuracy of FCTF in depicting intestinal fistulas 
(defined as channels filled with contrast material connecting two intestinal 
structures) was evaluated with respect to CF. Mean fluoro-time was compared 
with Student’s t-test. A p value )0.05 was considered significant
Results: FCTF presented 90% sensitivity and 100% specificity in diagnosing 
intestinal fistulas, missing only a fistula (because of small amount of contrast 
material injected), without false positive cases. Mean fluoro-time registered for 
FCTF and CF was similar (p = 0.1, 7.2 versus 8.1 sec).
Conclusion: FCTF is a reliable imaging tool for depicting intestinal fistulas if 
compared with CF, giving at the same time additional information regarding 
site and extent of fluid collections, and eventually the possibility to rule out 
other associated complications.
SS 15.10
Delayed presentation of splenic rupture following 
colonoscopy: clinical and CT findings
P.J. Pickhardt1, S. Fishback1, S. Bhalla2, C. Menias2, M. Macari3; 
1Madison, WI/US, 2St. Louis, MO/US, 3New York, NY/US
Purpose: To assess the clinical and CT findings of symptomatic colonoscopy-
induced splenic injury.
Material and Methods: Multi-center search yielded 11 adults with 
symptomatic splenic injury related to colonoscopy. Work-up included 
abdominal CT in 10 (91%) cases and abdominal radiography in one 
hemodynamically unstable patient. Colonoscopy findings, post-procedural 
course, and CT findings were systematically reviewed.
Results: Mean patient age was 62.2 years (range, 51-84 years); 8 (73%) of 11 
were female. The majority (64%) of colonoscopies were for screening. No 
immediate complications were reported at OC; tortuosity/redundancy was 
noted in 5 cases. Except for one patient with a 6 mm polyp and one with a 10 
mm polyp, the remaining nine patients had either diminutive or no polyps. Only 
one patient presented with early symptoms during post-colonoscopy recovery, 
the other 10 had a delayed presentation ranging from 8 hours to 8 days (mean, 
2.1 days). All patients presented with abdominal pain. CT was diagnostic for 
splenic injury with subcaspular and/or perisplenic hematoma in all 10 CT 
cases. Other CT findings included hemoperitoneum (n = 8), visible splenic 
laceration (n = 3), and splenic artery pseudoaneurysm (n = 1). Five patients 
underwent splenectomy (four emergent) and six patients were treated 
conservatively. Average hospital stay was 5.5 days (range, 3-10 days).
Conclusion: Colonoscopy-induced splenic injury characteristically presents as 
a delayed and often serious complication. In cases of apparent non-traumatic 
splenic hematoma/rupture at CT, history of recent colonoscopy is relevant.
11:15 -12:45 Sala Mosaici 2
Scientific Session 16
Imaging Crohn disease activity (Tube 5)
SS 16.01
Contrast-enhanced MR enterography as a stand-alone 
tool to evaluate Crohn’s disease in a pediatric population
S. Kim, B. Spieler, N. Hindman, J. Levy, D. Sahlein,  
R. Rivera, A.J. Megibow; New York, NY/US
Purpose: To assess the performance using post-contrast MRI sequences as a 
stand-alone tool to evaluate disease activity in Crohn’s disease in comparison 
to all images sequences together in an attempt to suggest limitation of the 
number of overall non-contrast sequences need for the follow-up evaluation of 
Crohn’s disease in a pediatric population.
Material and Methods: Twenty-five pediatric patients (mean 11.2 years, M = 12, 
F = 13) with Crohn’s disease who underwent MRI at 1.5 T were included. Two 
radiologists reviewed images in 2 separate sessions in consensus; post-contrast 
sequences only and whole images including non-contrast and post-contrast 
sequences. The intestine was divided into 10 segments. Readers evaluated the 
presence or absence of active inflammation using a five-point grading system 
(grade 1-5). Sensitivity, specificity and accuracy were calculated for detecting 
segments showed definitive active inflammation (Score = 5). The complete MRI 
examination was used as a reference standard.
Conclusion: Our results of pre-operative MDCT staging of colonic cancer in locally 
advanced tumors are at odds with those published from the major UK centre involved 
in the FOxTROT trial. There is good correlation with T staging but poor correlation 
with EMVI and depth of tumor invasion. These findings may have implications in the 
assessment of future trials using different neo-adjuvant chemotherapy agents to 
down stage colonic cancer (Dighe et al BJS 2010;97:1407).
SS 15.07
Detection of relevant colonic neoplasms with PET/CT: 
promising accuracy with minimal CT dose and a 
standardised PET cut-off
W. Luboldt, T. Volker, K. Zoephel, B. Wiedemann; Munich/DE
Purpose: To determine the performance of FDG-PET/CT in the detection of relevant 
colorectal neoplasms (adenomas * 10 mm, with high-grade dysplasia or cancer) in 
relation to CT dose and contrast administration and to find a PET cut-off.
Material and Methods: 84 patients, who underwent PET/CT and colonoscopy 
(n = 79)/sigmoidoscopy (n = 5) for (79 x 6 + 5 x 2) = 484 colonic segments, were 
included in a retrospective study. The accuracy of low-dose PET/CT in detecting 
mass-positive segments was evaluated by ROC analysis by two blinded 
independent reviewers relative to contrast-enhanced PET/CT. On a per-lesion 
basis characteristic PET values (SUVmax, SUVmean, and SUV-bordered volumes) 
as well as their combinatory products and ratios were tested as cut-offs.
Results: Low-dose PET/CT and contrast-enhanced PET/CT provide similar 
accuracies (area under the curve for the average ROC ratings: 0.925 vs. 0.929). 
PET demonstrated all carcinomas (n = 23) and 83% (30/36) of relevant 
adenomas. In all carcinomas and adenomas with high-grade dysplasia (n = 10) 
the SUVmax was *5. This cut-off resulted in a better per-segment sensitivity and 
negative predictive value (NPV) than the average PET/CT reviews (sensitivity: 
89% vs. 82%; NPV: 99% vs. 98%). All other tested cut-offs were inferior to the 
SUVmax in separating true positive (TP) from false positive (FP) findings.
Conclusion: FDG-PET/CT provides promising accuracy for colorectal mass 
detection. Low dose and lack of iodine contrast in the CT component do not 
impact the accuracy. The PET cut-off SUVmax *5 improves the accuracy.
SS 15.08
What is the most accurate whole-body imaging modality 
for assessment of local and distant recurrent disease in 
colorectal cancer? A meta-analysis
M. Maas, I.J.G. Rutten, P.J. Nelemans, D.M.J. Lambregts, 
V.C. Cappendijk, G. Beets, R.G.H. Beets-Tan; Maastricht/NL
Purpose: Up to 40% of colorectal cancer (CRC) patients develop recurrence. Early 
and accurate identification is important to improve survival. Aim was to determine 
the most accurate whole-body imaging (WBI) modality for detection of recurrent/
metastatic disease in patients with suspected recurrent CRC during follow-up.
Material and Methods: Medline and Embase were searched. Studies evaluating 
the accuracy of WBI with CT/PET-CT/MRI/PET for recurrence detection in 
patients with suspected recurrent CRC were included. Studies evaluating liver 
only or response to therapy were excluded. 2x2-contingency tables were 
extracted and summary receiver operator characteristics (sROC) curves with 
area under the curves (AUC) were constructed by a regression model. Subgroup 
analyses were performed to correct for interstudy heterogeneity.
Results: 14 studies were included which evaluated PET, PET/CT, CT and/or 
MRI. Study results were available in 12 studies for PET, in 5 studies for CT, in 5 
studies for PET/CT and in 1 study for MRI. All studies used histopathology and 
clinical&radiological follow-up as reference method. AUCs for PET, PET/CT 
were 0.94 (0.90-0.97) and 0.94 (0.87-0.98), respectively. CT had significantly 
lower performance: AUC 0.83 (0.72-0.90), p < 0.05. After correction for 
heterogeneity, CT remained the modality with lowest diagnostic performance.
Conclusion: PET-CT and PET have the highest diagnostic performance for the 
detection of metastases/recurrence in patients with suspected recurrent CRC. 
CT has significantly lower diagnostic performance, probably because CT has 
lower performance in populations with high prevalence of metastasis/recurrence 
and CT has lower accuracy for the detection of extrahepatic metastases.
SS 15.09
Fluoro-guided CT fistulography in the occurrence of 
intestinal fistulas: diagnostic accuracy with respect to 
conventional fistulography
G. Foti, N. Faccioli, R. Pozzi Mucelli; Verona/IT
Purpose: To assess diagnostic accuracy of fluoro-guided CT fistulography 
(FCTF) in the evaluation of intestinal fistulas, using conventional fistulography 
(CF) as reference standard.
Material and Methods: In a 2-year period, 14 consecutive patients with 
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SS 16.04
Whole intestinal distension with oral administration of 
polyethylene glycol in “2 steps” to monitor Crohn’s 
disease activity through biphasic-lumen MR examination
I. Sansoni, C.L. Piccolo, C.A. Mallio, I. Di Giampietro,  
R. DelVescovo, M. Cicala, B. Beomonte Zobel; Rome/IT
Purpose: Dark lumen technique (MRE and MRC) provides good results for IBD 
diagnosis, but it can cause discomfort for patient. We propose an alternative 
method to distend and evaluate the entire unprepared bowel by applying dark 
lumen technique: 2 time polyethylene glycol (PEG) administrations.
Material and Methods: 158 examinations in patients with known CD; they were 
asked to drink twice 1.5 L of PEG solution: 2-4 hours and during 45 minutes 
before MR examination. On axial and coronal planes we obtained T2-weighted, 
True-FISP and T1-weighted fat-saturation sequences, before and after i.v. 
dynamic administration of gadolinium. Average scanner time was ~23 min. 
Grading of bowel distension, cleansing and parietal inflammation (active, 
inactive, none) was defined, using conventional colonoscopy (CC) and post-
biopsy hystopatologic results as gold standard of disease activity assessment.
Results: With respect to CC (in 125/158 pts), in 162 sick segments MR showed 
complete correlation of presence and localization of inflammation, and partial 
but good correlation of inflammatory grading (PPV 95.8%, NVP 92.3 %). Only 
in 84/926 evaluated colonic segments, the high amounts of residual stools 
made an adequate intraluminal diagnosis impracticable.
Conclusion: The combination of MRE and MRC allows complete assessment 
of inflammation in small and large bowel of patients with CD, requiring minimal 
effort to patient before MR scanning. Whole bowel assessment with “2 steps” 
distension is feasible, satisfying, does not need for manual colon distension.
SS 16.05
Magnetic resonance enterography in the differential 
diagnosis between fibrotic and active inflammatory 
small bowel stenosis in patients with Crohn’s disease
F. Fornasa, C. Benassuti, L. Benazzato; San Bonifacio; Verona/IT
Purpose: To assess the accuracy of MRI in prospectively differentiating between 
fibrotic and active inflammatory small bowel stenosis in Crohn’s disease.
Material and Methods: 111 patients with histologically proven Crohn’s disease 
referring with clinical and plain radiographic signs of intestinal obstruction 
underwent coronal and axial MRI scans (T2 and pre/post-gadolinium T1 
sequences) after oral administration of a polyetylenglycol solution. A stenosis 
was defined as a >80% lumen reduction associated with focal wall thickening. 
At the level of the stenosis, both the T2 signal intensity and the post-gadolinium 
T1 enhancement were quantified using a 5-point scale (0: very low; 1: low; 2: 
moderate; 3: high; 4: very high). A stenosis was judged fibrotic if the sum of the 
two values (activity score: AS) did not exceed 1.
Results: 48/111 patients had a small bowel stenosis. Fibrosis was confirmed 
at histology in 23 patients (AS 0-1) who underwent surgery within 3 days. In the 
remaining 25 patients (AS: 2-8) an active inflammatory stenosis was suspected 
and drug-induced remission of the obstruction was obtained; one patient (AS: 
2), however, underwent surgery after 14 days due to recurrence (histology: 
severe fibrosis overlapping mild inflammation). MRI resulted 95.8% sensitive, 
100% specific and 97.9% accurate in the diagnosis of fibrotic stenosis.
Conclusion: MRI reliably differentiates between fibrotic and inflammatory 
small bowel stenosis in Crohn’s disease.
SS 16.06
Quantified small bowel motility during MR enterography 
in Crohn’s disease as a marker of inflammatory activity
A. Menys, A. Ahmed, S. Punwani, F. Odille, M. Steward,  
D. Atkinson, D. Hawkes, S. Halligan, S.A. Taylor; London/UK
Purpose: To investigate the relationship between software-derived small bowel 
motility index and conventional MRI markers of Crohn’s disease activity.
Material and Methods: Bowel wall motion quantification software was applied to 
a coronal breath-hold cine FISP sequence (20s breath-hold, TR 4ms, TE1.7ms, 
slice thickness 10mm, 1 slice/0.8sec) through the terminal ileum (TI) in 16 patients 
(5 females, mean age 31) undergoing MR enterography. The validated software 
uses non-rigid registration to quantify motion changes over time in a manually 
placed polygonal region of interest within the bowel, providing automated 
estimation of bowel wall displacement, expressed as the standard deviation of 
Jacobian determinant (motility index). Two observers graded TI disease activity 
using conventional MRI markers (wall thickness, T2 signal, perimural oedema, 
enhancement, all scored 0-3, and enhancement pattern (1 = homogenous, 2 = 
mucosal 3 = layered). The scoring system has been previously validated against a 
histological reference. On statistical advice correlation between the motility index 
and activity score was performed using Kendall’s rank correlation.
Results: There were 53 bowel segments with active inflammation on reference 
standard in 25 subjects. Inter-reader agreement had a Kappa 0.622. Sensitivity, 
specificity, PPV, NPV, and accuracy for diagnosing definite active inflammation 
using post-contrast images alone were 83.3%, 86.9%, 89.3%, 80%, and 
84.9%, respectively, for agreement of definite active inflammation (score 5) 
using post-contrast images alone.
Conclusion: Follow-up MRI in pediatric Crohn’s patents monitoring disease activity 
can be performed by decreased number of sequences while maintaining diagnostic 
accuracy using post-contrast T1 and non-contrast HASTE sequences.
SS 16.02
Evaluation of Crohn’s disease activity in children with 
magnetic resonance enterography and colonography
I. Holjar Erlic1, R. Antulov2, D. Miletic2; 1Kastav/HR, 2Rijeka/HR
Purpose: To determine the activity of Crohn’s disease (CD) using magnetic 
resonance enterography and colonography (MREC) in pediatric patients 
with suspected or known CD.
Material and Methods: Eighteen consecutive pediatric patients with CD 
(median age 14.8 years) underwent MREC. MREC was performed with oral 
application of 5% manitol solution, rectal application of water and gadolinium 
injection. CD activity was measured with the Pediatric Crohn’s disease 
activity index (PCDAI). MREC activity findings included presence of fistula, 
stratification, bowel wall enhancement and gadolinium enhancement of 
regional lymph nodes were evaluated by two blinded radiologist. MREC 
findings were scored findings from 0 to 5. Spearman rank correlation was 
used to compare PCDAI and positive MREC findings for CD; a p value of less 
then 0.05 indicated a statistically significant difference.
Results: In 12 patients MREC findings were positive for CD, intravenous application 
of paramagnetic Gadolinium contrast detect 9 (75%) with active disease. We 
diagnosed CD in 5 (29%) new patients. In all MREC-positive patients a significant 
correlation was observed between MREC score and PCDAI (r = 0.736, p < 0.05).
Conclusion: According to our results, MREC is a valuable diagnostic tool to 
evaluate CD activity in pediatric patients with suspected or known CD.
SS 16.03
Magnetic resonance enterography with and without 
biphasic contrast agent enema compared to conventional 
ileocolonoscopy in patients with Crohn’s disease
C. Friedrich, G. Schill, C. Stroszczynski, A. Schreyer; 
Regensburg/DE
Purpose: Magnetic resonance imaging (MRI) of the bowel is a valuable 
diagnostic tool for assessing disease activity and complications in patients 
with inflammatory bowel disease (IBD). Major advantages of the technique 
are the absence of ionizing radiation, its non-invasive nature and the ability 
to detect extra-mural pathologies. In this study, we compared magnetic 
resonance enterography (MRE) with and without water enema to conventional 
ileoscopy as a reference method to evaluate the additional advantage of a 
rectal enema with biphasic contrast agent for MRI diagnostics of Crohn´s 
disease (CD) in the terminal ileum and the colon.
Material and Methods: We prospectively evaluated 50 patients with known 
CD. MRE with biphasic contrast enema was performed in 23 cases, whereas 
27 patients received an MRE without rectal water enema. All included 
patients had a conventional ileocolonoscopy within 3 weeks before or after 
MRE. During the MRE, T2-weighted and contrast-enhanced T1-weighted 
sequences were acquired in dark lumen technique. We assessed the degree 
of inflammation in both modalities on a scale from 0 (no inflammation) to 3 
(severe inflammation), evaluating a total of up to 7 bowel segments in each 
patient separately. Afterwards, we compared the results of MRE with and 
without rectal enema to each other and to the findings of conventional 
ileocolonoscopy as a reference method.
Results: MRE with biphasic contrast enema achieved a sensitivity and 
specificity of 100% and 74% for detection of inflammation in the terminal ileum 
while we found a sensitivity of 72% and a specificity of 87% for the examination 
without enema. Considering the entire colon MRE examinations with enema 
had a sensitivity of 79% (specificity 96%) while the examination without enema 
showed a sensitivity of 38% (specificity 99%). The MRE technique using an 
enema proved statistically superior to MRE without rectal enema in detecting 
inflammation in the terminal ileum, ascending colon and rectum.
Conclusion: MRE with rectal enema is a valuable non-invasive diagnostic 
tool for the assessment of inflammation in patients with CD. Rectal 
application of a biphasic contrast agent is well tolerated and significantly 
improves detection of inflammation in three bowel segments, among them 
the terminal ileum, which is the segment most frequently affected in CD. 
Rectal enema should therefore be included in MRE protocols when examining 
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SS 16.09
Therapeutic response assessment by MRI for mucosal 
healing in Crohn’s disease: preliminary results in a 
multicentric study
J. Rimola1, I. Ordás1, M.J. Jimenez2, J.M. Paredes2,  
S. Rodríguez1, C. Ayuso1, J. Panés1; 1Barcelona/ES, 
2Valencia/ES
Purpose: To assess the ability of MRI to reflect therapy-induced changes in Crohn’s 
disease (CD) inflammatory lesions, using ileocolonoscopy as reference standard.
Material and Methods: Patients with active CD (CDAI > 200), and ulcers in at least 
one segment at ileocolonoscopy, received corticosteroids (n = 7) or adalimumab (n 
= 20) for induction of remission. Colonic and ileal disease activity was assessed by 
magnetic resonance index of activity (MaRIA), endoscopy (CDEIS), clinical evaluation 
(CDAI), and biomarkers at baseline and week 12 after initiation of therapy.
Results: 27 patients have completed the study. Clinical remission (CDAI < 150) 
was achieved in 4/7 patients treated with steroids and 15/20 of those treated 
with adalimumab. Mucosal healing (CDEIS < 3.5) was observed in 2/5 steroid 
treated patients and 15/20 adalimumab treated patients. Complete healing of 
all segments with ulcers detected by endoscopy at baseline was observed in 
2/5 patients treated with steroids and 9/20 treated with adalimumab. A 
significant correlation was observed between CDEIS and MaRIA both at 
baseline (r = 0.73, p < 0.001) and at week-12 (r = 0.70, p < 0.001). The 
magnitude of reduction in MaRIA closely paralleled changes in CDEIS (r = 
0.74; p < 0.001). A global MaRIA score )40 predicted endoscopic remission 
(sensitivity = 0.82; specificity = 0.85). The kappa coefficient between 
endoscopical and MRI healing (MaRIA < 11) was 0.72 ± 0.09 (p < 0.001).
Conclusion: MRI is an accurate method to assess therapeutic responses in CD, 
sensitive to changes in lesion severity, and able to determine mucosal healing.
SS 16.10
Dynamic contrast-enhanced MRI for the evaluation of 
perianal fistulas in patients with Crohn’s disease
M.L.W. Ziech, C. Lavini, A.J. Nederveen, S. Bipat,  
A.M. Spijkerboer, P.C.F. Stokkers, C.Y. Ponsioen, J. Stoker; 
Amsterdam/NL
Purpose: To determine if dynamic contrast-enhanced MRI (DCE-MRI) can 
evaluate disease activity in patients with perianal fistulizing Crohn’s disease.
Material and Methods: Patients with perianal fistulizing Crohn’s disease 
underwent DCE-MRI. The van Assche MRI-based score and perianal disease 
activity index (PDAI) were determined. Transversal DCE-MRI was performed at 3T 
during intravenous contrast injection (TE 2.3, TR 5.1, FA 30, 15 slices, total duration 
of dynamic scan 5.05 min, 70 scans per slice, temporal resolution 4.2 sec per 
volume). The qualitative parameters maximum enhancement (ME), slope of the 
enhancement curve (SoE) and curve shape type (as by Lavini et al) as well as the 
quantitative parameters Ktrans, Vep, Kep as in the Tofts model were calculated 
(using a measured arterial input function) on a pixel by pixel basis, and then 
averaged of over an ROI drawn around the fistula. Spearman correlations between 
DCE-MRI parameters and PDAI and MRI-based score were calculated.
Results: Sixteen patients (7 males) were included, mean age 37 (range 18-
63). PDAI correlated with ME (r = 0.669, p = 0.005), SoE (r = 0.582, p = 0.018), 
ROI volume (r = 0.786, p < 0.001) and MRI-based score (r = 0.574, p = 0.020), 
but not with Ktrans, Vep and Kep. ME correlated with Ktrans (r = 0.701, p = 
0.002) and Kep (r = 0.626, p = 0.009).
Conclusion: ME, SoE and MRI-based score seems to be the best choice to 
evaluate perianal disease activity. None of the quantitative model-based 
parameters showed a direct significant correlation with disease activity.
SS 16.11
Diffusion weighted MRI of primary squamous cell 
carcinoma of the anal canal treated with chemoradiation
A. Gogbashian1, E. Tam1, J. Stirling1, N.J. Taylor1,  
S. Mawdsley1, R. Glynne-Jones1, V. Goh2; 1Middlesex/UK, 
2Northwood/UK
Purpose: To assess the diffusion weighted MRI (DW-MRI) characteristics of 
anal canal cancer.
Material and Methods: 20 patients with squamous cancer and 20 controls 
underwent T1W, T2W and STIR pelvic sequences, supplemented by DW-MRI 
(b-values: 0, 150, 500, 800 s/mm2) (Avanto, Siemens Healthcare). Tumor stage, 
signal intensity and whole tumor apparent diffusion coefficient (ADC; mean and 
functional ADC histogram) were assessed using commercial software (Oncotreat, 
Siemens Healthcare) before and 8 weeks after chemoradiation (50.4 Gy 
radiotherapy, 5-flurouracil and mitomycin-C). ADC pre- and post-chemoradiation 
were compared using t-test; statistical significance 5%.
Results: The mean motility index and activity score was 0.31 (range 0.07-0.53), and 
4 (range 0-11), respectively. There was a significant negative correlation between the 
motility index and activity score (Kendall tau) -0.50 (95% CI -0.81 to -0.18), p = 0.01.
Conclusion: Quantified small bowel motility is negatively correlated with 
conventional MRI scores of disease activity suggesting it may be a new 
quantitative marker of inflammation.
SS 16.07
MR motility measurement for the evaluation of Crohn’s 
disease activity compared to biopsy
M.A. Patak1, J.L.C. Cullmann1, Z. Szucs-Farkas1, N. Patuto1, 
R. Tutuian1, S. Raible2, J.M. Froehlich1; 1Bern/CH, 2Biel/CH
Purpose: The purpose of this study is to correlate MR-motility alterations with the 
activity of the disease and the presence of chronic changes based on histopathologic 
samples of the terminal ileum in patients with Crohn’s disease (CD).
Material and Methods: 43 patients with known CD underwent MRI (1.5T) using 
2D TrueFisp cine sequences in addition to a standard imaging protocol. An oral 
non-invasive preparation method (1000ml of mannitol 3% over 1h) was used for 
optimal distension. MR motility was measured at the level of the terminal ileum as 
diameter changes over time on each slice orthogonally to the small bowel axis. 
Motility was graded as normal, hypomotility or absence. This was correlated with 
biopsy of the terminal ileum, not more than 14 days from the MR. The biopsies 
were graded for the presence of disease, disease activity (high activity, mild 
activity, no activity) and for chronic changes (severe, mild or no chronic changes). 
The motility alterations were correlated with the presence of disease, the activity 
and the chronic changes using the Spearman rank order correlation.
Results: Biopsy proved CD in 28 patients at the level of the terminal ileum, 
15 had active CD (7 highly active, 8 mild) while 17 showed chronic changes 
(4 severe, 13 mild). MRI revealed motility changes in 21 patients (13 
hypomotility, 8 absent). The degree of motility alterations correlated with the 
grade of activity (R = 0.522) and chronic changes (R = 0.521; p 0.001 ). The 
sensitivity and specificity for motility changes were 0.79/0.67 for detection 
of activity and 0.81/0.72 for detection of chronic changes.
Conclusion: MR-motility alterations of the terminal ileum in patients with CD 
correlate with biopsy proven active and chronic changes. MR-motility scans 
are good alternative to endoscopy in evaluating inflammatory changes in the 
terminal ileum in CD patients.
SS 16.08
Activity assessment of Crohn’s disease of terminal 
ileum: MR with free-breathing diffusion-weighted 
imaging and dynamic motility evaluation as a possible 
alternative to MR with intravenous contrast agent
I. Sansoni, C.L. Piccolo, C.A. Mallio, I. Di Giampietro,  
R. DelVescovo, B. Beomonte Zobel; Rome/IT
Purpose: MR-enterography (D-CE-MRE) is accepted method to assess 
Crohn’s disease(CD) activity, although dynamic-contrasted-enhanced MR-
enterography (D-CE-MRE) needs for gadolinium contrast agent. Recently, 
diffusion-weighted MR imaging (DWI) and its related ADC map have been 
used in multiple clinical conditions. Our purpose is to investigate the value of 
free-breathing DWI MRI in assessing small bowel CD activity.
Material and Methods: 77 patients with terminal ileum CD underwent MR-
examination after bowel oral distension with polyethyleneglycol solution. We 
based MR-assessment of disease activity on morphology and motility of small 
bowel and perivisceral structures evaluation (true-FISP, cine-true-FISP, 
HASTE T2W sequences), parietal signal intensity in DWI and parietal D-CE 
(FLASH T1W-sequence). Patients were divided into three categories (negative, 
inactive and active), using endoscopic biopsy as the standard reference (38 
cases) or whole of clinical findings and MR sequences (24 cases).
Results: On DWI, inflammatory bowel tracts showed higher signal intensity 
compared to normal segments (accuracy: 89.1%, sensitivity: 89.7%, 
specificity: 88.2%, PPV: 92.9%, NPV: 83.3). For quantitative assessment, 
ADC value in active disease was lower than in inactive disease (negative: 
1.9x10-3±0.3x10-3mm2/s, inactive: 1.38x10-3±0,26x10-3mm2/s, active: 
1.08x10-3±0.22x10-3mm2/s). In all patients complete MR examination allowed 
to perform detailed and panoramic evaluation of small bowel.
Conclusion: Valuable functional information about motility of affected loops 
and condition of proximal loops are allowed by cine-MR mode. Free-
breathing-DWI gives some information in visual assessment of CD activity; 
ADC values may facilitate quantitative analysis of disease activity, decreasing 
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(p > 0.001). There were significant differences also in abdominal adipose (p 
= 0.015) and CRP (p > 0.001) (Kruskal-Wallis) between diagnostic groups. 
Elevated CRP was significantly associated with a positive scan result (p > 
0.001) and this increased in significance as CRP level increased. There was 
no significant association however between CRP and levels of abdominal 
adipose in patients with positive CT scan findings (p = 0.425).
Conclusion: Elevated C-reactive protein is a predictor of positve findings 
on CT in the clinical setting of the acute abdomen. We found no association 
however between CRP levels and volumetric abdominal adipose levels in 
this patient cohort.
SS 17.03
Diffusion-weighted 3T MRI of peritoneal carcinosis: 
comparison with 64 MDCT and surgical and 
histopathologic findings—a feasibility study
F. Iafrate1, M. Ciolina1, M. Iannitti1, A. Pichi1, P. Baldassari1,  
P. Lucchesi1, A. Laghi2; 1Rome/IT, 2Latina/IT
Purpose: To evaluate the utility of single-shot spin-echo echo-planar 
diffusion-weighted imaging (DWI) using a b value of 1000 s/mm2 for depicting 
peritoneal metastases. To retrospectively measure the diagnostic performance 
of 64 MDCT and DWI 3T MRI results in the detection of peritoneal metastases 
(PMs) in patients with advanced ovarian cancer undergoing peritonectomy 
and hypertermic intraperitoneal chemotherapy (HIPEC).
Material and Methods: In 68 patients with ovarian cancer who were 
undergoing cytoreductive surgery the presence of PM was prospectively 
rated as grade 0 (absent), grade 1 (equivocal), or grade 2 (present) on CT 
scans and 3T MRI using DW sequences after dividing abdomen into 14 
different sites. Results of HIPEC surgey and histopathologic evaluation were 
compared with DWI MRI and MDCT results. Sensitivity, specificity, and 
accuracy were calculated for DWI, MDCT, and combined DWI and MDCT.
Results: 447/952 sites of PMs were proven by surgical and histopathologic 
findings. The combination of DWI and MDCT was most sensitive and 
accurate for PMs for the two observers (sensitivity, 89%, 82%) compared 
with DWI alone, with sensitivity of 74%, 73%, and MDCT alone (sensitivity of 
85%, 80%). Combining DWI and MDCT, sensitivity increases but remaining 
low for lesions <0.5 cm (51% , 54%).
Conclusion: Adding DWI MRI to MDCT seems to improve the sensitivity and 
specificity for depicting PMs providing precise location of implants and 
showing a satisfactory correlation with surgical findings.
SS 17.04
MDCT in the early diagnosis of recurrence in patients 
with peritoneal carcinomatosis treated by means of 
cytoreductive surgery and hyperthermic intraoperative 
peritoneal chemotherapy: correlation with serum 
tumor markers
R. Basilico, M. Maccarone, E. Rodolfino, V. Calamita,  
R. Massari, M. De Tursi, A.R. Cotroneo; Chieti/IT
Purpose: To assess the value of MDCT in the early detection of peritoneal 
recurrence in patients with peritoneal carcinomatosis (PC) treated by means 
of cytoreductive surgery and HIPEC, in comparison to serum tumor markers.
Material and Methods: Thirty-five patients with PC from ovarian (n = 21), 
colorectal (n = 9) tumors, uterine sarcoma (n = 2) , fallopian tube tumors (n = 
2) and peritoneal liposarcoma (n = 1) treated by means of cytoreductive 
surgery and HIPEC were included. They underwent serum tumor marker 
measurements (CEA, CA 125) every month after surgery and MDCT follow 
up at 3 and 6 months interval. Two readers in consensus evaluated axial and 
multiplanar reconstructed MDCT images of the abdomen obtained during 
the portal venous phase of contrast material enhancement, with a collimation 
of 4 x 2.5 mm and a slice-width of 3 mm. MDCT findings were correlated to 
tumor markers measurements obtained within 15 days.
Results: Sensitivity, specificity and diagnostic accuracy were, respectively, 
75%, 100% and 77% for serum tumor markers and 94%, 66% and 91% for 
MDCT. In 8/11 patients with normal tumor markers, MDCT showed peritoneal 
neoplastic implants confirmed at pathology and MDCT follow up. In 1/11 
patients with normal tumor marker levels, MDCT revealed one peritoneal 
nodule demonstrated to be necrotic lesion at pathology.
Conclusion: MDCT is able to early detect peritoneal recurrence in patients 
treated by means of cytoreductive surgery and HIPEC and can predate 
rising tumor markers levels.
Results: Median follow-up was 21.3 months. There were T1 (3), T2 (8), T3 (6), T4 
(3) cancers; 13/20 had nodal involvement: N1 (3), N2 (4), N3 (6). Tumors were 
hyperintense on T2, STIR and b 800 DWI sequences. Mean tumor ADC was lower 
than controls (1.08 X 10-3 versus 1.42 X 10-3 mm2/s, respectively; p = <0.001). 
14/20 (70%) cancers underwent additional MRI 8 weeks following completion of 
chemoradiation: there was a reduction in tumor size (mean reduction = 69.3%; 
p = 0.002), signal intensity (iso- or hypointense) and an increase in ADC (mean 
increase = 48.8%; p = <0.001). Functional ADC histograms demonstrated a shift 
to the right. Disease relapse was noted in 2 patients. Baseline ADC was slightly 
higher for relapsed tumors (1.14 X 10-3 mm2/s versus 1.07 X 10-3 mm2/s).
Conclusion: Tumor ADC increases following chemoradiation indicating cell 
kill. DW-MRI may augment morphological assessment.
11:15 -12:45 Mangano
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SS 17.01
Abdominal fat distribution at CT as a predictor for the 
metabolic syndrome
P.J. Pickhardt, Y. Jee, S. O’Connor, A. Munoz del Rio; 
Madison, WI/US
Purpose: The metabolic syndrome describes a cluster of metabolic 
disturbances associated with an increased risk of cardiovascular events. 
Distribution of abdominal fat may be a useful indicator for metabolic 
syndrome. The purpose of this study was to assess subcutaneous fat area 
(SFA), visceral fat area (VFA), visceral fat percentage (VF%), and other CT-
based measurements for predicting the metabolic syndrome.
Material and Methods: Standard SFA, VFA, and VF% measurements were 
obtained at the umbilical level from CT colonography studies in 474 consecutive 
asymptomatic adults (217 men, 257 women) using a dedicated software 
application (Fat Assessment Tool, EBW 4.5, Philips). Noncontrast liver 
attenuation was also recorded. Diagnosis of the metabolic syndrome was based 
on the 2005 International Diabetes Foundation (IDF) criteria, which incorporates 
abdominal obesity, glucose intolerance, hypertension, and dyslipidemia. Uni- 
and multivariate gender-specific analyses were performed.
Results: The ROC area under the curve (AUC) for SFA was 0.865 (95% CI: 
0.823-0.899) in men and 0.762 (0.711-0.806) in women (p = 0.0238). AUC for 
VFA was 0.887 (0.848-0.918) in women and 0.830 (0.784-0.867) in men (p = 
0.162). AUC for VF% was 0.527 (0.472-0.581) in men and 0.820 (0.774-0.859) 
in women (p < 0.001). SFA threshold value of 204.7 cm2 in men yielded a 
sensitivity and specificity of 80.3% and 84.5%, respectively. VFA threshold 
value of 71.5 cm2 in women yielded a sensitivity and specificity of 83.7% and 
80.7%, respectively. The best multivariate models did not substantially 
improve performance over SFA in men and VFA in women alone.
Conclusion: Important gender-specific differences were observed. SFA 
alone was a better predictor than either VFA of VF% for metabolic syndrome 
in men, whereas VFA was the single best predictor in women. These 
straightforward CT measures appear to have prognostic importance and 
could be reported prospectively in practice.
SS 17.02
Does size matter? Correlation of volumetric abdominal 
adipose and C-reactive protein with CT findings of 
inflammatory response in the acute abdomen
J.P. Coyle, C. Brennan, P. Mc Laughlin, S. Parfrey,  
S. Mac Williams, M. Maher; Cork/IE
Purpose: To correlate positive CT findings with CT determined volumetric 
abdominal adipose measurements and raised inflammatory markers in the 
setting of the acute abdomen.
Material and Methods: We conducted a study of 653 patients with an acute 
abdomen presenting to the emergency department of a single tertiary referral 
centre. Patients with known malignancy were excluded. All patients underwent 
CT abdomen/pelvis and a series of laboratory tests including CRP. Scans 
were reviewed by two independently blinded radiologists and a coding system 
for diagnostic grouping and severity of inflammatory change was developed. 
Volumetric visceral and subcutaneous adipose was measured using Osirix 
3.7.1, 2010 (Apple Freeware, California, USA). Statistical analysis was 
performed used Chi-squared and Kruskal-Wallis tests.
Results: A total of 411 patients were included. 128 were females and 113 
were males. Average age was 54. There were very significant differences 
between CT inflammatory findings when grouped by CRP quartile 
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or CE images (p ) 0.01). There was no significant difference between the 
detection rate of T2-w+DWI and T2-w+CE image combinations. Confidence 
scores with CE-images and T2-w images combined were significantly 
greater than DWI+T2-w images (p = 0.01 for reader 1 and 0.03 for reader 2).
Conclusion: DWI showed additional value to T2-weighted imaging in the 
diagnosis of abdominopelvic IFs by improving their detection rate and 
confidence level of diagnosis.
SS 17.08
Primary treatment of visceral pseudoaneurysms with 
percutaneous injection of thrombin: a viable 
alternative to angiographic embolization?
R. Jain1, A. Khandelwal2, V. Jain2, S.S. Baijal2; 1New Delhi/
IN, 2Gurgaon/IN
Purpose: To study the efficacy of percutaneous thrombin injection as 
primary mode of treatment for visceral pseudoaneurysms and as a viable 
alternative to angiographic embolization.
Material and Methods: Over nine months, 12 patients with pseudoaneurysms 
were treated with percutaneous human thrombin injection. Of these, seven 
patients had previous attempted angiographic embolization. Human 
thrombin (500 to 1000 IU) (Tisseel VH; Baxter, Glendale, CA) was injected 
into the pseudoaneurysm under USG guidance. Follow-up USG was 
performed 24 hours and one week after the procedure to confirm persistent 
thrombosis. If residual flow was present, the procedure was repeated. 
Complete persistent thrombosis at one week was considered as cure.
Results: Of 12 pseudoaneurysms, five were treated primarily with 
percutaneous thrombin injection. Cure was achieved in all five. Seven were 
treated following failure of attempted angiographic embolization. Cure was 
achieved in six; one remained patent but did not bleed. Five patients of 12 
required repeat thrombin injections (2 to 3 attempts). The mean number of 
required injections was 1.5 (18/12). The mean dose of thrombin required was 
812.5 IU (9750/12). There were no embolic complications related to the 
procedure. Considering the angiographic failures as the control group: RRR 
= 1; ARR = 0.143(-0.11, 0.402); NNT = 7 (2.48, -8.59).
Conclusion: Percutaneous thrombin injection is an effective and safe technique 
as the primary mode of treatment for amenable visceral pseudoaneurysms, and 
can be used even in the absence of angiographic equipment.
SS 17.09
Visualization of mesh implants using conventional MRI 
and positive-contrast susceptibility imaging in an 
animal model
N.A. Kraemer, H.C.W. Donker, J. Otto, S. Schrading,  
N. Kuehnert, U. Klinge, I. Slabu, M. Baumann, C.K. Kuhl; 
Aachen/DE
Purpose: Polymer-based textile meshes often cause complications. In most 
cases, conventional imaging methods, including MRI, fail to delineate these 
implants. By integrating tiny iron particles in the mesh base material, MRI-
visualization of meshes becomes feasible. To differentiate iron-induced voids from 
proton-free structures such as bowl gas, positive-contrast-susceptibility-imaging 
(PCSI) was proposed. Purpose of the study was to evaluate conventional MRI and 
PCSI for assessment of iron-loaded surgical meshes in an animal model.
Material and Methods: Iron-loaded polymer meshes were implanted into 
the abdominal wall of 9 rabbits. After 7, 30, and 90 days, MRI using 
conventional gradient-echo (GRE), turbo-spin-echo (TSE), and PCSI 
sequences were performed at 1.5 Tesla. On transverse and sagittal MR-
images, the visibility and diagnostic value of the sequences for mesh 
visualization was scored and statistically compared.
Results: GRE-sequences were rated best and clearly depicted the meshes 
as signal voids allowing for a precise assessment of the mesh deformation. 
PCSI contributed valuable information in discrimination between different 
signal voids. TSE-sequences were rated worst and only delineated the 
meshes when surrounded by fat as a thin hypointense line.
Conclusion: Both, PCSI and conventional MRI, contribute valuable 
information for precise mesh assessment and precisely delineated SPIO-
loaded meshes in vivo. Gradient echo sequences facilitated best mesh 
delineation. The hyperintense mesh signal on PCSI clearly delineates the 
meshes and facilitates a good discrimination against signal free-structures 
and other off-resonant sources.
SS 17.05
Abdominopelvic actinomycosis: analysis of imaging 
findings and which diseases does it mimick?
A.J. Van der Molen1, M. Giannila2, A.G.C.M. Van Es1,  
C. Triantopoulou2; 1Leiden/NL, 2Athens/GR
Purpose: Abdominopelvic actinomycosis is often a retrospective diagnosis by 
exclusion with much overlap to imaging findings of more serious, often neoplastic 
disease. The purpose of the study was to analyze the imaging findings of the 
disease and to indicate discriminative findings for a better prospective diagnosis.
Material and Methods: The radiology, pathology and infectious disease 
databases of two hospitals, one university and one general, were structurally 
searched for cases of actinomycosis. Ten cases (6 women, 4 men) were 
selected and all cross-sectional imaging studies were reviewed and checked 
against pathological and clinical records of the participating institutions.
Results: The sigmoid colon was most commonly involved. Most patients 
showed concentric bowel wall thickening, enhancing homogeneously. 
Inflammatory infiltration of the pericolonic fat was diffuse and severe in 5 cases, 
while in 7 patients one or more pelvic abscesses were revealed. A pelvic mass 
adjacent to the involved bowel segment was seen in 3 cases and lymphadenopathy 
was noted in 5 patients. Infiltration into the abdominal wall was seen in two 
patients, while in one case there was thoracic dissemination. Five cases were 
misdiagnosed at imaging as complicated diverticulitis, Crohn’s disease, 
ulcerative colitis, tubo-ovarian abscess and perforated colonic cancer.
Conclusion: Actinomycosis is not only related to long-term use of 
intrauterine contraceptive devices but should also be included in the 
differential diagnosis when imaging shows bowel wall thickening with pelvic 
masses and extensive inflammatory fat infiltration.
SS 17.06
Rectosigmoid endometriosis: comparison between CT 
findings and laparoscopy
M. Moschetta, F. Lorusso, A.A. Stabile Ianora, F. Cazzato,  
A. Scardapane, G. Angelelli; Bari/IT
Purpose: This study aims to evaluate the diagnostic accuracy of MDCT 
examination for the preoperative definition of rectosigmoid endometriosis in 
patients for whom MRI is contraindicated.
Material and Methods: Seventeen patients (mean age 32) affected by 
endometriosis and with contraindications to MR examination underwent 
preoperative 16-row CT water colonography with intravenous injection of 
contrast material. Axial and MPR images were retrospectively evaluated 
searching for site, number, enhancement and longitudinal extension of bowel 
implants; alterations of intestinal peristalsis; presence of bowel wall thickenings 
or other extraintestinal endometriotic implants. CT findings were then compared 
with surgical and pathological data, having the latest as the reference standard. 
Three patients affected by ileo-cecal endometriosis were excluded.
Results: Fourteen rectosigmoid endometriotic implants were diagnosed by 
CT examination. A diagnostic accuracy value of 79% was found for CT 
examination with a correct diagnosis in 11 out of 14 cases.
Conclusion: CT examination with water colonography provides useful 
information for the diagnosis and evaluation of extension of rectosigmoid 
endometriotic implants in patients for whom MRI is contraindicated and 
allows to identify a correct therapeutic strategy.
SS 17.07
Diffusion-weighted MR-imaging in diagnosis of 
abdominopelvic internal fistulae: comparison with 
T2-weighted and contrast-enhanced MR images
C. Schmid-Tannwald, G. Agrawal, F. Dahi, J. Yacoub,  
A. Oto; Chicago, IL/US
Purpose: To retrospectively determine additional value of diffusion-weighted 
MR-imaging (DWI) to T2-w and contrast-enhanced (CE) images in the 
diagnosis of abdominopelvic internal fistulae (IFs).
Material and Methods: Fourteen patients with 25 IFs arising from the small 
bowel (16), in the colon (8) and biliary tract (1) were included. Two independent 
observers reviewed T2-w images alone, T2-w images together with DWI 
images and T2-w images together with CE images at three sessions to detect 
IFs based on a confidence scale of five. Sensitivity of each session was 
calculated considering the confidence rating of 4 or 5 as positive for diagnosis. 
Sensitivity and confidence score of each session was compared.
Results: Nine (36%) and ten (40%) IFs were detected on T2-w images by 
observer 1 and 2, respectively. Both observers detected 19 (76%) and 24 
(96%) IFs on their review of T2-w+DWI and T2-w+CE image combinations, 
respectively. Detection rate and confidence scores improved significantly 
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SS 17.10
Peritoneal carcinomatosis due to ovarian cancer: 
comparison between MDCT, MRI and positron 
emission tomography-computed tomography with 
F18-fluorodeoxyglucose
S. Schmidt, R. Meuli, J.O. Prior; Lausanne/CH
Purpose: To compare MDCT, MRI and positron emission tomography-
computed tomography with F18-fluorodeoxyglucose (18F-FDG PET/CT) for 
the detection of peritoneal carcinomatosis due to ovarian cancer.
Material and Methods: Fifteen women (mean age 65) with clinical suspicion of 
ovarian cancer and peritoneal carcinomatosis underwent MDCT, MRI and 
18F-FDG PET/CT, simultaneously and shortly performed before surgery (delay 
8.1 days). According to the peritoneal cancer index, nine abdominopelvic 
regions were defined. We applied four scores of lesion size on MDCT and MR 
images, while the maximal standard uptake value (SUVmax) was measured on 
18F-FDG PET/CT. Three sites of lymphadenopathy and posterobasal pleural 
carcinomatosis were also analyzed.  First, one radiologist blindly and separately 
read MDCT and MR images, while one nuclear physician blindly read PET/CT 
images grading each lesion according to four diagnostic certitudes. Secondly, 
all the images were reviewed jointly and compared with histopathology. Receiver 
operating characteristics (ROC) analysis was performed.
Results: Peritoneal implants were proven in ten women (75%). Altogether, 
228 abdominopelvic sites were compared. Sensitivity and specificity for 
MDCT was 90.2% and 90.6%, for MRI 93.5% and 86.3%, and for 18F-FDG 
PET/CT 92.7% and 95.7%, respectively. ROC area under the curve were 
0.93 for MDCT and MRI, and 0.96 for 18F-FDG PET/CT, respectively. No 
significant differences (p = 0.11) were found between the three modalities.
Conclusion: Although MRI revealed to be the most sensitive and 18F-FDG 
PET/CT the most specific modality, no significant differences were shown 
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Fusco R.: SS 8.06
Fuser M.: SS 9.09
G
Guzzetta G.: SS 5.06
Guzzetta M.: SS 5.06
Gagarina N.: SS 4.06
Gale A.: SS 5.07
Galia M.: SS 1.09
Gallipoli A.: SS 4.09, SS 8.06
Gallix B.: SS 8.03, SS 8.08
Gallotti A.: SS 9.02, SS 9.04
Ganeshan B.: SS 3.10
Garteiser P.: SS 2.04, SS 12.09
Gelson W.: SS 2.08
Genova C.: SS 12.03
Ghanouni A.: SS 10.05
Giannila M.: SS 17.05
Giannitrapani L.: SS 1.10
Gibertini M.: SS 6.03
Gigoni R.: SS 11.10, SS 14.07
Giorgio A.: SS 11.03
Girometti R.: SS 7.10
Glynne-Jones R.: SS 3.02, SS 3.04,  
SS 3.10, SS 16.11
Godfrey E.: SS 2.08
Gogbashian A.: SS 3.10, SS 16.11
Goh V.: SS 3.02, SS 3.04, SS 3.10, SS 16.11
Gollub M.: SS 3.01
Goodman K.: SS 3.01
Gorman F.: SS 11.08
Granata V.: SS 4.09
Grassi R.: SS 8.06
Grasso R.: SS 3.05
Graziani R.: SS 9.06
Grazioli L.: SS 1.03, SS 6.08, SS 7.03, 
SS 7.06, SS 12.04
Grenacher L.: SS 14.10
Grieser C.: SS 7.04, SS 14.04
Griffin N.: SS 2.08
Gryspeerdt S.: SS 5.10, SS 10.10
Gschwendtner M.: SS 5.01
Guedes da Silva J.: SS 4.07
H
Hacking C.: SS 11.01
Haddad N.: SS 12.06, SS 12.09
Hafeez R.: SS 15.01
Halligan S.: SS 5.07, SS 5.09, SS 10.04, 
SS 10.05, SS 15.01, SS 16.06
Hamer O.: SS 6.02
Hamm B.: SS 7.04, SS 14.04
Hampshire T.: SS 10.04
Han J.: SS 4.05, SS 9.10, SS 14.05
Hansen B.: SS 1.08
Haradome H.: SS 1.03, SS 7.03,  
SS 7.06, SS 12.04
Hardie A.: SS 1.06
Hatch G.: SS 6.05
Havlík R.: SS 9.05
Hawkes D.: SS 10.04, SS 16.06
Heiss P.: SS 6.02
Heredia V.: SS 2.03
Hersey N.: SS 7.02, SS 14.03
Hindman N.: SS 16.01
Holjar Erlic I.: SS 16.02
Holzschuh M.: SS 14.10
Hong S.: SS 4.05, SS 9.10, SS 14.05
Hoppe H.: SS 12.01
Houterman S.: SS 5.10
Houwen R.: SS 2.10
Hu M.: SS 10.04
Huete A.: SS 6.09
I
Iacozzi M.: SS 4.08
Iafrate F.: SS 5.03, SS 5.04, SS 5.05,  
SS 5.08, SS 10.03, SS 10.08, SS 17.03
Iannitti M.: SS 5.05, SS 17.03
Ibtissam Ashwar N.: SS 15.05
Ichikawa T.: SS 2.06
Ijzermans J.: SS 1.08
Iussich G.: SS 5.03, SS 5.04, SS 10.08
J
Jaffer O.: SS 11.08
Jagtiani Sangwaiya M.: SS 2.05,  
SS 2.07, SS 5.02
Jain R.: SS 17.08
Jain V.: SS 17.08
Jakobsen A.: SS 12.02
Jee Y.: SS 17.01
Jeon H.: SS 8.09
Jeong H.: SS 7.07
Jiang Y.: SS 12.07
Jimenez M.: SS 16.09
Johnson M.: SS 11.01
Joubert I.: SS 2.08
Jung S.: SS 8.09
K
Kachramanoglou C.: SS 11.08
Kalogeropoulou C.: SS 13.09
Kambadakone A.: SS 13.06
Karani J.: SS 11.08
Karatzas A.: SS 13.09
Karcz W.: SS 4.03
Karpat Z.: SS 12.08
Kauczor H.: SS 14.10
Kaya E.: SS 12.08
Khan A.: SS 3.02, SS 3.04, SS 3.10
Khandelwal A.: SS 17.08
Kim H.: SS 2.09
Kim J.: SS 4.05, SS 9.10, SS 14.05
Kim K.: SS 1.02, SS 7.01, SS 7.07
Kim M.: SS 1.02, SS 7.01, SS 7.07
Kim S.: SS 16.01
Kim Y.: SS 1.02, SS 2.09, SS 7.01, SS 8.09
Kinner S.: SS 7.09
Kitsos D.: SS 6.04
Klinge U.: SS 17.09
Konstadatou E.: SS 13.09
Koranda P.: SS 9.05
Kostaras V.: SS 6.04
Kotter E.: SS 4.03
Kraemer N.: SS 17.09
Krishnan A.: SS 2.08
Kuehnert N.: SS 17.09
Kuhl C.: SS 17.09
Kuipers E.: SS 10.06, SS 10.07, SS 10.09
Kulkarni N.: SS 13.04, SS 13.06
Küsters S.: SS 4.03
KysuĀan J.: SS 9.05
L
La Grutta L.: SS 12.03
Lagalla R.: SS 1.10, SS 12.03
Laghi A.: SS 5.03, SS 5.04, SS 5.05,  
SS 5.08, SS 10.03, SS 10.08, SS 17.03
Lalji U.: SS 3.07
Lambregts D.: SS 3.03, SS 3.07, SS 3.08, 
SS 8.01, SS 8.04, SS 8.05, SS 8.07, 
SS 15.08
Lammering G.: SS 3.08














Langer M.: SS 4.03, SS 13.10
Lauenstein T.: SS 7.09
Lauridsen C.: SS 10.10
Lavini C.: SS 16.10
Lazarioti F.: SS 6.04
Leal C.: SS 4.07
Lee S.: SS 2.09, SS 15.04, SS 15.06
Leeuwenburgh M.: SS 6.06, SS 6.07
Lefere P.: SS 5.10, SS 10.10
Leijtens J.: SS 8.07
Leitão H.: SS 2.04, SS 12.06, SS 12.09
Lencioni R.: SS 11.04
Leong S.: SS 13.05
Lepanto L.: SS 14.09
Levkin V.: SS 4.06
Levy J.: SS 16.01
Lewis D.: SS 11.08
Lim H.: SS 2.09
Lim J.: SS 7.01
Lo Re G.: SS 1.09
Lomas D.: SS 2.08
Lombardo F.: SS 9.03
Lombardo V.: SS 1.04
Lorusso F.: SS 17.06
Lorusso V.: SS 4.04
Lovell J.: SS 5.02
Lubner M.: SS 13.08
Luboldt W.: SS 9.08, SS 15.07
Lucchesi P.: SS 17.03
M
Maas M.: SS 3.01, SS 3.03, SS 3.07,  
SS 3.08, SS 8.01, SS 8.04, SS 8.05, 
SS 8.07, SS 15.08
MacEneaney P.: SS 14.08
Mac Williams S.: SS 17.02
Macari M.: SS 15.10
Maccarone M.: SS 17.04
Maccioni F.: SS 8.10
Maceroni M.: SS 5.08
Maciel J.: SS 14.01
Magnaldi S.: SS 11.09, SS 14.06
Maher M.: SS 13.03, SS 13.05, SS 13.07, 
SS 14.08, SS 17.02
Malagò R.: SS 9.02
Malleo G.: SS 9.07
Mallett S.: SS 5.07, SS 5.09
Mallio C.: SS 4.01, SS 16.04, SS 16.08
Manfredi R.: SS 9.06, SS 9.07
Manning D.: SS 5.07
Marcus A.: SS 5.02
Maretto I.: SS 3.06
Marin D.: SS 1.07, SS 1.10
Marini M.: SS 8.10
Markl M.: SS 13.10
Maroldi R.: SS 6.08
Marsigie M.: SS 13.09
Martinelli M.: SS 8.10
Martone E.: SS 9.02
Massari R.: SS 17.04
Mateus Marques R.: SS 4.07
Matos C.: SS 9.01, SS 14.01
Matsumoto C.: SS 10.01
Mawdsley S.: SS 16.11
Mazzamurro F.: SS 8.10
Mazzeo S.: SS 11.04
McClelland J.: SS 10.04
McGarrigle A.: SS 13.03, SS 13.05
McGrath S.: SS 15.06
Mc Laughlin P.: SS 14.08, SS 17.02
Mcwilliams S.: SS 13.03, SS 13.05,  
SS 13.07
Megibow A.: SS 16.01
Mehrabi S.: SS 9.06
Mehsen R.: SS 3.01, SS 3.08
Mendonça P.: SS 4.07
Menias C.: SS 15.10
Mennini M.: SS 1.04
Menys A.: SS 16.06
Messina A.: SS 4.09
Metens T.: SS 9.01, SS 14.01
Meuli R.: SS 17.10
Midiri M.: SS 1.07, SS 1.09, SS 12.03
Miles K.: SS 3.10
Miletic D.: SS 16.02
Mishra A.: SS 4.02
Missere M.: SS 2.02, SS 14.02
Morana G.: SS 9.09
Morra L.: SS 5.03, SS 10.08
Mort A.: SS 15.04
Moschetta M.: SS 4.04, SS 17.06
Motosugi U.: SS 2.06
Muhi A.: SS 2.06
Muin D.: SS 11.09, SS 14.06
Mukhammatullina E.: SS 4.06
Muller H.: SS 13.02
Munoz del Rio A.: SS 17.01
Murphy-Lavallée J.: SS 14.09
Murphy K.: SS 14.08
Musson R.: SS 7.02, SS 14.03
Muzzio P.: SS 3.06
MysliveĀek M.: SS 9.05
N
Nkontchou G.: SS 11.02
Nagornyy M.: SS 4.06
Naguib N.: SS 11.05
Navarria M.: SS 6.08
Nederveen A.: SS 15.02, SS 16.10
Nelemans P.: SS 15.08
Neri E.: SS 5.03, SS 5.04, SS 10.02,  
SS 10.08
Nitti D.: SS 3.06
Nougaret S.: SS 8.03, SS 8.08
Nour-Eldin N.: SS 11.05
O
O’Connor B.: SS 14.08
O’Connor S.: SS 17.01
O’Neill F.: SS 13.03, SS 13.05
O’Neill S.: SS 13.07
O’Neill S.: SS 13.03, SS 13.05
O’Shea S.: SS 15.04, SS 15.06
O’Suilleabhain C.: SS 14.08
Occhionero M.: SS 2.02, SS 14.02
Odille F.: SS 16.06
Olivié D.: SS 14.09
Ordás I.: SS 16.09
Oto A.: SS 12.07, SS 17.07
Otto J.: SS 17.09
Ozel A.: SS 12.08
P
Pace E.: SS 3.09
Pache G.: SS 4.03
Padhani A.: SS 3.02, SS 3.04
Panés J.: SS 16.09
Paolantonio G.: SS 14.02
Papachristou G.: SS 6.01
Paredes J.: SS 16.09
Parfrey S.: SS 17.02
Park B.: SS 6.01
Park H.: SS 8.09
Park M.: SS 1.02, SS 2.09, SS 7.01, SS 7.07
Park S.: SS 8.09
Park U.: SS 8.09
Parlamenti A.: SS 6.04
Pasin M.: SS 8.02
Passamonti M.: SS 6.08
Passariello R.: SS 1.04
Patak M.: SS 6.05, SS 16.07
Patel P.: SS 11.01
Patel V.: SS 11.08
Patuto N.: SS 16.07
Pavageau A.: SS 15.05
Pecchi A.: SS 6.03, SS 12.05
Pepe A.: SS 2.02
Perez Fernandez C.: SS 7.04, SS 14.04
Peters N.: SS 2.08
Petralia G.: SS 8.02
Petrillo A.: SS 8.06
Petrillo M.: SS 8.06
Petsas T.: SS 13.09
Phillips P.: SS 5.07
Phoa S.: SS 7.05
Picano E.: SS 10.02
Piccardo A.: SS 4.08
Piccolo C.: SS 4.01, SS 16.04, SS 16.08
Pichi A.: SS 5.05, SS 10.03, SS 17.03
Pickhardt P.: SS 13.08, SS 15.10, SS 17.01
Pierredon Foulongne M.: SS 8.03, SS 8.08
Pieters I.: SS 2.10
Piperopoulos P.: SS 6.04
Pomerri F.: SS 3.06
Ponsioen C.: SS 16.10
Pooler B.: SS 13.08
Pozzi Mucelli R.: SS 1.01, SS 9.02, SS 9.03, 
SS 9.04, SS 9.06, SS 9.07, SS 15.09
Preiss U.: SS 6.05
Priest A.: SS 2.08
Principe F.: SS 9.02
Prior J.: SS 17.10
Pucciarelli S.: SS 3.06
Pullini S.: SS 7.10
Punwani S.: SS 15.01, SS 16.06
R
Radeleff B.: SS 14.10
Rafaelsen S.: SS 12.02
Raible S.: SS 16.07
Ramalho M.: SS 2.03
Raupach R.: SS 12.01, SS 13.02
Regge D.: SS 5.03, SS 5.04, SS 10.08
Reinhard R.: SS 2.10
Reiser M.: SS 4.10
Reitsma R.: SS 7.05
Rengo M.: SS 5.08, SS 10.03





Ridereau-Zins C.: SS 15.05
Riedl R.: SS 3.03, SS 8.05
Righi M.: SS 12.05
Rimola J.: SS 16.09
Rivera R.: SS 16.01
Rodolfino E.: SS 17.04
Rodríguez S.: SS 16.09
Roiati S.: SS 2.02
Rollandi G.: SS 4.08
Romanini L.: SS 6.08
Ross S.: SS 6.05
Roth H.: SS 10.04
Rothe J.: SS 7.04, SS 14.04
Rotondo A.: SS 8.06
Rouanet P.: SS 8.03, SS 8.08
Ruder T.: SS 6.05, SS 12.01
Rusch O.: SS 13.02
Rutten I.: SS 8.05, SS 15.08
S
Sabatino F.: SS 1.05, SS 3.09, SS 7.08
Sacco R.: SS 11.06
Sahani D.: SS 13.04, SS 13.06
Sahlein D.: SS 16.01
Salemi S.: SS 11.10, SS 14.07
Sallustio G.: SS 2.02, SS 14.02
Salvaggio G.: SS 1.10
Salzberger B.: SS 6.02
Sano K.: SS 2.06
Sansone M.: SS 8.06
Sansoni I.: SS 3.05, SS 4.01, SS 16.04, 
SS 16.08
Santiago I.: SS 14.01
Santinelli S.: SS 1.04
Scandiffio R.: SS 10.02
Scardapane A.: SS 4.04, SS 17.06
Schill G.: SS 13.01, SS 16.03
Schimetta W.: SS 5.01
Schindera S.: SS 12.01, SS 13.02, SS 14.10
Schlemmer M.: SS 4.10
Schmid-Tannwald C.: SS 12.07, SS 17.07
Schmidt B.: SS 12.01, SS 13.02
Schmidt J.: SS 14.10
Schmidt S.: SS 17.10
Schnapauff D.: SS 7.04
Schrading S.: SS 17.09
Schramm N.: SS 4.10
Schreyer A.: SS 13.01, SS 16.03
Schwarzwaelder C.: SS 14.10
Segnan N.: SS 5.03, SS 5.04, SS 10.08
Sellier N.: SS 11.02
Semelka R.: SS 2.03
Senore C.: SS 5.03, SS 5.04, SS 10.08
Seror O.: SS 11.02
Sethi I.: SS 12.07
Sethi R.: SS 15.04
Setola S.: SS 4.09
Shanahan F.: SS 13.03, SS 13.05
Sherman D.: SS 2.05, SS 2.07
Shin S.: SS 7.07
Shorvon P.: SS 2.05, SS 2.07
Sibileau E.: SS 15.05
Simcock I.: SS 3.02, SS 3.04, SS 3.10
Sinkus R.: SS 2.04, SS 12.06, SS 12.09
Siripongsakun S.: SS 15.03
Slabu I.: SS 17.09
Slooter G.: SS 5.10
Smith S.: SS 10.05
Sommer C.: SS 14.10
Sou H.: SS 2.06
Spieler B.: SS 16.01
Spijkerboer A.: SS 16.10
Stabile Ianora A.: SS 4.04, SS 17.06
Stagnitti A.: SS 5.05
Staltari I.: SS 8.10
Stampfl U.: SS 14.10
Stankovic Z.: SS 13.10
Stedman B.: SS 11.01
Stefanidis K.: SS 6.04
Steffen I.: SS 7.04
Stelter L.: SS 7.04, SS 14.04
Steward M.: SS 16.06
Steyerberg E.: SS 10.07
Stiller W.: SS 14.10
Stirling J.: SS 3.02, SS 3.04, SS 3.10, 
SS 16.11
Stoker J.: SS 6.06, SS 6.07, SS 10.06,  
SS 10.07, SS 10.09, SS 15.02, SS 16.10
Stokkers P.: SS 16.10
Stoop E.: SS 10.06, SS 10.07, SS 10.09
Stroszczynski C.: SS 6.02, SS 13.01,  
SS 16.03
Summers P.: SS 8.02
Szucs-Farkas Z.: SS 12.01, SS 13.02, 
SS 16.07
T
Taibbi A.: SS 1.07, SS 1.09, SS 12.03
Tam E.: SS 16.11
Tang A.: SS 14.09
Tartaro A.: SS 1.05, SS 3.09, SS 7.08
Tavernaraki E.: SS 6.04
Taylor N.: SS 3.02, SS 3.04, SS 16.11
Taylor S.: SS 5.07, SS 5.09, SS 10.04, 
SS 10.05, SS 15.01, SS 16.06
Thabet A.: SS 13.04, SS 13.06
Thali M.: SS 6.05
Thieme M.: SS 6.06, SS 6.07
Thomeer M.: SS 10.06, SS 10.07, SS 10.09
Thomopoulos K.: SS 13.09
Thywissen T.: SS 3.03
Tiferes D.: SS 10.01
Togni S.: SS 12.05
Torricelli P.: SS 6.03, SS 12.05
Tortorici L.: SS 1.09, SS 12.03
Train M.: SS 5.02
Triantopoulou C.: SS 17.05
Triantos C.: SS 13.09
Trinchet J.: SS 11.02
Tserotas P.: SS 6.04
Tufaner O.: SS 12.08
Turini F.: SS 11.04, SS 11.06
Tutuian R.: SS 16.07
U
Umutlu L.: SS 7.09
V
Vagli P.: SS 10.02
Valette P.: SS 15.05
Van Ballegooijen M.: SS 10.07, SS 10.09
Van Beers B.: SS 2.04, SS 12.06, SS 12.09
Van Dam L.: SS 10.07
Van Dam R.: SS 8.07
Van den Esschert J.: SS 7.05
Van der Molen A.: SS 17.05
Van der Paardt M.: SS 15.02
Van der Veer S.: SS 1.08
Van de Vijver M.: SS 10.09
Van Drogenbroeck T.: SS 6.10
Van Es A.: SS 17.05
Van Gulik T.: SS 7.05
Van Leerdam M.: SS 10.06, SS 10.07, 
SS 10.09
Vecchietti F.: SS 5.08
Ventriglia A.: SS 9.04
Verheij J.: SS 1.08
Verhoef C.: SS 1.08
Verhulst M.: SS 5.10
Vidas N.: SS 11.08
Vierasu O.: SS 9.01
Vilgrain V.: SS 2.04, SS 12.06, SS 12.09
Viotti S.: SS 8.02
Vock P.: SS 12.01, SS 13.02
Vogl T.: SS 11.05
Volker T.: SS 15.07
Von Wagner C.: SS 10.05
W
Wagner M.: SS 12.06, SS 12.09
Wardle J.: SS 10.05
Weiser M.: SS 3.01
Weitz J.: SS 14.10
Wendon J.: SS 11.08
Wiarda B.: SS 6.06, SS 6.07
Wibmer A.: SS 11.09, SS 14.06
Wiedemann B.: SS 9.08, SS 15.07
Willemssen F.: SS 1.08, SS 2.10
Witjes C.: SS 1.08
Woosley J.: SS 2.03
Y
Yacoub J.: SS 17.07
Yapici O.: SS 12.08
Yung Nio C.: SS 7.05, SS 10.09
Z
Zadeh Z.: SS 13.10
Zafiraki Z.: SS 6.04
Zamboni G.: SS 1.01, SS 9.03, SS 9.07
Zampakis P.: SS 13.09
Zapata, E.: SS 2.01
Ziech M.: SS 16.10
Zijta F.: SS 15.02
Zoephel K.: SS 9.08, SS 15.07
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